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ABSTRACT
A COMPREHENSIVE VALIDATION OF ACTIVITY TRACKERS FOR
ESTIMATING PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOR IN
FREE-LIVING SETTINGS
SEPTEMBER 2017
ALBERT R. MENDOZA, B.S., SAN FRANCISCO STATE UNIVERSITY
M.S., SAN FRANCISCO STATE UNIVERSITY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Patty S. Freedson

The aim of study one of this dissertation was to compare consumer activity
trackers (ATs) with the research-grade ActiGraph™ GT3X-BT accelerometer (AG) in
estimating energy expenditure (EE) and steps during orbital shaking at different
frequencies. To address this aim, we utilized an electronic orbital shaking protocol
(twenty-four, 3-minute trials; 2-hour trials). For all comparisons, the AG served as the
reference measure. In the 3-min protocol, we showed that on average, the NL-1000
pedometer (NL) produced the lowest error (-9 steps/3-min) at 0.9 Hz (corresponding to
moderate intensity). The magnitude of the error for the NL was 14 steps/3-min at a 3.0
Hz frequency (corresponding to very vigorous intensity). For the 2-hr protocol, estimates
from all others were equivocal, with some overestimating steps (bias range: 1,331
steps/2-hrs for the Misfit Shine to 1,921 steps/2-hrs for the Misfit Flash [MFF]). For
estimated EE bias ranged from26.6 kcals/2-hrs for the MFF to 45.8 kcals/2-hrs for the
Misfit Shine. For other ATs, steps were underestimated (bias range: -5,770 steps/2-hrs
for the Garmin Vivofit [GV] to -570 steps/2-hrs for the NL). For EE, the bias ranged
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from -436.8 kcals/2-hrs for the GV to -261.7 kcals/2-hrs for the Fitbit Flex [FBF]). This
study provides evidence about the differences in prediction algorithms by device across a
broad range of oscillation frequencies that corresponded to different PA intensity levels.
For study two, we sought determine the accuracy and precision of activity
trackers (ATs) in estimating steps, EE, activity minutes and sedentary time compared to
direct observation (DO)-derived measures (criterion measures) in free-living settings.
We also validated commonly used research-grade devices (e.g. hip-worn AG (AGhip),
wrist-worn AG (AGwrist). Thirty-two healthy men and women (50% female, 37.5%
minority; mean ± SD: Age = 32.3 ± 13.3 years; BMI = 24.4 ± 3.3 kg·m-2) were directly
observed while completing three, 2-hour visits on different days while wearing ten ATs,
three research-grade devices and a biometric shirt. A validated DO system was used to
derive criterion measures for activity and sedentary time (ST) outcomes. ATs were
accurate with varying precision in estimating physical activity (PA) behaviors in freeliving settings. Additionally, ATs and research-grade accelerometers performed similarly
(e.g. more accurate in estimating steps and less accurate in estimating moderate-tovigorous PA [MVPA] minutes). For all devices, step estimates were accurate and
strongly correlated (r range: 0.91 for the Apple iWatch to 0.97 for the AGhip) with
criterion measures but EE and MVPA estimates were less accurate and more variable
(EE: r = 0.32 [GV] to r = 0.85 [AGhip]; MVPA: r = 0.2 [NL] to r = 0.75 [AGhip]). For
ATs, estimates of sedentary time were the least accurate and weakly correlated (r=0.06
Fitbit One [FBO] and FBF) with criterion measures derived from DO. Implications from
this study are that consumers and the research community using ATs such as Fitbit (FB)
to track steps can be confident in estimating steps but less confident in estimating
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sedentary time. This study advances our understanding of the performance
characteristics of ATs in free-living natural settings using a validated DO method to
derive PA and ST measures. This work significantly advances the field of activity
monitor validation that should set the standard for future work.
The aims of study three were: 1) to examine the ability of ATs to detect change in
PA and ST in free-living settings and 2) to examine the ability of research-grade
accelerometers to detect change in PA and ST in free-living settings. To address these
aims, we used an innovative approach to analyze data from study two. We defined
change as a visit-to-visit difference that was greater than the within-subject standard
deviation of the criterion measure (estimated by a linear-mixed model). Confusion
matrices were used to examine percent agreement between DO visit-to-visit change and
device visit-to-visit change. Key findings were focused on the widely used FBO and
FBF and research-grade devices. We showed that, there was similar agreement between
the hip-worn FBO and FBF with AGhip and AGwrist in estimates of change in steps
(89.1% FBO, 88.8% FBF and 88.3% AGwrist, 91.4% AGhip correct classification), EE
(73.4% FBO, 70.6% FBF and 77.0% AGhip correct classification) and MVPA minutes
(accept FBF) (79.7% FBO, 65.2% FBF and 71.2% AGwrist, 77.0% AGhip correct
classification) with criterion measured change. However, change in ST was more
difficult to detect for the FB and AGhip (46.8% FBO, 42.3% FBF, 53.1% AGhip and
72.7% AGwrist correct classification). This novel study provides evidence that as an
alternative to research-grade accelerometers, researchers may employ FB to measure step
accumulation pre- and post-intervention and have a satisfactory level of confidence in FB
change detection.
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This work significantly advances the field of activity monitor validation research
and informs intervention practices that should set the standard for future work. This body
of work provides the first comprehensive validation of ATs from highly controlled orbital
shaker testing to directly-observed free-living settings. This translational research which
has broad applications for using ATs for surveillance and intervention research and by
the consumer.
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CHAPTER 1
INTRODUCTION
Statement of the Problem
Lack of physical activity (PA) is strongly implicated in virtually all leading causes
of chronic disease morbidity and mortality. To attenuate the prevalence of these
preventable chronic diseases and promote health benefits, the U.S. Government
recommends that Americans engage in at least 150 minutes of moderate PA per week, 1
increase daily expenditure approximately 150 kilocalories (kcals) per day (equivalent to
about 1,000 kilocalories/week) 2 and/or accumulate at least 10,000 steps/day. 3
Additionally, sedentary behavior (SB) recommendations from Australia state that adults
should minimize the amount of time spent in prolonged sitting and break up long periods
of sitting. 4 Dissemination of these recommendations has led to a heightened awareness
of the importance of PA monitoring as a strategy for chronic disease management. Tools
such as wearable devices to track personal PA provide a mechanism to be more informed
about activity behavior. As a result, consumer devices that track PA behavior are
increasingly popular for researchers, the general public, and developers and
manufacturers of activity trackers (ATs).
According to a recent report, the global wearable technology market will grow
from over $30 billion in 2016 and should reach over $150 billion in 2026. 5 Activity
trackers such as, the Fitbit (Fitbit Inc., San Francisco, CA) provide estimates of activity
minutes, sedentary time (sitting), energy expenditure (EE) and steps. According to a
recent report, Fitbit remained the leading brand in ATs in 2015, accounting for 79 percent
of sales. 6 This expanding market for ATs is driven in part by lower cost, longer battery

1

life, more memory (e.g. to store data for days or weeks. However, growth of the market
and advances in consumer device technology far outpace our knowledge about the
validity of such devices. This gap is of major concern since it is not clear if these devices
provide accurate information. Therefore, to address this problem, it is essential to
improve our understanding of the accuracy and precision of the activity output measures
of consumer devices.
Our group 7-9 and several other research teams 10-14 have conducted research to
improve our understanding of the accuracy and precision of research-grade activity
monitors to estimate PA intensity (e.g. minutes of moderate-to-vigorous physical activity
[MVPA]) and activity EE. The vast majority of this validation work has been performed
in laboratory settings where specific activities are performed over pre-determined and
fixed time intervals where EE is measured with portable metabolic measurement
equipment. 7,9,15 This calibration work on research-quality activity monitors uses signals
from the monitors to generate simple (e.g. linear regression) to complex (e.g. machine
learning) algorithms to estimate activity intensity, activity type, and EE that are freely
available to apply to data collected with these research-quality devices. In contrast, the
consumer monitors use proprietary algorithms that provide users with estimates of steps,
EE, activity minutes, sedentary time, and other related measures. The accuracy and
precision of the AT output (e.g. steps, PA EE, minutes of activity) in free-living settings,
is not well understood.
To date, most AT validation studies have been performed under controlled
laboratory conditions. This is a reasonable first step, but to truly understand the accuracy
and precision of consumer ATs, validation studies must be performed in free-living
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settings while people are engaged in natural behaviors. In addition, ATs are often
implemented to monitor improvements in PA behaviors, thus, exploring and
understanding the accuracy of ATs in detecting change in PA and ST 16 is needed.
Four output variables have been studied in the investigations that have tested the
accuracy of ATs: number of steps, EE, activity minutes (moderate-to-vigorous activity),
achievement of PA recommendations and sedentary time. The results of these studies are
equivocal. Activity trackers under- or overestimate these measures with substantial
between-subject variability.

For step counts, seven studies showed, ATs overestimated

steps in laboratory settings 17-23 and thirteen studies showed ATs underestimated steps. 1720,23-31

In free-living settings, four studies showed that ATs overestimated steps and lack

precision, 21,32-34 and two studies showed that ATs underestimated steps. 31,32 For EE, six
studies showed ATs overestimated kcals, 18,25,30,35-37 and 12 studies showed that ATs
underestimated kcals 18,24-27,30,35-40 with variable precision and are most accurate for
during locomotion and in lab-setting testing conditions 18,25-27,30,36,38,39 compared with
non-locomotive activities 18,26,35,36,38,40 and free-living settings. 31,32,37 For activity
minutes, one study reported, ATs overestimated MVPA in free-living settings, 32 and two
studies reported, ATs underestimated MVPA in free-living settings. 31,33 For sedentary
time, only one study has shown, ATs overestimated sedentary time and lack precision in
free-living settings. 41
Based on this evidence, we sought to expand our understanding of the accuracy
and precision of ATs in estimating steps, EE, activity minutes and sedentary time in freeliving settings using a validated direct observation (DO) system as the criterion
measure.42 Previous free-living studies employed accelerometers as a surrogate for gold-
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standard criterion measures (e.g. DO, doubly labeled water) to assess PA. 32-34,43-46
Limitations in using accelerometers as criterion measure to assess PA in free-living
settings include 1) the inability to validate compliance (e.g. wear-time, wear-location)
and 2) substantial variability in prediction equations used to convert accelerometer data
into meaningful PA outcomes (e.g. moderate intensity activity, metabolic equivalents
[METs]). 47-49 The use of DO as a criterion measure in free-living settings address these
limitations and will attenuate the sources of error inherent in previous free-living studies.
The evidence from this novel study will inform consumers, researchers, clinicians and
interventionists about the utility of ATs as intervention tools and potentially, assessment
tools for research. This dissertation addressed three knowledge gaps in assessing activity
tracker performance. The first study addressed differences in ATs outputs compared to
research-grade accelerometers in a tightly controlled environment. The second study
validated consumer and research-grade activity monitors in estimating PA and ST
compared to criterion measured PA and ST in free-living settings. The third study
examined the ability of ATs to detect change in PA and ST in free-living settings. We
also examined this question for commonly used research-grade devices.
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Aims of Dissertation Studies
Study One: A Comparison of Consumer Activity Tracker Accelerometer Output
and a Research-Grade Accelerometer Output During Orbital Shaking
The ActiGraph (AG)(ActiGraph, LLC, Pensacola, FL) accelerometer provides an
objective estimate of human PA and is used in many research and clinical applications. 5052

Standardized electronic validation and reliability testing of the AG have been

performed on the GT3X+, GT3X, GT1M, 7164 and 71256 models. In these studies,
electronic devices such as wheels, 53,54 a table, 55 and orbital shaking 56-58 were employed
in controlled laboratory settings. In general, ActiGraph accelerometers are valid and
reliable during electronic oscillation testing. Validity and reliability are improved with
the low frequency extension filter at lower frequency oscillations (e.g. ≤ 0.6 Hz) and
plateau beyond its bandpass filter limit of 2.5 Hz. 54,56,59-61
The benefits of electronic orbital shaker testing are that it allows us to: (1) expose
activity trackers (ATs) to different oscillation frequencies to simulate different movement
intensities and (2) vary oscillation frequencies to simulate variation in free-living whole
body acceleration. Orbital shaker testing removes human variation. As a result, observed
differences would be due to technological features of the devices – not impacted by
human variation. The electronic orbital shaker informed us of how ATs perform under
highly controlled conditions.
Recently, our lab employed an electronic orbital shaker to assess the validity of
several consumer ATs compared to the AG GT3X+ accelerometer (unpublished
observations). 62 We found that AT output was highly correlated with oscillation
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frequency (r range: 0.92 to 0.99). Activity trackers output variables increased as
oscillation frequency increased (p range: < 0.001 to 0.04).
The objective of this study was to examine estimates of EE and steps from
commercially available consumer ATs, compared to the research-grade GT3X-BT
accelerometer using an electronic orbital shaker as the standardized motion detector.
Therefore, the first dissertation study addressed the limitations in the current
literature by exposing ATs to known frequencies and durations and comparing their
output to research-grade accelerometer output.
1. Specific Aim: To compare consumer ATs with the research-grade ActiGraph™
GT3X-BT (GT3X-BT) accelerometer in estimating energy expenditure (EE) and
steps during orbital shaking at different frequencies.
a. Hypothesis: Energy expenditure and step estimates from consumer ATs
will be similar to the EE and step estimates of the research grade GT3XBT accelerometer during standardized testing using an electronic orbital
shaker.
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Study Two: Validation of Consumer and Research-Grade Monitors in Free-Living
Settings
We evaluated the performance of consumer ATs in free-living settings using DO
as the criterion measure for steps, EE, MET-minutes and time spent in different
intensities of activity. 63-65 Our lab has validated DO in estimating PA and ST 42,65 using
indirect calorimetry as the criterion measure.
Several studies have validated ATs in free-living settings, however, none have
employed DO as the criterion measure for steps, EE, activity minutes or sedentary time.
Therefore, the aim of this study was to validate AT estimates of steps, PA and ST in freeliving settings compared to criterion measures.

2. Specific Aim: to determine the accuracy and precision of ATs in estimating steps,
EE, activity minutes and sedentary time compared to direct observation-derived
measures (criterion measures) in free-living settings. We also validated
commonly used research-grade devices.
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Study Three: Activity Trackers Sensitive to Change in Physical Activity and
Sedentary Behaviors in Free-Living Settings
Tools such as wearable devices to track personal physical activity (PA) provide a
mechanism to be more informed about activity behavior. Consumer devices that track PA
behavior are increasingly popular for consumers and for researchers, clinicians and of
interest to National Institutes of Health66 who recognize the value of using sensor-based
wearable monitors to assess PA behaviors. Currently, there are at least 149 active or
recruiting clinical trials funded by NIH that are employing consumer ATs to measure
(estimate) change in PA behaviors such as energy expenditure (EE) and/or steps. 67
The research and clinical communities have rapidly adapted ATs, however, their
utility within these communities has yet to be realized. Moreover, unlike research-grade
devices that have been utilized by the research and clinical communities in the past, ATs
have yet to undergo rigorous testing in both laboratory and free-living settings. In
particular, there is no evidence examining the effectiveness of ATs for detecting change
in PA behaviors in free-living settings. This knowledge gap is of major concern since
ATs are widely used to monitor change in PA behaviors. Therefore, the aim of this study
was to examine the ability of ATs to detect change in PA and ST in free-living settings.
We also examined this question with research-grade accelerometers.
From study 2, we calculated criterion measured and AT estimated visit-to-visit
change in steps, EE, activity minutes and sedentary time. The objective of this
exploratory study was to examine AT estimates of change in comparison to the criterion
measure estimates of change.

8

3. Specific Aim one: To examine the ability of ATs to detect change in PA and ST
in free-living settings.
4. Specific Aim two: To examine the ability of research-grade accelerometers to
detect change in PA and ST in free-living settings.
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Significance of Dissertation Studies
Americans suffer from preventable chronic diseases such as heart disease, stroke,
obesity and type 2 diabetes mellitus. 68 Current recommendations for PA and ST seek to
use positive changes in these behaviors to improve chronic disease morbidity and
mortality. These recommendations have led to increased public awareness of the
importance of engaging in daily PA and the negative consequences of not engaging in
daily PA. Tools such as, ATs to monitor PA behaviors are emerging as a valuable
mechanism to be more informed about PA and ST.
Technological advancements such as, improved battery life, affordability and
personalized feedback capabilities have helped lead the general public and researchers to
use ATs as a PA behavior measurement instrument. However, unlike previous
measurement instruments used by researchers, ATs have not been scrupulously tested for
the validity of the estimates they provide in the natural environment where they are used.
Several lab-based validation studies have been performed comparing activity tracker PA
estimates (e.g. EE) to criterion measured PA (e.g. indirect calorimetry). To our
knowledge, no studies validating activity tracker PA estimates compared to DO-criterion
measured PA in free-living settings have been performed.
In two recent projects, our lab successfully employed lab-based protocols to 1)
validate an AT in estimating EE compared to indirect calorimetry and 2) a DO system in
estimating PA and ST. We expanded and integrated these two protocols to include ten of
the most popular ATs currently on the market and compare their estimates of PA and ST
to DO measured PA and ST in free-living settings. This study setting and criterion
measure are superior to lab-based and comparison measures (e.g. accelerometer-based).
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We directly observed participants while wearing ATs in their natural environment, which
allowed us to capture and quantify PA, and ST where activity type and duration were not
regulated. We chose an ecologically valid study setting and criterion measures, which
advanced our understanding of AT performance under conditions in which they are used.
This information is beneficial to both the general public and research community.
Providing the evidence of the accuracy and precision of ATs in estimating PA and ST
improves the general public and researchers ability to make evidence-based decisions
regarding selection of devices for their specific needs. Activity tracker estimates of PA
and ST have been validated in free-living settings using research-grade accelerometers.
However, validating ATs employing DO as a criterion measure for PA and ST in freeliving settings is unexplored. A comprehensive understanding of activity tracker PA and
ST estimates and associated errors are important for the general public and researchers
seeking to understand the dose-response relationships between activity, ST and health.
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CHAPTER 2
REVIEW OF THE LITERATURE

Accurate measurement of physical activity (PA) and sedentary time (ST) is
important to improve our understanding of the dose-response relationship between these
lifestyle behaviors and risk of numerous chronic diseases. The U.S. relies on large-scale
surveillance studies (e.g. National Health and Nutrition Examination Survey [NHANES],
Women’ Health Study [WHS]) to quantify, analyze and interpret PA and ST. In part
these data are used to 1) inform the public, 2) update existing and/or design new public
health policies, 3) publish PA and ST statistics and recommendations, and 4) evaluate
trends in PA over time.
The NHANES and WHS began using accelerometers in 2003 69 and 2011, 70
respectively. For several decades accelerometers have been employed to objectively
measure PA and are currently the device of choice for researchers. Accelerometers have
been well received by the research community, as they are relatively low burden on
participants and researchers. Advancements in technology have led to increased memory
capacity, reduction in size of the devices, and improved filtering capabilities.
Advancements in software and firmware provide greater user autonomy (e.g.
initialization/download options) so that accelerometer sensors are easy to use in lab and
field-based settings.

Advancements in accelerometer sensor technology coupled with the lower costs
of accelerometer sensors led to the development and marketing of consumer-grade
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activity trackers (ATs). However, unlike research-grade accelerometers, ATs have yet to
undergo rigorous and comprehensive testing to understand the benefits and limitations of
the PA and ST estimates they produce. The evidence of ATs’ accuracy and precision in
estimating PA and ST is limited and there is no evidence about how well these consumer
devices detect activity changes in these behaviors. This knowledge gap is of major
concern since these devices are often used to monitor PA and ST improvements (i.e.
detect change). This review of the literature will describe the main areas of research that
were addressed in this dissertation. First, describing what is known about the accuracy
and precision in estimating ST and PA from research-grade accelerometers. Second,
describing and analyzing what is known about consumer ATs regarding accuracy and
precision. Lastly, presenting current knowledge of ATs and detection of change in PA
behaviors.

Study One: A Comparison of Consumer Activity Tracker Accelerometer Output
and a Research-Grade Accelerometer Output During Orbital Shaking
Calibration of Research-Grade Monitors
Since the early 1930s, accelerometers have been employed to assess PA
parameters such as gait 71 and whole body movement. 72-74 Originally, accelerometers
were used to estimate steps, 75 energy expenditure (EE) 76 and determining external
mechanical work during locomotion. 73 These and other initial studies demonstrated the
capacity of accelerometers to objectively estimate PA, giving rise to the first generation
(in the1980’s) of accelerometers, which were developed to estimate PA and EE.
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Laboratory Studies
Calibration and validation. Accelerometer calibration and validation studies have
been performed in laboratory and free-living settings. A strength of a laboratory setting is
that it allows easy replication of experimental protocols.
There are limitations to this method for testing accelerometers. Evaluating
accelerometers in estimating PA EE in a laboratory is scripted and structured in
comparison to PA behavior in free-living settings where behaviors are random, sporadic,
and variable. As a result, laboratory-based study results do not directly translate to study
results obtained from free-living settings. Unlike laboratory settings, free-living settings
allow researchers to capture and measure “real-world” PA behavior. Another strength is
enhanced generalizability over laboratory-based studies.

Unit Calibration of Wearable Accelerometers: Machine Testing.
Unit calibration of accelerometers is performed by comparing the direct
acceleration signals to a “gold standard.” Typically, this is accomplished by spinning the
accelerometer in an electronic oscillator with a known radius and frequency (RPM),
intra- and inter-unit variability and can be determined and also one can verify that values
are within the manufacturer's stated tolerance limits. 63
Several groups have calibrated accelerometers using electronic methods. In 1987,
Bassey et al.75 employed an electronic turntable to test the stability, range (e.g. threshold
accelerations) and reproducibility of the Yamasa Digiwalker when exposed to different
acceleration frequencies. They reported an acceleration threshold below which the
Digiwalker does not respond. Sensitivity increases linearly and rapidly (1-4 m/s) until
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reaching a plateau response. Next, Brage et al. (2003) 54 employed an electronic wheel to
examine the intra- and inter-instrument reliability; influence of movement frequency and
filtering on validity of the ActiGraph (AG) 7164 accelerometer when exposed to varying
radii (22.0, 35.5, 49.0 mm), oscillation frequencies (Range 0.5-4.0 Hz ) and oscillation
frequency increments (0.25 Hz and 0.125 Hz). They reported large relative variability at
very low and very high oscillation frequencies. Mean intra-instrument coefficient of
variation, which is a measure of variability, was 4.4% for all units in all trials. Excluding
two lowest frequencies, max intra-instrument coefficient of variation was 18%. Detection
of changes in oscillation frequencies varied between units, with larger errors at the lowest
oscillation frequencies, and for each frequency and across radius settings between unit
correlation coefficients ranged from 0.92-1.00. Lastly, in 2008, Rothney, M.P. et al. 56
employed an electronic oscillator to characterize dynamic responses and inter-monitor
and inter-generational variability of several AG accelerometer models (7164, 71256, and
GT1M) when exposed to varying radii at a constant frequency (150 rpm) and varying
frequencies with a fixed radius (46.6 mm). A linear relationship between counts and
radius for all measured values, all generations were significantly different from each
other at frequencies >160 rpm. For example, at the lowest frequencies the 7164 and
71256 responded similarly but GT1M required greater accelerations to detect changes,
suggesting differences in sensitivity or filtering approach used in different models.
From these studies, and others, 54,56,59-61 it can be concluded that these
accelerometers are valid and reliable based on electronic oscillation testing. Validity and
reliability are higher if a low frequency extension filter is used at lower frequency
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oscillations (e.g. ≤ 0.6 Hz) and does not continue to increase beyond its bandpass filter
limit of 2.5 Hz.

Value Calibration of Wearable Accelerometers: Human Studies
Value calibration of wearable accelerometers is described as converting
accelerometer signals into estimates of EE, time spent in various intensity categories,
and/or activity type while simultaneously collecting criterion data (e.g. indirect
calorimetry). 63 Several accelerometers have been developed and calibrated for research
on quantifying PA and EE. Examples include, the AG,77-81 Tritrac,82 Actical,78,83 and the
GENEA 55 accelerometers. Two laboratory based and two free-living setting calibration
studies laid the groundwork for subsequent accelerometer research, discovery and
development.
First, in 1983, Montoye et al. 76 examined if the waist-worn Caltrac accelerometer
and the Large-Scale Integrated Motor Activity Monitors, ‘LSI’ mounted at the waist and
wrist could estimate oxygen consumption during various activities, including locomotion.
It was reported that the standard error of estimate for the EE algorithm used in the Caltrac
was ± 6.6 ml/kg/min. Further, the reproducibility of the waist-worn Caltrac output during
locomotion and various activities was high (r=0.94). 76 These findings demonstrated the
ability of a waist-worn device to estimate EE during specific activities in a lab setting.
In a study of another accelerometer sensor, Freedson et al. 77 estimated PA
intensity categories and EE from treadmill walking and running. The criterion measure
was indirect calorimetry and the data revealed a linear relationship (r=0.88) between
counts per minute from the accelerometer and EE (METs). A linear regression model
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was developed to predict point estimates of EE. Accelerometer count cut-points were
also created to classify PA as light (< 3 METs), moderate (3-5.99 METs), vigorous (68.99 METs) and very vigorous ≤ 9 METs). Though this linear regression model was
built from only controlled treadmill walking and running, the simple regression remains a
primary tool to translate activity counts from an AG accelerometer into minutes of
activity in different absolute intensity levels and EE.
Laboratory based calibration studies were a good first step, but to advance this
knowledge base, accelerometers were also tested in free-living settings. Several freeliving accelerometer studies have been conducted and this review will highlight two
studies executed by Pfeiffer et al. 83 and Pate et al. 84 Both investigators sought to
calibrate and cross-validate accelerometers in estimating PA for use with 3-5 year old
children compared to indirect calorimetry (criterion). Both studies employed structured
and unstructured sedentary (e.g. sitting), locomotive (e.g. overgound brisk walk) and nonlocomotive (e.g. sports/play) activities while simultaneously collecting metabolic data.
Pfeiffer et al. employed a right hip-worn Actical accelerometer and Pate et al. employed a
right hip-worn AG 7164 accelerometer. It was reported that the Actical and AG counts
strongly correlated with the criterion EE (r=0.89 and r=0.82, respectively). Cut-points
for the Actical and AG were established for moderate intensity activity (20 mL/kg/min),
715 counts/15 seconds and 420 counts/15 seconds, respectively. Cut-points for vigorous
intensity activity (30 mL/kg/min), were 1411 counts/15 seconds and 842 counts/15
seconds for the Actical and AG, respectively. Cross-validation of structured to
unstructured activities revealed that both the Actical and AG 7164 accelerometers are
valid and appropriate tools for measuring PA in young children. These data demonstrate
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the ability of accelerometers to estimate PA energy expenditure over a broad range of
activities (e.g. sedentary to vigorous) in children, and underscores device-specific
differences in absolute count values even though the EE is the same.
Many other accelerometer calibration studies that included a variety of
sedentary/lifestyle activities, 8,78-80 locomotion 8,78,81,82,85 and/or sports, 8,78,85 have been
published. The evidence indicates that an accelerometer worn on the hip or wrist is a
good tool to estimate features about PA and EE in children and adults.

Algorithms to Quantify Physical Activity Behaviors
Originally, simple regression models to quantify PA intensity were constructed
using accelerometer counts to generate cut-points, such as, sedentary, moderate and
vigorous intensity using indirect calorimetry as the criterion measure of intensity.
77,52,78,84,86-91

This was an important first step, however, a single regression cannot

accurately estimate EE across a wide range of activities and intensities. 92 For example,
the Freedson model was derived from the count-EE relationship during treadmill walking
and running. Thus, this model may under- or over-estimate EE for non-locomotive
activities and/or free-living PA. In 2000, Hendelman et al.79 applied a linear regression
model developed from locomotion activities to a data set of locomotive and nonlocomotive activities yielded a modest relationship between hip monitor counts and EE of
r = 0.59. These results led researchers to include non-locomotion activities in model
development 49,80,93,94 and use of additional accelerometers positioned at various wearlocations. 80,95-97 In general, the addition of output from several wear locations (e.g. hipand wrist worn accelerometer) into models improved EE estimations. A two-regression
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model using the standard deviation of counts/min to identify the appropriate regression
model to predict EE from accelerometers have also been developed. 98-101

These

methods improved EE estimates across a wider range of activity types and intensities and
led to advanced techniques (e.g. pattern recognition) for conducting accelerometer value
calibration. Employing machine-learning pattern recognition techniques uses the activity
counts 94,102-104 or raw acceleration patterns 13,105 within the accelerometer signal to
estimate activity type and intensity. Signal features (e.g. time- and frequency-domain) are
used to predict PA measures. For example, Staudenmayer et al. 9 developed pattern
recognition methods to estimate PA energy expenditure and activity type during a wide
range of activity intensities and activity types in a lab-based setting using the AG 7164.
They reported that a neural network pattern recognition prediction of METs root mean
squared error was 1.22 METs and correctly classified activity type 88.8% of the time.
This method was an improvement over previous methods for estimating EE and activity
type. Recently, Lyden et al. 102 broadened the scope of machine-learning by applying it
to a free-living setting. The Sojourn-1 Axis (soj-1x) and Sojourn-3 Axis (soj-3x) were
shown to be more accurate at estimates of MET-hours (soj-1x: % bias = 1.9 [-2.0 to 5.9],
root-mean-squared error (RMSE) = 1.0 [0.6 to 1.3]; soj-3x: % bias = 3.4 [0.0 to 6.7],
RMSE = 1.0 [0.6 to 1.5]) and activity minutes (soj-1x: % bias = 8.8 (sedentary), -18.5
(light), and -1.0 (MVPA); soj-3x: % bias = 0.5 (sedentary), -0.8 (light), and -1.0 (MVPA)
compared to previous methods. These and other studies employing pattern recognition/
machine-leaning techniques such as, Hidden Markov Methods, 106 artificial neural
networks (ANNs), 11-13,103,104,107 and support vector machines 108,109 are superior
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compared to simple linear regression modeling and offer the advantage of identifying
activity type in addition to activity intensity.
Study Two: Validation of Consumer and Research-Grade Activity Monitors in
Free-Living Settings
Validation of Research-Grade Monitors
The purpose of validating accelerometers against gold standard methods is to
evaluate the accuracy and precision in estimating the specific outcome(s) such as steps,
EE, activity intensity and activity type. Gold standard methods for EE include direct and
indirect calorimetry, doubly labeled water (DLW) and DO. Direct observation is also the
gold standard method for measuring steps. Validation studies of accelerometers are
device, population, protocol and outcome specific. For example, the AG GT3X+
accelerometer has been shown to be valid in estimating minutes spent in MVPA during
treadmill walking/running in a group of men and women ages 21 to 39 years may not be
valid for minutes of MVPA in free-living older adults.

Laboratory Studies
Validation studies date back to the early 1980s when Montoye et al.76 tested the
Caltrac accelerometer for estimating EE compared to indirect calorimetry in a laboratory
setting. In 1995, Melanson et al.97 conducted a validation study of the Computer Science
and Applications, Inc. (CSA) accelerometer in assessing PA during treadmill walking and
running at varying grades compared to indirect calorimetry. The CSAs were worn on the
hip, wrist and ankle. The most accurate prediction of EE was obtained when body mass
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and CSA ankle, hip, and wrist activity counts were used as predictors. This model
predicted mean EE within 1%, but had a relatively large SEE of 0.85 kcals per min
(11.4%). The CSA counts from any location were significantly correlated with EE
(r=0.77-0.89). The main findings of Montoye et al. and Melanson et al., were that on
average accelerometer(s), 1) estimated EE was highly correlated with speed and 2)
underestimated EE during graded treadmill exercise. These results were confirmed by
Nichols et al. 82 who validated the Tritrac accelerometer in estimating EE compared to
indirect calorimetery during treadmill walking and running. The Tritrac was found to be
highly correlated with speed (r=0.97, p<0.0001), the relationship between vector
magnitude and EE across all speeds (1.9, 3.9, and 6.0 mph) was highly linear (R2 = 0.90,
SEE = 0.014 kcal/kg/min), and underestimated EE at 5% grade (Mean difference at
6.4km/h=-0.0107 kcal/kg/min). These studies and others 52,110,111 supported that
generally, accelerometers correlated with criterion EE and activity type during
locomotion.
The relationship between EE and counts during non-locomotive activities such as
activities of daily living (ADLs) and cycling is less linear and more variable. For
example, during non-weight bearing exercise a waist-worn accelerometer underestimates
EE. Puyau et al. 86 employed a room calorimeter to validate accelerometers during
locomotion, sedentary behaviors, ADLs and sport. Dissociation between EE and
accelerometer counts was observed during weight lifting and stair climbing as well.
Hickey at al.112 compared step output from several different research-grade
accelerometers during ST, locomotion and ADLs compared to manually counted steps
(DO). The largest errors reported were during ADLs (mean difference range: -178 to 78
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steps/5-minutes) and the highest accuracy was during rhythmic/ anterior-posterior
movements (percent error range: 0.2 to 15.0%) compared to non-rhythmic movements
(percent error range: 6.5 to 78.0%). These and other lab-based studies, 113-116 showed that
in general during rhythmic locomotion accelerometers were valid in estimating EE and
activity type, and that the relationship between EE and accelerometer counts is influenced
by factors such as intensity and activity type.
Device Location
Device location influences estimates of PA and ST. There are differences in
output from hip and wrist locations depending on activity type and intensity and
environment (i.e. lab-based or free-living). Generally, hip-worn accelerometers
underestimate EE during non-weight bearing activities (e.g. cycling) and graded
locomotion (e.g. ascending stairs). The wrist-worn accelerometers tend to overestimate
EE during overground walking, some ADLs (e.g. vacuuming) and SB (e.g. computer
work). Trost el al.105 employed the AG GT3X+ to develop an activity recognition
algorithm and compared rates of activity classifiers trained on the raw triaxial
acceleration signal collected from accelerometers worn on the wrist and hip. They
reported that wrist-worn accelerometers misclassify upright, non-ambulatory activities
with significant arm movement (e.g. sweeping the floor) compared to hip-worn
accelerometers. Several other investigators also reported differences in hip and wrist
output. For example, McMinn et al.114 reported that both EE and steps were different
between the hip and wrist worn AG (GT3X+) accelerometer during self-selected
treadmill walking and running compared to indirect calorimetry and manually counted
steps. For example, the mean difference between GT3X+ steps for hip and wrist
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locations for the medium and fast walk were 2 and 7, and 1 and 14 steps, respectively.
The authors concluded that wrist-mounted device outputs were not comparable to waistmounted outputs. Mahar et al. 117 examined output from hip and wrist worn GT3X+ from
treadmill walking and running and 2-days of free-living time. They reported minutes of
moderate (hip: 46 ± 21 min; wrist 143 ± 51 min; r = .52) and vigorous (hip: 4 ± 6; wrist
16 ± 14 min; r = .83) PA were higher (p < .05) for the wrist worn than for the hip worn
monitors. Later, Hildebrand et al.118 found significantly higher output from wrist
monitors than hip observed for children and adults during treadmill and simulated freeliving activities.

Free-Living Studies
Validation studies of accelerometers in estimating EE and activity type in freeliving settings are integral to building a comprehensive knowledge base of accelerometer
accuracy and precision. Free-living accelerometer validation studies have relied upon
indirect calorimetry, DLW or DO as criterion measures for EE and each of these criterion
measures have its limitations. Limitations include 1) indirect calorimetry is expensive
and impedes numerous free-living activities, 2) DLW is expensive and only provides a
measure of total EE and 3) DO is highly dependent on observer training and requires
observer judgment of intensity. Because of these limitations, it is imperative that
researchers choose the appropriate criterion measure for validating wearable
accelerometers in free-living settings. For example, if quantification of MET-minutes of
activity is required, DLW is not the appropriate criterion measure. However, DLW has
been used extensively as a criterion measure of EE for validating wearable accelerometer
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estimates of EE in free-living settings. The DLW technique is an isotope-based method
that measures the EE of subjects based on the difference in enrichments of 2 isotopes:
hydrogen and oxygen. 119 In 1991, Heyman et al.120 validated the Caltrac activity
monitor compared to DLW in estimating EE in free-living young adult men over 10-days.
They found that though the total EE estimates from the Caltrac were strongly correlated
with DLW (r=0.87, p<0.05), it underestimated total EE by %22 (r=0.87, p<0.001).
These results were not surprising as all of the participants had full time sedentary jobs
and the Caltrac was worn on the waist. Thus, most upper body movements and
associated energy costs performed while seated could not be detected. In an effort to
capture upper body movement and more accurately estimate EE, devices such as the
Sensewear Armband (BodyMedia L.L.C., Pittsburgh, PA) have been designed to be worn
on the upper arm.
The Sensewear Armband is worn over the left tricep, and integrates motion data
from a triaxial accelerometer along with several other physiological sensors (heat flux,
skin temperature, and galvanic skin response). These data are applied to proprietary
algorithms to estimate EE. Free-living validation studies of the Sensewear Armband
compared to DLW have shown that in youth a total error 44 kcals/day and mean absolute
percent error (MAPE)=11.7%, 121 in adults a total error 22 kcals/day and MAPE=8.3%,122
and in older adults a total error -21.5 kcals/day and MAPE=8.0%.123 The MAPE is a
common metric used by researchers to allow for comparisons of error between monitors
and should be approached with caution, as the MAPE provides no information pertaining
to device bias or individual errors. Instead, the MAPE indicates the absolute, average
group error. These are only a few examples to illustrate the use of DLW as a criterion
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measure for EE in free-living settings, and though considered a “gold standard” many
limitations are noted. For example, the high cost of isotopes (e.g.18O) sum to about
$1,000 to 1,500 per subject and sophisticated equipment is required for analysis. More
importantly, the DLW method does not allow for quantification of minutes of MVPA, PA
bouts (i.e. ≥ 10 min) and steps. Of course, in science, the methods are driven by the
question(s) being asked. Thus, in some cases DLW should be the criterion measure of
choice, in other cases, alternative criterion measures such as DO should be the method of
choice.
Direct Observation
Direct observation as the criterion in free-living validation studies of
accelerometers in estimating PA energy expenditure date back to the mid 1980s. Klesges
et al.124 were the first to employ DO as a criterion measure to validate the Caltrac
accelerometer in free-living adults (N=50) and preschoolers (N=30). Another aim was to
compare the Caltrac to the then widely used, Large Scale Integrated Moving Activity
Counter (LSI). The LSI houses a ball of mercury with a mercury switch that registers an
internal counter when exposed to a 3% incline or decline. The Caltrac, uses a
piezoelectric accelerometer that measures vertical dynamic changes in accelerations and
converts them to voltages. Briefly, participants were observed for 1-hour using focal
sampling (10-seconds observed, 10-seconds record) and activity type (e.g. sitting,
walking, running) and intensity (e.g. minimal, moderate, extreme) were recorded. The
DO training included rigorous quality control and reliability assessments to insure that
the observational data were collected accurately. For example, a trained observer
designation required inter-rater correlations of at least r = 0.90. By the end of observer
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training period inter-rater reliability was 97%. For adults, it was reported that, on
average, the accelerometer was strongly correlated with DO for activity type (r=0.70,
p<0.001) and intensity (r=0.76, p<0.001) and with the LSI (r=0.83, p<0.001). For
preschoolers on average, the accelerometer was moderately correlated with DO for
activity type (r=0.39, p<0.05) and the LSI (r=0.42, p<0.001) but weakly correlated with
intensity (r=0.25). The inability of either device to estimate PA levels of preschoolers
was attributed in part to not adequately detecting and quantifying “short burst” activities.
These data provided the first evidence that the Caltrac accelerometer is a valid tool for
estimating activity levels in adults but not preschoolers in free-living settings.
Recently, Lyden et al. 42 were the first to validate DO as a criterion in estimating
PA and ST compared to indirect calorimetry. Briefly, participants were observed for
three, 2-hour sessions in the laboratory while engaging in sedentary (reading, writing,
computer use) and PA behaviors (walking, treadmill use, cycling) while simultaneously
collecting metabolic data. Though this was a laboratory setting, participants’ behaviors
were designed to resemble the free-living nature of behaviors. Behaviors (activities)
were observed and recorded by a trained researcher. A hand-held personal digital
assistant (PDA) with custom software (The Observer, Noldus Inc., Wageningen,
Netherlands) was used to record participant behavior (e.g. activity type and associated
MET value). They reported that DO accurately and precisely estimated MET-hours [%
bias (95% Cl) =-12.7% (-16.4, -7.3), ICC = 0.98], time in low intensity activity [% bias
(95% Cl) = 2.1% (1.1, 3.2), ICC = 1.00] and time in moderate to vigorous intensity
activity [% bias (95% Cl) -4.9% (-7.4, -2.5), ICC = 1.00]. This study provided the first
evidence to support the use of DO as a criterion for PA and ST in free-living settings.
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The same DO system validated by Lyden et al.42 was employed as the criterion in
several validation studies of accelerometers in free-living settings. First, Kozey et al.65
employed DO to validate the activPAL (AP; Physical Activity Technologies, Glasgow,
Scotland) and the AG (GT3X) in estimating ST in free-living settings. Participants were
observed for two (1, normal behavior; 1, less sitting) 6-hour sessions while wearing the
AP on mid-thigh of the right leg and the GT3X on the right hip. They noted that the
correlation between the AP and DO was R2 = 0.94, and the AG 100 counts per minute
threshold for sedentary and DO sedentary minutes was R2 = 0.39. Only the AP was able
to detect reductions in sitting time. The ActiGraph 150-counts-per-minute threshold
demonstrated the lowest bias (1.8%) of the ActiGraph cut-points. These data provided
the evidence that the activPAL is a valid tool for quantifying ST and detecting change in
ST in free-living settings. Next, Lyden et al.125 extended this work by using DO to
validate the AP and AG (GT3X) in estimating breaks from sedentary behaviors, absolute
number of breaks and break-rate in free-living settings. Participants were observed for
two, 10-hour conditions (1, normal daily activity; 1, reduced and intermittent sedentary
time). The AP produced valid estimates of all ST measures and was sensitive to changes
in break-rate between conditions (baseline: 5.1 [2.8 to 7.1] brks.sed-hr−1, treatment: 8.0
[5.8 to 10.2] brks.sed-hr−1). Additionally, the GT3X was not accurate in estimating
break-rate or absolute number of breaks and were not sensitive to changes between
conditions. These results further support the utility of expressing break-rate from
sedentary time as a metric specifically relevant to free-living behavior, and that the AP is
a valid tool for measuring ST in free-living environments. Lastly, Lyden et al.102
compared artificial neural network (ANN) techniques “sojourn methods” estimates of
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active and ST from a waist-worn GT3X to DO in free-living settings. As previously
discussed, both novel ANNs (soj-1x and soj-3x) improved the accuracy and precision in
estimating free-living MET-hours, sedentary time, and time spent in light-intensity
activity and MVPA compared to a previously developed 9 and validated 7 ANN method.
Further, the soj-3x was found to be the superior method for differentiating ST from lightintensity activity. Together, these studies 1) serve as the foundation that DO is a valid
criterion for estimating PA and sedentary time in free-living settings, and 2) further
support and underscore the utility of wearable accelerometers’ in estimating PA and
sedentary time in free-living settings.

Summary
Both unit machine oscillation calibration studies and several human studies have
shown that accelerometers are valid and reliable in estimating features of activity and SB.
53,55,57,75

In addition, the relationship between EE and counts per minute is not linear for a

wide range of activity types and intensities. As a result, a single regression model will
not sufficiently estimate EE and other measures of activity and ST. Also, accurate
detection of high intensity activity accelerometer signals plateau (~6.2 to 7.4 mph,
~10,000 counts per minute). 59,81 There is a rich set of signal features within the
accelerometer that is captured but not analyzed. The detailed features of the signal are
used with pattern recognition techniques for estimating PA energy expenditure and
activity type. These techniques improve estimates by utilizing more signal information,
such as time and or frequency domain features.
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The differences in output by monitor location is significant as large surveillance
studies have transitioned from hip-worn to wrist-worn accelerometers in an effort to
increase compliance. For example, the National Health and Nutrition Examination
Survey (NHANES) 2011-2014 data collection cycle has implemented a new protocol
where wrist-worn accelerometers are being used for objective assessment of PA. This
protocol was initiated based on evidence of increased adherence to monitor use 126 and
for the measurement of sleep. Unfortunately, compliance is increased at the expense of
data analysis. To date, there is no uniform decision from the PA community of how to
analyze the data. Recently, Staudenmayer et al. addressed this issue. Specifically, wristworn accelerometer data were used to build machine-learning and regression models that
estimated 1) MET-hours, 2) time in different activity intensity categories (light,
moderate, and vigorous), 3) the amount of time the wearer is sedentary or not, and 4) the
amount of time the wearer is locomoting or not. The wrist models estimated METs with
a RMSE of 1.21 METs, and classified: activity intensity 75% correct, sedentary time 96%
correct, and locomotion time 99% correct. These methods offer a validated technique
with which to analyze NHANES accelerometer data.
Over the past several decades significant advances have been made toward a
comprehensive understanding of the strengths and limitations accelerometers’ possess in
estimating PA and sedentary time. The advances in objective measurements of PA and
ST have provided a blueprint of how to 1) ask poignant scientific questions related to PA
and health, 2) design and execute meaningful accelerometer experiments, 3) develop
simple and complex methods to analyze accelerometer data, 4) identify limitations of
accelerometer data and suggest methods to for improvement, and 5) provide evidence of

29

the relationships of accelerometer-based activity and sedentary time estimates for
quantification of dose of exposures of these behaviors and health outcomes
Activity Trackers: Introduction
In contrast to research-grade accelerometers, ATs have largely bypassed rigorous,
scientific testing and proceeded directly to the consumer market.
Validation of four monitor output variables have been reported by studies that
have tested the accuracy of activity trackers: step counts, EE, activity minutes (analogous
to MVPA) and sedentary time. The following section of this literature review will
summarize the current state of the evidence regarding the validity of ATs in estimating
each of these output variables.
Producers of ATs have promoted self-monitoring PA and ST by providing output
to users that allow self-tracking and inform users about successful achievement of U.S.
PA recommendations and/or Australian SB recommendations. For example, Fitbit
provides output in “active minutes.” According to Fitbit, active minutes are defined by
activities at or above about 3 METs. To satisfy the Center for Disease Control's “10
minutes at a time is fine” concept, minutes are only awarded after 10 minutes of
continuous moderate-to-intense activity. 127 Given the importance and public awareness
of meeting PA and SB recommendations, steps, EE, activity minutes and sedentary time
are a critical metrics to provide users of wearable devices
Researchers are testing the relationship between AT output with criterion and/or
comparison measures and the accuracy of ATs in estimating steps, EE, activity minutes
and sedentary time compared to criterion/comparison measures. Preliminary results from
this body of research reveal moderate to strong relationships between AT estimates of
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steps, EE and activity minutes in both lab and free-living settings (range: r= .52 to .99).
However, many AT estimates of PA and ST lack accuracy and precision.
In this review, ATs will be identified by location of wear. For example, hip-worn
AT. Tables 1 and 2 summarize the results from AT validation studies. Activity trackers
with corresponding output and data extraction method and features are provided in Table
4 and Appendix E.
Validation of Activity Trackers
Laboratory Studies
Steps
In general, ATs are accurate and precise in step estimates during locomotion. Not
surprisingly, differences in step estimations between lab and free-living settings and, the
hip and the wrist location have been reported.
To date, thirteen studies have validated ATs in estimating steps in lab-based
settings. All but three of these studies employed DO as the criterion measure for steps.
From these studies, two protocol trends have emerged: simulated free-living and
locomotion only.
Simulated free-living. Simulated free-living protocols include long and short
durations engaged in varying activity types and intensities, either or both self-selected
and predetermined. A total of four studies have been published validating ATs in
estimating steps in lab settings. All have employed DO (step counting) as the criterion
measure for steps.
Chen et al. 20 validated wrist-worn ATs during locomotive and non-locomotive
(e.g. ADL’s) activities. They reported an absolute percent error (APE) ranging from
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1.5% to 9.6% during treadmill walking and running. In addition, accuracy was improved
at faster speeds (4.9 mph) for all the monitors (APE < 2.5%). Mean bias (±SD) for
locomotive activities ranged from -13.5 (±2) to -35.4 (±2.4) steps. For non-locomotive
activities, mean bias (±SD) ranged from 2.9 (±45.5) to -65.9 (±25.8) steps and significant
differences between dominant and non-dominant were also reported. Mammen et al. 17
validated hip-, pocket- and collar-worn ATs during overground walking (20 steps),
treadmill walking and running and while driving. They reported that all ATs estimated
steps within ±5%, only one AT (pedometer) detected steps while driving, and statistically
significant differences were found between the criterion and steps detected by two hipworn ATs (p<0.001, p<0.05) at 1.2 mph and by a hip-worn AT at 1.8 mph (p<0.05). All
ATs were accurate at normal walking speeds (2.7 and 3.7 mph). Nelson et al. 18
examined the accuracy of hip- and wrist-worn ATs in estimating steps for specific
activities and activity categories. Results showed that for the household activity
category, MAPE ranged from 54% to 79%. In contrast, for the ambulatory category,
MAPE ranged from 3% to 6%. For walking and jogging, hip- and wrist worn ATs
produced MAPEs of 2% to 3%, and 8% to 11%, respectively. For cycling, all ATs
displayed large MAPEs ranging from 70% to 93%.
Differences in AT step estimates during non-locomotive activities have also been
reported by Stackpool et al. 26 Employing a protocol that included self-selected walking
and running and sports. They found that during locomotion, ATs were accurate within
10% of total steps, and collectively they averaged 4% underestimation. During sport
activities, the errors in step counts were systematically less than the criterion measure,
ranging from 3-24%, and averaging 18%.
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In summary, on average, hip-worn ATs are more accurate and precise in
estimating steps as compared to wrist-worn ATs during simulated free-living
activities/behaviors. Especially during locomotion, hip-worn ATs produce errors that are
within 5% of criterion measured, which is within the generally acceptable range of less
than 5%. 128-131 As expected, this trend has been consistent throughout the literature.

Locomotion only. Twelve studies have validated ATs in estimating steps during
locomotion. Of these, nine have employed DO as the criterion for steps and three have
employed secondary measures as the step criterion. Regardless of which step criterion
was employed, findings from all studies are in agreement.
In general, ATs are accurate and precise in estimating steps during locomotion.
However, differences between hip- worn and wrist-worn ATs exist. Case et al. 29
evaluated the step count accuracy of hip- and wrist-worn ATs during treadmill walking at
3.0 mph for 500 and 1500 steps. Compared with DO, the relative difference in mean step
count ranged from −0.3% to 1.0% for hip-worn ATs, and −22.7% to −1.5% for wristworn ATs.

Storm et al. 22 tested the accuracy of hip- and wrist-worn ATs in estimating

steps during indoor and outdoor walking and descending and ascending stairs. They
reported step underestimations of -15±18 (MAPE=1.6±1) by hip-worn ATs and 253±156 (MAPE=24±14) by wrist-worn ATs. Several other groups have reported
similar findings from wrist-worn AT estimates during locomotion.

21,22,24,25,30,31

Diaz et al. 25 sought to validate hip- and wrist-worn ATs in estimating steps
during treadmill walking and jogging.

They found that the wrist-worn AT significantly

underestimated steps. Mean differences ranged from -26 to -3 steps. No significant
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differences in step estimates were observed between the hip-worn AT and the criterion.
Recently, Diaz et al. 30 employed the same treadmill protocol to validate hip-wrist- and
bra-worn ATs. They reported that the wrist-worn AT significantly underestimated steps
(mean bias: -11 steps) for all treadmill walking and running speeds (range: 1.9 to 5.2
mph), and produced large errors ranging from 16±28% to 2±6%. In contrast, percent
error for step estimates for the hip- and bra-worn ATs were ≤3% for all walking and
running speeds. In both studies, the step estimates from the hip-worn AT was more
accurate (e.g. mean difference range: -0.7 to 2.0 steps) and precise (e.g. mean percent
error = -0.8±2.0), as compared to the wrist-worn AT (e.g. mean difference range: -15.5 to
3.4 steps; mean percent error -4.0±15.2).
At slower walking speeds (e.g. ≤ 1.9 mph), hip-worn ATs have been shown to
produce relative errors as great as 40% with large variation. For example, Beevi et al. 28
evaluate the step count accuracy of hip-worn ATs during slow walking at 0.6, 1.2, and
1.8 mph. All ATs underestimated steps. Mean biases (±SD) ranged from -37.5 (±16.1)
to -52.0 (±26.6), and the error rate of all ATs decreased with the increase of speed.
These data provide evidence that in general: 1) hip-worn ATs are accurate and
precise in estimating steps during locomotion that is ≥ 1.9 mph 2) wrist-worn ATs
significantly underestimate steps during locomotion, 3) differences are market at slower
speeds (e.g. 3.0 mph), and 4) hip-worn ATs estimates of steps are more precise (less
variable) as compared to wrist-worn AT estimates of steps. ATs are less valid in
estimating steps is in free-living settings as compared to lab settings.
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Energy Expenditure
A total of twelve validation studies evaluating AT estimates of EE have been
performed using one either a room calorimeter or breath-by-breath metabolic
measurement systems as the criterion measure.
Criterion: room calorimetry. Two studies have evaluated AT estimates of EE
compared to room calorimeter. Both study protocols included locomotion, lifestyle
activities and ST; one included cycling. Dannecker et al. 40 tested the accuracy of a hipworn AT during 4-hours of data collection. Briefly, participants performed a series of
randomly assigned postures (e.g. sitting) and activities (e.g. treadmill walking) for 3hours. The last hour of data collection consisted of self-selected free-living activities.
They found that the hip-worn AT significantly underestimated EE by 143.2 kcal
compared criterion kcals. The large underestimation may have resulted from activities
with movement not detected by the hip-worn ATs such as cycling and computer work.
Recently, Murakami et al. 37 extended this idea to include more time in the room
calorimeter, more ATs and meals. They sought to validate ten ATs worn at various
locations including the wrist, waist and pocket in estimating EE over 24-hours. For this
study, participants completed a standardized protocol simulating normal daily life, which
included 3 meals, deskwork, watching TV, housework, treadmill walking, and sleeping.
Results showed that despite strong correlations with criterion measured kcals (rho range=
.71 to .93). Three wrist-worn ATs significantly underestimated kcals ranging from -278
to -249 kcals. A waist- and a pocket-worn AT significantly overestimated kcals by 175
and 205 kcals respectively.
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Criterion: indirect calorimetry. A total of ten studies have been published
validating ATs estimate of EE compared to indirect calorimetry. From these studies, two
protocol trends have emerged: simulated free-living and locomotion only.

Simulated free-living. Simulated free-living protocols include long and short
durations engaged in varying activity types and intensities, either or both self-selected
and predetermined. Lee et al. published the first large-scale (N=60) validation study of
ATs in 2014. 35 The purpose of this study was to examine the validity of EE estimates
from a variety of ATs (chest-, hip-and wrist-worn) under free-living conditions. To
simulate free-living conditions, the protocol consisted of 13 different activities and SBs
that were performed for 5-minutes each (3-minutes each for treadmill activities) for a
total of 69-minutes. Total EE estimated from the ATs was compared to criterion EE.
The results showed differences between ATs and AT location. The MAPEs for hip-worn
ATs were 10.1% and 10.4%, wrist-worn ATs ranged from 12.2% to 23.5% and 12.8% for
chest-worn ATs. Mean biases for hip-worn ATs were -26.0 and 13.2, wrist-worn ATs
ranged from -85.5 to -6.7 and

-23.1 kcals/69-minutes for chest-worn ATs. It was

concluded that the majority of the ATs yielded reasonably accurate estimates of EE
compared with the criterion values (i.e. within 10% – 15% error).
In 2016, Bai et al. 36 conducted a validation study of ATs during large time-blocks
of activities. For this study, participants performed semi-structured periods (25 minutes
each) of self-selected sedentary activity, aerobic exercise, and resistance exercise while
wearing several wrist monitors for a total of 80-minutes. Mean absolute percent error (all
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activities) ranged from 16.8% to 30.4%. Mean biases (SD) ranged from -72.4 (87.2) to
42.3 (55.1) kcals/80-minutes.
Three studies have validated ATs in estimating EE during simulated free-living
activities such as locomotion, sports, lifestyle and SBs. First, Sasaki et al. 38 validated a
hip-worn AT in estimating EE compared to criterion measured EE and found that the
mean bias across all activities was -4.5 ± 1.0 kcals/6-min. with 95% limits of agreement
(LOA) ranging from -25.2 to 15.8 kcals/6-min. Also, the hip-worn AT significantly
underestimated EE during household activities and graded locomotion. Differences in
estimates by activity were also reported by Nelson et al. 132 whom examined the accuracy
of hip- and wrist-worn ATs in estimating EE for specific activities and activity
categories. They reported that all ATs predicted EE within 8% of criterion measured EE
for sedentary activity but overestimated activity EE by 16%–40% during ambulatory
activity. Similar to the findings of Sasaki et al., all ATs significantly underestimated EE
for cycling by 37%– 59% (p=0.025–<0.001). Lastly, for all activity categories
(sedentary, household, and ambulatory), all ATs displayed high MAPE (>10% of
criterion) for EE estimation, ranging from 13% to 35%. In agreement with other studies,
overall EE estimates may be interpreted differently if analyzed by activity type.
Differences in hip-worn AT energy expenditure estimates during non-locomotive
activities have also been reported by Stackpool etl al. 26 The protocol included
locomotion and sports. They found that the hip-worn AT significantly underestimated EE
during non-locomotive activities and no significant differences in EE during locomotive
activities.
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These data provide evidence that in general: 1) hip-worn ATs significantly
underestimate EE during cycling, upper-body activities of daily living and inclined
locomotion, 2) wrist-worn ATs significantly overestimate EE during locomotion and
some sedentary activities, 3) differences are less striking if data are averaged across
activities, and 4) hip-worn ATs estimates of EE are more precise (less variable) as
compared to wrist-worn AT estimates of EE. Differences in AT estimates during
simulated free-living activities and ST extend to locomotion only.

Locomotion only. Five studies have validated ATs in estimating EE during
locomotion and the results are equivocal. For example, Diaz et al. 25 sought to validate
hip- and wrist-worn ATs in estimating EE during treadmill walking and jogging.

They

found that the wrist-worn AT significantly overestimated EE during moderate (3.0 mph)
and brisk (4.0 mph) walking by 52.4% and 33.3%, respectively. No significant
differences in EE estimates were observed between the hip-worn AT and the criterion.
Recently, Diaz et al. 30 employed the same treadmill protocol to validate hip-wrist- and
bra-worn ATs. They reported that the wrist-worn AT significantly overestimated EE for
all treadmill walking and running speeds (range: 1.9 to 5.2 mph), and produced large
errors ranging from to 24.5±28.0% to 83.4±45.2%. In contrast, the hip-worn AT
significantly underestimated EE during slow walking (1.9 mph) and the bra-worn AT
outperformed the wrist-worn AT; errors ranged from 9 to 19%. In both studies, the
estimates of EE from the hip-worn AT were more accurate (e.g. mean difference range: 0.8 to 0.4 kcals) and precise (e.g. mean percent error 5.15±0.97), as compared to the
wrist-worn AT (e.g. mean difference range: -0.2 to 2.6 kcals; mean percent error
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51.4±34.0). Different from these findings, Alsubheen et al. 24 validated a wrist-worn AT
in estimating EE during self-selected walking at varying grades (0, 5 and 10%). They
found that the wrist-worn AT significantly underestimated kcals by 29% (mean bias: 20.2 kcals) across all conditions. These findings were supported by Dondzila et al. 39 In
this study, participants walked and ran at speeds ranging from 3.0 to 6.0 mph. Results
showed that, the wrist-worn AT overestimated EE during walking (3.0 mph) and
significantly (p<0.05) underestimated EE, overall. Lastly, Noah et al. 27 validated a hipworn AT during flat and graded walking, running and stairs. They found that the hipworn AT significantly (p<0.001) underestimated EE during inclined walking and stairs
by an average of 40%. It was concluded that the hip-worn AT is valid for monitoring
overground EE.
These data provide evidence that in general: 1) hip-worn ATs significantly
underestimate EE during slow waling and inclined locomotion, 2) wrist-worn ATs
significantly overestimate EE during locomotion and significantly underestimate EE
during graded locomotion, 3) bra-worn ATs are less accurate and precise than hip-worn
ATs but outperform wrist-worn ATs, and 4) hip-worn ATs estimates of EE are more
precise (less variable) as compared to wrist-worn AT estimates of EE. Differences in
hip- and wrist-worn AT estimates of EE have also been reported in free-living
environments.
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Free-Living Studies
Steps
Seven studies have validated ATs in estimating steps in free-living settings and
the results are equivocal. All have employed research-grade accelerometers (i.e.
secondary measures) as the step comparison measure. Several studies have shown that in
free-living settings, wrist-worn ATs tend to significantly underestimate steps. 21,31,32
However, in cardiac patients significant step overestimations as great as 1,038 steps per
day have been reported. 43
The trend in significant underestimation is extended to hip-worn ATs as well.
However, the accuracy and precision of step estimates from hip-worn ATs is superior to
step estimates from wrist-worn ATs. Studies have reported mean absolute differences
ranging from 6.3% to 7.4% for hip-worn ATs compared to 8.1% to 25.6% for wrist-worn
ATs. 32 In contrast, studies have reported significant overestimation of steps from hipworn a ATs (e.g. 7,477 steps/d).34 Lastly, pocket-worn ATs show promise yet tend to
overestimate (not significantly) steps even when compared to the thigh-worn ActivPAL.
21

These data provide evidence that in general: 1) hip-worn ATs underestimate and
overestimate steps, 2) wrist-worn ATs underestimate and overestimate steps, and 3) hipworn ATs are more accurate and precise in estimating steps in free-living compared to
wrist-worn ATs.
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Energy Expenditure
Three studies have validated ATs in estimating EE in free-living settings, and
each differs in criterion measure and duration. One study employed DLW, a criterion
standard method for measuring total EE.
Murakami et al. 37 validated several ATs (hip-, wrist- and pocket-worn) in
estimating EE during 15-days of free-living time compared to DLW. They found that all
ATs underestimated total kcals. Mean biases ranged from -590.2 to -171.9 kcals/d (wristworn), -280.0 to -69.2 kcals/d (hip-worn) and -220.0 to -93.1 kcals/d (pocket-worn)
compared to DLW. It was concluded that most ATs do not produce a valid measure of
total EE. The authors speculated that underestimation might be due to periods of not
wearing the devices. Ferguson et al. 32 validated several ATs (hip- and wrist-worn) in
estimating EE compared to the BodyMedia SenseWear during 48-hours of free-living
time. Similar to previous findings, all ATs underestimated total kcals and the wrist-worn
ATs produced the greatest bias and least precision compared to hip-worn ATs. For total
kcals, mean biases ranged from -533 to -475 (hip-worn) and from -898 to -479 (wristworn). The mean absolute differences ranged from 11.6% to 16.1% (hip-worn) and from
to 15.6% to 28.8% (wrist-worn). It was concluded that hip-worn ATs outperformed
wrist-worn ATs in estimating total EE in free-living settings. Sushames et al. 31
examined the validity of a wrist-worn AT in estimating EE compared to the hip-worn AG
(GT3X+) accelerometer during an unspecified time (“several hours”) in free-living
settings. Data from the ActiGraph accelerometer were post-processed and EE was
estimated via a previously validated equation 52 in ActiLife. In contrast to findings in
previous free-living studies, the results showed that the wrist-worn AT recorded
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consistently higher estimated EE by 50% higher (808.1±282.9 kcals) compared to the AG
(GT3X+)(538.9±194.0 kcals), with a mean bias (95% CI) of 269.2 (182.6, 355.8) kcals.
Activity Minutes
To date, four studies have reported on ATs in estimating activity minutes (e.g.
active time), all were performed in free-living settings. In 2015, Gomersall et al. 33
compared active minutes from a hip-worn AT to a the hip-worn AG (GT3X-BT)
(standard using Troiano cut-points) during 14-days free-living time. The AT was found
to be strongly correlated rho=0.80 (0.73-0.85; p<0.01) with the GT3X-BT but
underestimated MVPA by 18±9 minutes per day. Underestimations of MVPA ranged
from -189 to -77 minutes per week, which may misclassify a person as not meeting PA
recommendations and negatively influence their health. Applying the Freedson 1998 cutpoints, 77 Ferguson et al. 32 reported only moderately-to-strong correlations of MVPA
(r=0.52-0.91) between ATs and the AG (GT3X+). This study compared several hip- and
wrist-worn ATs in estimating activity minutes to a hip-worn ActiGraph (standard
measure) during 48-hours of free-living time. They observed large median absolute
differences between the AT estimate of activity minutes and the ActiGraph ranging from
26% (wrist-worn) to 298% (hip-worn). For minutes of MVPA, mean biases ranged from
65.9 to 190.4 and -5.2 to 22.7 for hip- and wrist-worn ATs, respectively. Recently,
Sushames et al. 31 examined the validity of a wrist-worn AT in estimating MVPA
compared to the hip-worn GT3X+ during unspecified (“several hours”) free-living time.
Utilizing the Freedson 1998 cut-points, they found that the wrist-worn AT produced a
mean bias of -35.4 minutes of MVPA. Lastly, Alharbi et al. 43 compared minutes of
MVPA from a wrist-worn AT to a hip-worn GT3X-BT in cardiac rehabilitation patients
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during 4-days of free-living time. Significant correlations (r=.74) between the wrist-worn
AT and AG were found for MVPA. However, the wrist-worn AT significantly
overestimated MVPA by 10 minutes per day. It was further reported that the wrist-worn
AT had high sensitivity (1.00 CI: 91.96, 100) and lower specificity (0.67 CI: 9.43, 99.16)
in classifying participants who achieved ≥150 minutes of MVPA per week thereby
meeting the recommended PA guidelines using the ActiGraph as the ground truth
measure.
The results of these studies are equivocal. Two studies reported ATs
underestimated MVPA in free-living settings,31,33 one study reported ATs overestimated
MVPA in free-living settings, 43 and one study reported ATs underestimated and
overestimated MVPA in free-living settings. 32
Sedentary Time
One study has validated an AT (wrist-worn) in estimating sedentary time
compared to a hip-worn AG (GT3X+) during 14 days of free-living time. 41 The cutpoints used for sedentary time were <100 CPM 133 and MVPA ≥2020 CPM. 90 Longest
idle time from the AT was compared to ActiGraph estimates of longest sedentary bout.
The results showed that the validity of the wrist-worn AT measure of sedentary time
(“longest idle time”) was poor. The differences between the AT and GT3X+ estimates of
longest sedentary bout were biased, with larger differences when bouts were longer. The
limits of agreement were unbiased but wide (mean difference ±88 minutes), varying by
up to 150% of the mean estimate according to GT3X+. Though it did accurately classify
more than 80% of the sample days as active or inactive based on the 10,000 steps
criterion, days were frequently misclassified for meeting public health guidelines of 30
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minutes/day of MVPA. The use of an ActiGraph to estimate sedentary time may not be
the optimal secondary measurement. If fact, the authors recommended that future studies
should consider using the activPAL (PAL Technologies Ltd, Glasgow, UK) device, a
thigh-worn accelerometer/inclinometer that evaluates time spent sedentary based on
posture rather than the cut-point method. Recently, our group has shown that the thighworn activPAL is superior to the hip-worn GT3X+ in estimating sedentary time. 65
Clearly, more studies are needed to validate ATs in estimating sedentary time.

Major Findings and Next Steps
Four output variables have been studied in the investigations that have tested the
accuracy of ATs: number of steps, EE, to estimate calories, activity minutes (moderateto-vigorous activity), achievement of PA recommendations, EE, to estimate calories and
sedentary time. The results of these studies are equivocal. Activity trackers under- or
overestimate these measures with substantial between-subject variability.

For step

counts, seven studies showed, ATs overestimated steps in laboratory settings17-23 and
thirteen studies showed ATs underestimated steps.17-20,23-31 In free-living settings, four
studies showed that ATs overestimated steps and lack precision,21,32-34 and two studies
showed that ATs underestimated steps.31,32 For EE, six studies showed ATs
overestimated kcals,18,25,30,35-37 and 12 studies showed that ATs underestimated kcals
18,24-27,30,35-40

with variable precision and are most accurate for during locomotion and in

lab-setting testing conditions18,25-27,30,36,38,39 compared with non-locomotive activities
18,26,35,36,38,40

and free-living settings.31,32,37 For activity minutes, one study reported, ATs

overestimated MVPA in free-living settings,32 and two studies reported, ATs
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underestimated MVPA in free-living settings. 31,33 For sedentary time, only one study
has shown, ATs overestimated sedentary time and lack precision in free-living settings. 41

Based on this evidence, we sought to expand our understanding of the accuracy
and precision of ATs in estimating steps, EE, activity minutes and sedentary time in freeliving settings using a validated DO system as the criterion measure.42 Previous freeliving studies employed accelerometers as a surrogate for gold-standard criterion
measures (e.g. direct observation, DLW) to assess PA.32-34,43-46 Limitations in using
accelerometers as criterion measure to assess PA in free-living settings include 1) the
inability to validate compliance (e.g. wear-time, wear-location) and 2) substantial
variability in prediction equations used to convert accelerometer data into meaningful PA
outcomes (e.g. moderate intensity activity, METs). 47-49 The use of DO as a criterion
measure in free-living settings address these limitations and will attenuate the sources of
error inherent in previous free-living studies. The evidence from this novel study will
inform consumers, researchers, clinicians and interventionists about the utility of ATs as
intervention tools and potentially, assessment tools for research.

Study Three: Activity Trackers are Sensitive to Change in Physical Activity and
Sedentary Behaviors in Free-Living Settings
To date, no studies have investigated the ability of ATs to detect change in PA
behaviors in free-living settings. Activity trackers are becoming increasingly popular
with consumers, researchers and clinicians, and used as both PA exposures and PA
outcomes. Examining the capacity of ATs to detect change in free-living PA behaviors is
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an important next step to broadening our understanding of these devices. Examining
research-grade accelerometers’ in detecting change in PA behaviors in free-living settings
is of equal importance.
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LOC: TRD walking & running; Sports:
Resistance EX; and SB
Criterion: EE=IC
Results:
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• FB-Hip d
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Results: ⫗
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Table 1. Summary of current Fitbit (FB) validation studies
LOC, locomotion
DOM, dominant hand
SB, sedentary behavior
TRANS, transportation
TRD, treadmill
EX, exercise
FB, Fitbit
EE, energy expenditure
IC, indirect calorimetry
DLW, doubly-labeled water
2MWT, 2-minute walk test
BS, BodyMedia Sensewear armband
a, mean bias (95% Limits of Agreement)
b, mean step count (relative difference)
c, RMSE
d, mean difference (range)
e, mean (range)
f, % relative error
g, mean (SD)
h, median (SD)
i, mean absolute percent error (95% CI)
j, mean % error (SD)
RC, room calorimeter
AG, ActiGraph
MVPA, moderate-to-vigorous physical activity

-25

+5029 -1216

+455 -4165

+14971

SS, self-selected
TBI, traumatic brain injury
NLQS, neighborhood quality of life study
, hip-worn Fitbit
, wrist-worn Fitbit
, bra-worn Fitbit
, collar-worn Fitbit
, pocket-worn Fitbit
, ankle-worn device
* , special population
⫗ , includes devices in both validation study tables.
Note. All studies were conducted on healthy populations (except for studies denoted with an *) and were approximately 50% female
(except for studies denoted with an ♂= all male; ♀= all female).
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Research Study
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• MS-Pocket
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• EP-Wrist d
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• OC-Pocket d
N=30 (18-80 yr)
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cycle ergometer, Lifestyle: sweeping, dusting,
laundry, bedding, gardening, standing; SB
Criterion: EE=IC; Steps=DO
Results: ⫗
• JB-Wrist i
N=16 (28.87±2.65 yr)
LOC: SS: indoor & outdoor overground
walking
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shanks)
Results: ⫗
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• JB-Wrist
• NFB-Wrist i
• YDW-Waist i
• MS-Pocket i
• OM-Pocket i
• WP-Pocket i
N=19 (18-80 yr). Duration: 15-days
Criterion: EE=DLW
Results: ⫗
• WP-Wrist d
• JB-Wrist d
• GAR-Wrist d
• SL-Waist d
• PA-Waist d
• EP-Wrist d
• TAN-Pocket d
• MS-Wrist d
• OA-Waist d
• OC-Pocket d

Table 2. Summary of current activity tracker validation
studies; Fitbit excluded
LOC, locomotion
DOM, dominant hand
SB, sedentary behavior
TRANS, transportation
TRD, treadmill
EX, exercise
EE, energy expenditure

-25

+155 -1216

+550 -5968

+8275
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IC, indirect calorimetry
DLW, doubly-labeled water
BS, BodyMedia Sensewear armband
a, mean bias (95% Limits of Agreement)
b, mean step count (relative difference)
c, RMSE
d, mean difference (range)
e, mean (range)
f, % relative error
g, mean (SD)
h, median (SD)
i, mean absolute percent error (95%CI)
j, mean % error (SD)
GAR, Garmin
JB, Jawbone
JE, Jabra earbuds
NFB, Nike Fuel Band
MS, Misfit Shine
PA, Panasonic Actimarker
OC, Omron CaloriScan
OA, Omron Active Style Pro
EP, Epson Pulsense
SL, Suzuken Lifecorder
TAN, Tanita AM- 160
WP: Withings Pulse O2
OM, Omron pedometer
YDW, Yamax Digi-Walker
SSP, Striiv smart pedometer
DL, DirectLife
B1, Basis 1
RC, room calorimeter

AG, ActiGraph
MVPA, moderate-to-vigorous physical activity
PED, pedometer
, hip-worn device
, wrist-worn device
, pocket-worn device
, ankle-worn device
, ear-worn device
, chest-worn device
⫗ , includes devices in both validation study tables.
Note. All studies were conducted on healthy populations (except for studies denoted with an *) and were approximately 50%
female.
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CHAPTER 3
METHODS
Study One: A Comparison of Activity Tracker and ActiGraph™ GT3X-BT
Accelerometers in Estimating Energy Expenditure and Steps During Orbital
Shaking

Experimental Instrumentation and Procedures

Instrumentation
Research-grade accelerometer: Reference Standard. The ActiGraph (AG) GT3XBT (GT3X-BT) accelerometer (ActiGraph™ LLC, Pensacola, Florida) served as the
reference standard to which all ATs were compared. This device is a lightweight triaxial
PA monitor (4.6cm x 3.3cm x 1.5cm, 19g) that measures acceleration ranging from -8 to
+8 g’s. The accelerometer output can be sampled at rates ranging from 30 to 100 Hz and
is digitized by a twelve-bit analog-to-digital converter. The AG includes a micro-electromechanical system (MEMS) based accelerometer. The acceleration data are sampled by
a 12-bit analog to digital converter and stored in a raw, non-filtered/accumulated format
in g’s. These data are stored directly in non-volatile flash memory. Raw data are
collected at the selected sample rate (80 Hz for this study) and are post-processed in the
ActiLife software. Users generate files containing any desired combination of parametric
data (e.g. 1-sec epoch, 60-sec epoch) during the data processing step.
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Activity Trackers. Activity trackers were chosen based on the following two
criteria: (1) no known gravimeter within the device, and (2) researchers had at least two
of the device. The rationale for not containing a gravimeter was that the electronic orbital
oscillator does not apply vertical accelerations and as a result, a device that contains a
gravimeter would produce inaccurate output. The rationale for at least two devices was
to counterbalance each other in the electronic orbital oscillator. As a result, six different
ATs were studied: 1) Fitbit Flex (FBF), 2) Fitbit One (FBO), 3) Garmin® Vivofit (GV),
4) Misfit Flash (MFF), 5) Misfit Shine (MFS) and 6) New Lifestyles NL-1000 pedometer
(NL). See Appendix E for detailed specifications of each AT.

Electronic Orbital Shaker. The electronic orbital shaker (Advanced Orbital
Shaker, Model 10000-2; VRW International, Radnor, PA) (Figure 1) produces controlled
oscillations between 0.25 and 5.0 Hz. The electronic orbital shaker oscillates at various
radii between 1.27 and 5.7 cm. Four trays (51 x 10 x 10 cm) are mounted on the base
oscillating plate (60 x 60 cm) of the shaker. Each tray has four custom foam cushion slots
that securely held the GT3X-BTs and ATs in place to eliminate device movement during
electronic orbital shaking (Figure 2).
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Figure 1. Electronic Orbital Shaker.
Procedures
Electronic Orbital shaker. The electronic orbital shaker (Figure 2) was used to
perform motion testing. Two of each device were tested at the same time. All devices
were placed in the custom foam cushion slots with their vertical plane perpendicular to
the control panel of the electronic orbital shaker (figure 2).
The GT3X-BTs and ATs were oscillated for three: (1) twenty-four, 3-minute
trials, and (2) 2-hour trials. Each 3-minute trial consisted of one monitor oscillation
frequency increased from zero to 3.0 Hz in 0.1 Hz increments on a fixed radius 56,134 of
5.08 cm. The three 2-hour trials consisted of oscillation frequencies ranging from zero to
3.0 Hz., based on the American Time Use Survey, to simulate free-living whole body
acceleration (e.g. variation). These frequencies simulate hip rotation ranging from no
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movement (e.g. sleep) to ambulation at speeds ranging between 1.5 and 16 miles per
hour. 81

Control panel

Figure 2. Electronic orbital shaker with devices in custom foam cushioned slots

65

Oscillation duration
The total oscillation duration for a given range of frequencies (range: 0.0, 0.25 to
3.0 Hz) reflected the American Time Use Survey (ATUS) percentages of time spent in
selected activities (Figure 3), normalized for 2-hours (versus 24-hours) and conformed to
5-minute trials (e.g. 44.5-minutes to 45 minutes) (Figure 4). The ATUS describes the
amount of time people spend doing various activities, such as paid work, childcare,
volunteering, and socializing. According to the ATUS, in 2014, working people aged 25
to 54 years spent the majority of their weekdays sleeping (~32%) and working (~37%),
with leisure and sport activities comprising 10% of daily activities (Figure 3).135 Thus,
the 2-hour oscillation trials reflected the ATUS percentages of time spent in each activity,
normalized for 2-hours (versus 24-hours)(Figure 4). See table 3 for examples of
activities and associated MET values.

Time use on an average work day for employed
persons ages 25 to 54 with children
Caring for others
(1.2 hours)

Other
(1.6 hours)
Sleeping
(7.7 hours)

Eating and drinking
(1.0 hours)

Household activities
(1.0 hours)

Leisure and sports
(2.5 hours)
Working and
related activities
(8.9 hours)
NOTE: Data include employed persons on days they worked, ages 25 to 54, who lived in households with
children under 18. Data include non-holiday weekdays and are annual averages for 2014. Data include related
travel for each activity.
SOURCE: Bureau of Labor Statistics, American Time Use Survey

Figure 3. ATUS: Time use on an average workday for employed persons ages 25-54
in 2014
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Total time (minutes) spent in each
activity category at a given frequency

Figure 4. Time spent in each activity category at a given frequency (range: 0.0, 0.25
to 3.0 Hz) for 2-hour trials.
Oscillation frequencies
Oscillation frequency ranges for each activity category were established by
electronically oscillating six GT3X-BT accelerometers at 0.0 to 3.0 Hz in 0.1 Hz
increments. Each 0.1 Hz. increment was oscillated for 3-minutes and the second minute
of each trial was used to determine counts per minute at each frequency. Using the
second minute ensured that the desired frequency was met. Figure 5 displays how
oscillation frequency ranges were derived. Briefly, the GT3X-BT data were initialized to
collect data at 80 Hz., with the low frequency extension for oscillation frequencies <0.7
Hz., post processed using ActiLife software (v 6.1.3) and aggregated into VM counts per
minute. These data were scored in ActiLife using the Freedson VM3 cut-points. 52
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Lastly, the intensity categories and their associated frequencies were used to determine
electronic oscillation trial: frequency, intensity and total time. Table 3 illustrates,
performing household activities such as washing dishes produces MET values ranging
from 1.5 (light) to 2.9 (light), which corresponds to oscillation frequencies ranging from
0.5 to 0.7 Hz.
15000

Oscillation Frequency versus GT3X-BT Vector Magnitude (CPM)

GT3X-BT Mean VM (CPM)

Very Vigorous

10000

Vigorous

5000
Moderate

Light

0

Sedentary

0.0

0.5

1.0

1.5

Frequency (Hz)

2.0

2.5

3.0

Figure 5. Determination of oscillation frequency ranges
During each 3-minute and 2-hour trial devices were oscillated at various
frequencies to simulate different movement intensities. To simulate variation in freeliving whole body acceleration, variation of the shaker oscillation frequencies occurred
during testing (Table 3).
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Frequency

ActiGraph

Range

GT3X-BT

(Hz)

(VMCPM)

Intensity

METs

Compendium of Physical Activities

Category

Activity
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0.0 – 0.4

0 – 99

Sedentary

≤ 1.5

Inactivity

Sleeping; sitting quietly

0.5 – 0.7

100 – 2690

Light

1.5 – 2.9

Home Activity

Washing dishes; cooking

0.8 – 1.0

2691 – 6166

Moderate

3.0 – 5.9

Occupational

Farming, feeding cattle; massage
therapist

1.1 – 1.3

6167 – 9642

Vigorous

6.0 – 8.9

Walking

Hiking, cross country; carrying load
upstairs, general

1.4 – 3.0

≥ 9643

Very
Vigorous

≥ 9.0

Sport

Track and field (e.g., steeplechase,
hurdles)

Table 3. Electronic orbital shaker frequency ranges with corresponding: VMCPM, intensity categories, METs and activities
VMCPM, vector magnitude counts per minute, MET, metabolic equivalent

Data collection and processing. The GT3X-BTs were synced to the same laptop
as the ATs and initialized in advance of data collection (sampling rate of 80Hz). These
raw data were post processed into 1-second epochs/counts and steps via ActiLife v6.1.3
software.
Minute-by-minute EE (kcals) were estimated and summed for all 3-minute trials
and for each 2-hour trial using the prediction equation previously developed by our
group, 52 labeled the “Freedson VM3 (2011)” equation in the ActiLife software. The
Freedson VM3 equation:
Kcals/min= 0.001064×VM + 0.087512(BM) - 5.500229
Where,
VM = Vector Magnitude Combination (per minute) of all 3 axes
(√ [(Axis 1) 2+(Axis 2) 2+(Axis 3) 2])
BM = Body Mass in kg

Weight was standardized for the GT3X-BTs and ATs. The low frequency
extension (LFE) option was selected in the ActiLife software to detect lower amplitude
movements. The LFE option lowers the baseband of the filter cut-off, expanding the
bandwidth of the accumulated data. The LFE was selected to ensure acceleration
detection at slower oscillation frequencies (e.g. 0.7 Hz).

Activity Trackers
Pre-3-minute oscillation trials and 2-hour oscillation trial. Thirty-minutes prior to
the first 3-minute and the 2-hour oscillation trial, all ATs were initialized/synched using
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the same user profile (e.g. date of birth, gender, height and weight) and the same
computer used to initialize the GT3X-BTs. Next, the GT3X-BT and activity trackers
(FBF, FBO, MFF, MFS, GV and NL) were secured into their respective customized foam
cushion slots within each tray of the electronic orbital shaker (Figure 2). Two of each
device were tested in the electronic orbital shaker.
Immediately prior to each 3-minute oscillation trial and each 2-hour oscillation
trial, researchers retrieved all Misfit data via the Misfit app (iPhone 6s) and recorded
baseline energy EE and step values for the MFS and MFF, as neither device is equipped
with a real-time display. The NL pedometers were set at 0 steps. The values for EE and
steps from the Fitbit FBF, FBO and the GT3X-BT were retrieved and recorded pre-and
post each 3-minute oscillation trial and each 2-hour oscillation trial. The start and stop
time for each 3-minute oscillation trial and each 2-hour oscillation trial were
synchronized with the time of the same laptop used for initialization/synching and
downloading of all devices.
Data Processing and Statistical Evaluation
Data Processing
Following each 3-minute oscillation trial and each 2-hour oscillation trial total EE
and steps for the: 1) MFF and MFS were downloaded via bluetooth and retrieved via the
Misfit app (iPhone 6s), 2) FBF and FBO were synched/downloaded to the Fitbit
Dashboard via Bluetooth and retrieved from the Fitabase website (described below), and
3) GV were retrieved from the real-time display. Total steps for the NL pedometer were
retrieved from the real-time display. The GT3X-BT data were collected at 80 Hz, with
the low frequency extension for oscillation frequencies <0.7 Hz, post processed using
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ActiLife software (v 6.1.3) and aggregated into VM counts per minute. Total estimated
kcals for each 3-minute oscillation trial and each 2-hour oscillation trial were calculated
and summed employing the “Freedson VM3 (2011)” equation in Actilife (v 6.1.3). Total
steps from the GT3X-BT were obtained by summing: 1) each 3-minute oscillation trial,
and 2) each 2-hour oscillation trial.

Fitabase (Small Steps Labs, LLC. San Diego, Ca). All Fitbit data were exported
using Fitabase. Fitabase is a research platform that accesses data from Internet connected
consumer devices. Currently, Fitbit is the only consumer device company that utilizes
Fitabase. The advantage of using this platform to acquire Fitbit data is that it provides
minute-by-minute data for activity minutes (intensity), kcals, MET-minutes and steps in
comparison to the Fitbit software and Dashboard which only provide total activity
minutes (intensity), kcals and steps for the monitoring period.

Statistical evaluation
All data cleaning, processing and analysis were done using the open source R
statistical software package, version 3.3.3 (www.r-project.org) and computing language
R. 136

Data Analysis. Three-minute oscillation trial and two-hour oscillation trials.
Repeated measure random effects models were assessed main effects of device and
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frequency and the interaction of device x frequency on AT estimates of EE and steps
compared to GT3X-BT estimates of EE and steps. Significance level was set at α = .05.

Study Two: Validation Consumer and Research-Grade Activity Monitors in FreeLiving Settings

Sample Size and Power
Using data from a previous (free-living) study,42 we found a between subject
standard deviation of 0.17 METs and a within subject standard deviation of 1.46 METs.
The relatively larger within subject variability informed our decision to measure each
subject multiple times. A sample of 32 subjects yielded at least 80% power to detect
average MET differences of less than 0.45 METs per hour.

Recruitment, Eligibility
Thirty-two adults (16 females and 16 males) 18-59 years of age were recruited to
participate in this study. Thirty-two participants yielded 192 hours of free-living data.
Volunteers were from the Amherst, Massachusetts’s area and were recruited using flyers
and word of mouth. Volunteers were screened either in person (in the Physical Activity
and Health Laboratory (PAHL)) or over the phone (from the PAHL) and were
automatically excluded if they had any diagnosed cardiovascular, pulmonary, metabolic,
joint, or chronic diseases, or limitation(s) in locomotion. If volunteers were considered
eligible, they were invited to the PAHL for an informed consent visit.
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Experimental Instrumentation and Procedures
Participants were fitted with a variety of activity monitors that were worn on the
wrists, hips and ankle, and a biometric shirt. The devices included: (1) wrist-worn,
GT3X-BT (AGwrist), Apple iWatch Sport (AiW), Fitbit Flex (FBF), Garmin Vivofit
(GV), Microsoft Band (MB), Misfit Shine (MFS) and Polar Loop (PL); (2) hip-worn,
GT3X-BT (AGhip), Fitbit One (FBO), Misfit Flash (MFF), New Lifestyles NL-1000
(NL) and Withings Pulse (WP); (3) ankle-worn, StepWatch (SW); and (4) Hexoskin
Biometric shirt (HxSkin) (i.e. smart shirt).
The researchers video recorded participants for each of the 2-hr sessions while
participants performed normal activities. If private time was required (i.e. going to the
bathroom), we did not observe participants during these private time periods. At the end
of the 2-hr recording period, the researchers removed the activity monitors and the
participants removed the smart shirt.

Instrumentation
Research-grade accelerometer. The previously described, ActiGraph GT3X-BT
(GT3X-BT) Accelerometer (ActiGraph™ LLC, Pensacola, Florida).

StepWatch™ (mōdus™ health llc, Washington, DC) monitor. The StepWatch
monitor is worn at the ankle of the dominant leg. The StepWatch is a reliable 137 and
accepted criterion measure for steps in healthy adults. 138 The StepWatch is a research
and clinical tool for assessment of ambulatory function in free-living settings. It is an
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ankle- worn, microprocessor-controlled step counter, and detects steps for a wide variety
of normal and abnormal gait styles and cadences. Step counts can be recorded every 3 to
60 seconds. The StepWatch has been cleared by the US government FDA as a class II
device.
Activity Trackers. Nine different activity trackers were studied: 1) AiW, 2) FBF,
3) FBO, 3) GV, 4) MB, 5) MFF, 6) MFS, 7) PL, 8) WP and 9) NL. For the NL,
participants’ stride length was determined according to the manufacturers recommended
method and programmed into the device. 139 See Appendix E for detailed specifications
of each activity tracker.

Biometric Shirt. The market for emerging wearable categories including smart
clothing is rapidly developing. According to a recent report, smart clothing shipments
will grow from 140,000 units in 2013 to 10.2 million units by 2020. 140 The Hexoskin
Biometric Shirt (Hexoskin) (Carré Technologies Inc., Montréal, Québec, Canada) is
sustained, in large part, by its utility as a tool for the management of athletes’ health, 141
remote medical monitoring for long-term space missions and space exploration 142 and
objectively measuring clinical populations in research settings. 143

The Hexoskin is a multi-parameter physiological recording system designed to
monitor levels of physical activity and energy expenditure, which combines
measurements of cardiac, ventilator, and hip-motion intensity (Figure 6).
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Figure 6. Hexoskin output from one observation session
Video Recording. We employed a GoPro Hero+ LCD (GOPRO, Inc. San Mateo,
Ca) camera to record all observation sessions. The GoPro Hero+ LCD is a small,
lightweight, waterproof camera that is capable of recording video at 1080 pixels and up
to 70 frames per second. The GoPro app was used to password protect the GoPro Hero+
LCD camera via wifi. A 64 GB SanDisk micoSD™ memory card (SanDisk, Inc.
Milpitas, Ca) was used to store the GoPro Hero+ LCD video files.
Noldus (Information Technology B.V: Wageningen, Netherlands). The Noldus
Observer® XT is the software package for the collection, analysis, and presentation of
observational data (Noldus Information Technology B.V: Wageningen, Netherlands).
The Observer XT- Media Module was used in combination with The Observer XT®
Base. This module allows for the playback of one video and the creation of video
highlights (Figure 7).
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Figure 7. Noldus: The Observer XT
The Observer XT- External Data Module (software module to include
physiological or other external data) supports the import and synchronization of data
from a wide range of data acquisition systems. The system combines, synchronizes and
analyzes accelerometer signals (e.g. ActiGraph GT3X-BT accelerations) with the
behavioral data and video (Direct Observation). The Observer® XT has been developed
to enable advanced analysis of multimodal data in relation to observational data (Figure
8).
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Subject
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Figure 8. Screenshot from The Observer XT while following one subject
The Observer XT coding synched with imported GT3X-BT accelerometer data from the vertical axis at 1-second epochs for the hip
(red box) and wrist (blue box) locations (the GT3X-BT is a triaxial (i.e. vertical axis, anterior-posterior axis and medial-lateral axis)
accelerometer). The subject transitioned from a run to a walk and then stretching

Compendium of Physical Activities: Estimation of METs and Kcals from Direct
Observation. The Compendium of Physical Activities was developed for use in
epidemiologic studies to standardize the assignment of MET intensities in physical
activity questionnaires. 144 A MET is defined as the ratio of the work metabolic rate to
the resting metabolic rate. One MET is defined as 1 kcal/kg/hour and is roughly
equivalent to the energy cost of sitting quietly. A MET also is defined, as oxygen uptake
in ml/kg/min with one MET equal to the oxygen cost of sitting quietly, equivalent to 3.5
ml/kg/min. The Compendium has been used in studies worldwide to assign intensity
units to physical activity questionnaires and to develop innovative ways to assess energy
expenditure in physical activity studies.

Procedures
Visit 1- Informed Consent, Questionnaires, Measurement of Height and Weight
During the informed consent visit, a researcher explained the study and answered
any questions. If the potential participant agreed to enroll as a subject, he/she signed the
UMass Institutional Review Board approved informed consent document (ICD) (see
Appendix B for approved ICD) and completed two questionnaires: 1) physical activity
readiness (PAR-Q) and 2) physical activity status (NASA physical activity scale (PAS))
(Appendices C and D). For the PAS, participants were asked to choose a number which
best describes their activity during the previous 30 days. Possible responses range from 0
to 7, with 0 corresponding to “avoided walking or exertion (e.g. always used the elevator,
drove whenever possible instead of walking)”, and 7 corresponding to “ran more than 10
miles per week or spent over 3 hours per week in comparable physical activity”. Next,
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participants’ height was measured using a standard floor stadiometer and weight was
measured using a Tanita scale (DC-430) to the nearest 0.25 cm and 0.1 kg, respectively.
Participants then provided demographic information (e.g. ethnicity) and were scheduled
for three 2-hr data collection (observation) sessions.
Research-grade accelerometer. Participants were fitted with two ActiGraph
GT3X-BT activity monitors. Both GT3X-BT monitors were synced to the same laptop
and initialized in advance to collect data at a sampling rate of 80 Hz. They were
positioned on the wrist and right hip of each participant. The wrist monitor was secured
using a Velcro strap to the non-dominant wrist (positioned over the dorsal aspect of the
wrist midway between the radial and ulnar styloid processes), and the hip monitor was
secured using a belt at the iliac crest in line with the anterior axilla. The initialization and
wrist wear location are consistent with the current National Health and Nutrition
Examination Survey (NHANES) activity monitoring study protocol. 145

StepWatch™ monitor. Participants were fitted with a SW monitor, fastened using
a Velcro strap to the dominant ankle (positioned superior to the lateral malleolus). The
SW was programmed to record at 3-second intervals, with sensitivity set to 13 and
cadence set to 73, consistent with a previous study that our lab conducted.112 Sensitivity,
the magnitude of acceleration that the device qualifies as constituting a step, and cadence,
how often the device searches for steps taken.

Activity Trackers. The device placement was counterbalanced across subjects.
For example, the total number of devices worn was the same for all subjects but the order
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in which the devices were placed on subjects was different between subjects. The same
placement positions within each participant across the 3 observation sessions (e.g.
participant 2, Misfit Flash, left hip for all observation sessions) was used.

Direct Observation
Criterion: Direct Observation. Participants were met by a trained observer in their
natural environment (e.g. home, place of work) and observed for approximately two
consecutive hours. The GoPro video files were imported into the Behavior coding
software The Observer® XT.
Focal sampling and duration coding (FSD) were used to record participant
behavior (activity type, body posture, intensity and duration). The FSD method is one
where every time a behavior changes (e.g. sitting to standing) the observer recorded the
new activity type, body posture and intensity into The Observer XT program. Each entry
of a behavior change was time stamped and the duration of each behavior bout was
saved. During the two-hour observation time, participants could have “private time”
when needed. Reasons for “private time” included behaviors such as using the restroom
and changing clothes. During these activities, the observer did not video the participant
and the camera was pointed to the ground and recorded as private time in Observer XT.

Direct observation observer training. Training involved research
assistants learning how to identify and record activities described in the direct
observation (DO) methods (Criterion DO below). The observer training objectives
were to: (1) complete an extensive verbal and video training and testing, (2) learn
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strategies to avoid disrupting free-living behavior, and (3) to accurately record
activity type and intensity, all prior to observing participants in a free-living
environment. Observers completed DO training that includes review of a training
manual, (2) 2-hours of training videos (videos include subjects in free-living settings
engaging in a variety of free-living behaviors such as, activities of daily living,
locomotion and exercise), and (3) DO practice sessions with the GoPro camera
(minimum of 12-hrs of training). After the training, study observers completed a
testing video that is ~10 minutes in duration and included different activities with
various postures. Before data collection, researchers were required to correctly
classify at least 90% (Cohen’s kappa coefficient (k) ≥ 0.90) of the body positions,
intensity levels, and duration of activities throughout the testing video.

Compendium of Physical Activities. The Compendium of Physical Activities was
not developed to determine the precise energy cost of physical activity within
individuals, but rather to provide a classification system that standardizes the
MET intensities of physical activities used in survey research. The values in the
Compendium do not estimate the energy cost of physical activity in individuals in
ways that account for differences in body mass, adiposity, age, sex, efficiency of
movement, and geographic and environmental conditions in which the activities
are performed. 146 Therefore, the Compendium of Physical Activities was used in
concert with the preceding coding scheme to estimate physical activity (MET
level) in free-living environments. Study observers were extensively trained
(previously described) in how to identify physical activity behaviors and their
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associated MET values within the Compendium of Physical Activities, before
observing participants in a free-living environment.

Direct Observation Sessions: Visit 2, 3 and 4. Participants were met by a trained
observer in their natural environment (e.g. home, place of work, school) and observed
for approximately two consecutive hours. A GoPro video camera was used to record
each observation session. Each of the 2-hr observation sessions were done at
different times of the day (e.g. Session 1: morning; Session 2: afternoon; Session 3:
evening), including one weekend day, in the participants’ free-living settings (e.g.
home, work, driving). If/when a participant drove; researchers either road with the
participant or followed from a safe distance in a separate car. Two researchers were
always present during the observation sessions, one videographer and one to take
notes, support videographer and drive if needed. For these three visits, researchers
initialized devices and met the participants in their free-living environment to be
fitted with a variety of activity monitors that were worn on the wrists, hip and ankle,
and a biometric shirt. Participants wore 7 monitors on the wrists (4 on one wrist and
3 on the other wrist), 5 monitors on the right and left hip, 1 monitor on the ankle of
the dominant leg and 1 biometric shirt worn as an undergarment (Figure 9). The
biometric shirt estimates energy expenditure and steps (Table 4).
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Figure 9. Participant equipped with all devices for observation session
The researchers video recorded participants for the 2-hr sessions while
participants performed normal activities (including driving). Every attempt was made to
avoid including faces in these video recordings. If any faces appear in the video we edited
these shots to blur from the video recording. If private time was required (i.e. going to the
bathroom), participants were not observed during these private time periods. At the end
of the 2-hr recording period, the researchers recorded the data from the ATs via the realtime display or iPhone app, and removed the activity monitors. Finally, researchers
returned to the lab and downloaded data from monitors and video recording.
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Other considerations. We expected that some participant’ normal
activities may bring them to the Recreation Center for individualized workouts or
group activity classes. We were sensitive to the privacy of our participants and those
persons of the surrounding environment and as a result we had safeguards in place to
ensure that privacy was preserved. For example, sound was not recorded, and
identities (faces) of all individuals in the video were blurred, thus, individuals are not
identifiable. If the participant took part in a group fitness class, we communicated
with the instructor, informing her of the purpose of our study and gave a short (~
60 seconds) explanation to the class and handed out study information (Appendix F).

Data Processing and Statistical Evaluation
Data Processing
All data cleaning, processing and analysis were done using the open source R
statistical software package (www.r-project.org) and computing language R. 136

Criterion: Direct observation. For an observation to be included in the analysis,
the full 2-hour observation was continuous including private time. Behavior coded, as
“private time” were eliminated from analysis.
Focal sampling and duration coding were used, with trained data collectors coding
the real-time occurrence (i.e. The Observer XT Media Module synchronized with activity
tracker data using The Observer XT External Data Module) of the eight activity
categories, body positions, and intensities described below:
1. Lying: Individuals were flat on their backs (horizontal); sedentary (<1.5 METs).
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2. Sitting: Individuals had some of their body weight supported by the buttocks or
thighs. The upper body was not parallel to the ground. If they kneeled, they were
coded based on the thigh position (i.e., if the thigh was parallel to the ground,
sitting was selected).
3. Standing still: Individuals were standing with little or no contribution from the
upper body. They were not carrying a load >1 kg. Standing still included talking
with hand gestures, looking at something, or waiting in a line; sedentary (<1.5
METs).
4. Standing with upper body movement: Individuals were upright with some
contribution from the upper body that causes an increase in energy expenditure
(holding a load >1 kg, filing papers, or doing a task that required the arms). The
purpose of the activity included the upper body; light (1.5 – 2.9 METs).
5. Standing/moving: Individuals were engaging in activities that were of light
intensity (1.5 – 2.9 METs); e.g., walking at a speed <2.5 mph and not be carrying
a load). These activities included movements around an office or a home but not
for locomotion (e.g., traveling between one place and another).
6. Moving moderate: Individuals were engaging in activities (3.0 – 5.9 METs).
Examples include walking >2.5 mph, gardening, vacuuming, and carrying a load.
7. Moving vigorous: Individuals were engaging in activities (6.0-8.9 METs). This
typically involves purposeful exercise including jogging, walking briskly uphill,
and sporting activities.
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8. Moving very vigorous: Individuals were engaging in activities >9.0 METs. This
typically involves purposeful exercise including running 6 mph, bicycling at 200
watts, and conditioning classes.

A log of the start and stop of each behavior recorded by the observer was
exported to a csv file using a custom software and profile (Noldus: The Observer XT
12.5). These data were used to determine criterion measures of activity and inactivity
including, MET-hours, MET-minutes (where, 1 MET = 1 kcal/kg/hr), kcals per hour
(where, Kcals=METs x time x BW (kg) and time in categories of intensity. The MifflinSt Jeor equation was used to estimate participant resting metabolic rate (RMR), 147 which
has been shown to be valid and reliable in estimating RMR in adults. 148,149 The RMR
was added to the EE estimates from the WP and summed to estimate total calories (e.g.
exercise + resting).
Total EE was determined by summing/totaling the amount of time spent in all
body positions from the DO coding system (e.g. total MET-minutes). METs were then
converted to Kcals/minute as recommended by Ainsworth et al.144
Kcals= METS x time x body weight in kilograms
Criterion. DO steps were defined as each event when the foot was completely
lifted off and lowered back to the ground. To determine criterion step count, steps were
manually counted twice for each 2-hour video recording session, and averaged. If there
was a 5% difference between total step counts, the video was analyzed a third time and
the average of the two closest total step counts was used for analysis (% difference =
((Count 1 – Count 2)/ Count 1) x 100)
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Research-grade accelerometers
ActiGraph GT3X-BT. Accelerometer data were downloaded to a laptop using the
ActiLife v6.1.1 software (ActiGraph, Pensacola, FL) and were later extracted to match the
corresponding DO time blocks. These data were then be processed to derive total time
spent in each activity type and intensity for each participant.

StepWatch™ monitor. StepWatch data were downloaded to the same laptop used
for all devices via the StepWatch software (v3.4). Next, the StepWatch data from the
observation session were exported and saved for analysis. Total steps were determined
by summing/totaling the number of steps taken.

Activity Trackers
Steps, EE, Activity minutes (if provided by activity tracker) and sedentary time (if
provided by AT) data from activity trackers were recorded at the beginning and at the end
of each observation session. Total estimates were then calculated by subtracting the
beginning values from the ending values.

Fitabase (Small Steps Labs, LLC. San Diego, Ca). All Fitbit data were exported
using Fitabase. Fitabase is a research platform that acquires data from Internet connected
consumer devices. Currently, Fitbit is the only consumer device company that utilizes
Fitabase. The advantage of using this platform to acquire Fitbit data is that it provides
minute-by-minute data for activity minutes (intensity), kcals, MET-minutes and steps in
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comparison to the Fitbit software and Dashboard which only provides totals for activity
minutes (intensity), kcals, MET-minutes and steps for the monitoring period.

Biometric Shirt. First, the Hexoskin Biometric Shirt data was downloaded to the
HxServices Dashboard. Next, an “Activity” was created in the myhexoskin website for
the 2-hour observation session (data are time stamped) (Figure 10) and EE and steps were
recorded.

Session date, time
and duration

Total Kcals

Participant ID
And session #

Total Steps

Figure 10. Hexoskin Biometric Shirt activity output
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Device (Location)

Output

Data Extraction Method
Upload

Retrieval
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Apple iWatch Sport (W)

EE, steps, active calories, min: exercise, total active time, stand hours

Bluetooth

Apple Activity App

GT3X-BT (W & H)

Steps, min: Sedentary, light, moderate, vigorous

USB cable

ActiLife

Fitbit Flex /One (W/H)

EE, steps, MET-min, min: sedentary, light, moderate, vigorous

Bluetooth

Fitabase

Garmin Vivofit (W)

EE, steps, active calories, %: sedentary, active, highly active

Bluetooth

Garmin Connect™ App

Hexoskin (T)

EE, steps

USB cable

Hexoskin dashboard

Microsoft Band (W)

EE, steps, active min

USB cable

MB dashboard

Misfit Flash/Shine (H/W)

EE, steps, active min: light, moderate, vigorous

Bluetooth

Misfit App

New Lifestyles NL-1000 (H)

Steps, MVPA min

RTD

RTD

The Observer XT (NA)

MET-hours, MET-min

The Observer XT

The Observer XT

Polar Loop (W)

EE, steps, time: lying, sitting, active, sitting, min: stand, walk, run

USB cable

Polar dashboard

StepWatch (A)

Steps

USB cable

StepWatch dashboard

Withings Pulse (H)

EE, steps

Bluetooth

Withings App

Table 4. Devices with corresponding output and data extraction method
H, hip; W, wrist: T, torso; A, Ankle; NA, not applicable; EE, energy expenditure; min, minutes; MVPA, moderate-to-vigorous
physical activity; MB, Microsoft Band; RTD, real-time display.

Video files. Video files were edited (e.g. combined and participants de-identified)
using CyberLink PowerDirector 13 Ultra (CyberLink LLC. Boyds, MD) video editing
software (Figure 10).

Figure 11. De-identified observation session video
Statistical Evaluation
Statistical Analysis Plan
Accuracy
Bias. We used bias in units of minutes, kcals and steps (activity tracker estimates
– criterion) and as a percentage [(mean difference between the activity tracker estimates
and the criterion/ criterion x 100].
Precision
We used confidence intervals (CI) as measures of precision. If the upper and
lower 95% confidence interval of the bias span 0, then the estimate was not considered
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significantly different from the criterion at α = .05. Higher precision was indicated by
higher correlations and smaller CI. Linear-mixed models were used to account for the
correlation within subjects, as each subject provides more than one observation (one from
each 2 hour session).
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Study Three: Activity Trackers are Sensitive to Change in Physical Activity and
Sedentary Behaviors in Free-Living Settings

Experimental Procedures
The data used in this study are from our previous study, “Validation of Consumer
and Research-Grade Activity Monitors in Free-Living Settings.”

Data Processing and Statistical Evaluation
The aims of this study were: 1) to examine the ability of ATs to detect change in
PA and ST in free-living settings and 2) to examine the ability of research-grade
accelerometer to detect change in PA and ST in free-living settings. Described below are
the statistical methods to address this aim.
Data Processing
All data cleaning, processing and analysis were done using the open source R
statistical software package (www.r-project.org) and computing language R. 136

Statistical Evaluation

Direct observation provided criterion measures of change in steps, EE, activity
minutes and sedentary time
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Visit 1

Visit 2

Visit-to-Visit
Change

Kcals/2-

MFS

DO

MFS

DO

MFS

DO

416

287

583

325

-167

-38

hrs
Table 5. Example of one subject’s data for Misfit Shine estimated kcals and DO
measured Kcals for visits 1 and 2.
MFS, Misfit Shine; DO, direct observation (criterion Kcals)

For both the criterion measure and the device estimates, we calculated the
differences between the visits (i.e. visit 1 minus visit 2, visit 1 minus visit 3 and visit 2
minus visit 3) for estimated steps, EE, activity minutes, and or sedentary time. We then
classified the criterion and device measured outcomes for visit-to-visit change into one of
three categories: increase, no change or decrease where an increase or decrease was
defined as a change that was greater than the within-subject standard deviation of the
criterion measure (estimated by a linear-mixed model). Finally, confusion matrices were
used to determine percent agreement between criterion visit-to-visit change and device
visit-to-visit change. Table 6 illustrates a confusion matrix and percent agreement for
DO visit-to-visit change and FBF visit-to-visit change for seven participants.
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Percent Agreement = 100
Fitbit Flex Changes
Decrease
Direct
Observation
Changes

Decrease

No Change

Increase

7

No Change

3

Increase

11

Table 6. Confusion matrix and percent agreement change in energy expenditure
between sessions (session 1 – session 2, session 1 – session 3, session 2 – session 3) for
seven participants
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CHAPTER 4
STUDY ONE – A COMPARISON OF CONSUMER ACTIVITY TRACKER
ACCELEROMETER OUTPUT AND A RESEARCH-GRADE
ACCELEROMETER OUTPUT DURING ORBITAL SHAKING

Introduction
Electronic testing of research-grade accelerometers has provided valuable
information about device performance during controlled accelerations at different
frequencies. This information has been essential for researchers to gain a more
comprehensive understanding of the strengths and weaknesses of accelerometers in
highly controlled testing conditions using electronic testing systems. The ActiGraph
(AG)(ActiGraph, LLC, Pensacola, FL) accelerometer provides an objective estimate of
human physical activity (PA) and is used in many research studies and in clinical
settings. 50-52 The ActiGraph GT3X-BT detects a wide range of accelerations and
samples acceleration from 30 to 100 Hz. Standardized electronic validation and
reliability testing of the AG has been performed using the GT3X+, GT3X, GT1M, 7164
and 71256. In these studies, electronic devices such as wheels, 53,54 a table, 55 and orbital
shaking 56-58 were employed to examine accelerometer output at fixed frequencies. From
these studies, we have advanced our understanding of differences in accelerometer
counts, steps, and raw acceleration as a function of model, band-pass filter methods,
sampling frequency, accelerometer type (piezoelectric versus solid state
microelectromechanical systems (MEMS)) and firmware.
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To date, our laboratory has published the only study that has applied electronic
testing techniques to examine the accelerometer output of consumer activity trackers
(ATs).150 The benefits of electronic orbital shaker testing are that it allows us to: (1)
expose ATs to different oscillation frequencies to simulate different movement intensities
and (2) vary oscillation frequencies to simulate variation in free-living whole-body
acceleration. The electronic orbital shaker will inform researchers of how ATs perform
under highly controlled conditions. Orbital shaker testing removes human variation from
the testing environment. As a result, observed differences would be due to technological
features of the devices that are not impacted by human variation. Our lab employed an
electronic orbital shaker to assess the data of several consumer ATs compared to the AG
GT3X+ accelerometer (unpublished observations). 62 We found that AT data was highly
correlated with oscillation frequency (r range: 0.92 to 0.99).
Electronic testing of ATs is a necessary first step in building a scientific
knowledge base of these increasingly popular devices. Therefore, the purpose of the
present study was to compare consumer ATs with the research-grade ActiGraph™
GT3X-BT accelerometer in estimating energy expenditure (EE) and steps during orbital
shaking at different frequencies. We hypothesized that EE and step estimates from
consumer ATs would be similar to the EE and step estimates of the research grade
GT3X-BT accelerometer during standardized testing using an electronic orbital shaker.
Methods
Instrumentation
Research-grade accelerometer: Reference Standard.

The ActiGraph GT3X-BT

(GT3X-BT) accelerometer (ActiGraph™ LLC, Pensacola, Florida) served as the
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reference standard to which all ATs were compared. This device is a lightweight triaxial
PA monitor (4.6cm x 3.3cm x 1.5cm, 19g) that measures acceleration ranging from -8 to
+8 g’s. Data were collected at a sample rate of 80 Hz and post-processed in the ActiLife
software version 6.1.3 to 60-second epochs.

Activity Trackers
Activity trackers were chosen based on three criteria: (1) no known gravimeter
within the device, (2) researchers had at least two of the device, and (3) the device fit in
the cushioned slots of the shaker. The rationale for excluding ATs that contain a
gravimeter was that the electronic orbital oscillator does not produce vertical
accelerations and as a result, a device that contains a gravimeter would produce
inaccurate data, as it would detect no change in gravitational position. The rationale for
at least two devices was to counterbalance each other in the electronic orbital oscillator.
Six different ATs were studied: 1) Fitbit Flex (FBF)(Fitbit® Inc., San Francisco,
California), 2) Fitbit One (FBO)(Fitbit® Inc., San Francisco, California), 3) Garmin®
Vivofit (GV)(Garmin Ltd., Schaffhausen, Switzerland), 4) Misfit Flash (MFF)(Fossil
Group, Inc.), 5) Misfit Shine (MFS)(Fossil Group, Inc.), and 6) New Lifestyles NL-1000
pedometer (NL)(New Lifestyles, Inc., Lee’s Summit, Missouri). See table 7 for detailed
specifications of each activity tracker.
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Device
Cost
Wear location

Tracks Calories
Burned
Tracks Active
Time
Tracks Steps
Tracks Distance
Tracks
Elevation/Stairs
Tracks Sleep
Tracks Heart
Rate
Battery or
Chargeable
Uploading Data
Tracker Display

Fitbit Flex

Fitbit One

Garmin
vívofit

$39.95
Wrist

$99.95
Clip on
(multiple
locations)

$99.99
Wrist

Chargeable
(every 5
days)
Bluetooth

Chargeable
(every 10+
days)
Bluetooth

Battery
(every 1+
years)
Bluetooth

LED
progress
indicator

Real-time
data

Real-time
data

New
Lifestyles
NL-1000
$54.95
Hip

Battery (up
to 18
months)
Real-time
data
Real-time
data

Misfit
Flash

Misfit
Shine

$19.99
Clip on
(multiple
locations)

$39.95
Clip on
(multiple
locations)

Battery
(lasts up to 6
months)
App

Battery
(lasts up to 6
months)
App

LED
progress
indicator

LED
progress
indicator

Table 7. Features of consumer-based activity trackers
LED, Light-Emitting Diode; USB, Universal Serial Bus; App, application

Electronic Orbital Shaker. The electronic orbital shaker (Advanced Orbital
Shaker, Model 10000-2; VRW International, Radnor, PA) (Figure 1) produces controlled
oscillations between 0.25 and 5.0 Hz. The electronic orbital shaker oscillates at various
radii between 1.27 and 5.7 cm. Four trays (51 x 10 x 10 cm) are mounted on the base
oscillating plate (60 x 60 cm) of the shaker. Each tray has four custom foam cushion slots
to securely hold the GT3X-BTs and ATs in place to eliminate device movement during
electronic orbital shaking (Figure 12).
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Figure 12. Electronic orbital shaker with devices in custom foam cushioned slots
Procedures
Electronic Orbital shaker. The electronic orbital shaker was used to perform
motion testing. Two of each device were tested at the same time. All devices were
placed in the custom foam cushion slots with their vertical plane perpendicular to the
control panel of the electronic orbital shaker (figure 12).
The GT3X-BTs and ATs were oscillated using two protocols, (1) 3-minute trials,
and (2) 2-hour trials. Each 3-minute trial consisted of one monitor oscillation frequency
(e.g. 0.9 Hz). Oscillation frequencies were increased from zero, 0.25 to 3.0 Hz in 0.1 Hz
increments for a total of 24-trials. The step-wise increase in frequency allowed
researchers to test the effect of specific frequencies on device output. Each protocol
(twenty-four, 3-min trials; 2-hour trial) was repeated three times. The 2-hour trials
consisted of oscillation frequencies ranging from zero to 3.0 Hz., based on the American
Time Use Survey (ATUS) percentages of time spent in selected activities, normalized for
2-hours, 135 to simulate free-living whole body acceleration (e.g. variation). These
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frequencies simulate hip rotation ranging from no movement (e.g. sleep) to ambulation at
speeds ranging between 1.5 and 16 miles per hour. 81 Two-hour blocks were chosen as it
was not feasible to test devices for 24-hours consecutively. All shaker oscillations were
performed on a fixed radius 56,134 of 5.08 cm.

Oscillation Frequencies. Oscillation frequency ranges for each activity category
were established by electronically oscillating six GT3X-BTs at 0.0, 0.25 to 3.0 Hz in 0.1
Hz increments and applying cutpoints. Each 0.1 Hz. increment was oscillated for 3minutes and the second minute of each trial was used to determine counts per minute at
each frequency. Using the second minute ensured that the desired frequency was
achieved for the entire minute. The GT3X-BT data were collected at 80 Hz., with the low
frequency extension for oscillation frequencies <0.7 Hz., post processed using ActiLife
software (v 6.1.3) and aggregated into VM counts per minute. These data were scored in
ActiLife using the Freedson VM3 cut-points. 52 Lastly, the intensity categories and their
associated frequencies were used to determine the 2-hour electronic oscillation trial:
frequency, intensity and total time.

Data Collection and Processing. The GT3X-BTs were synched to the same laptop
as the ATs and initialized in advance of data collection (sampling rate of 80Hz). These
raw data were post processed into 1-second epochs/counts and steps via ActiLife v6.1.3
software.
Minute-by-minute EE (kcals) was estimated and summed for all 3-minute trials
and for each 2-hour trial using the prediction equation previously developed by our
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group, 52 labeled the “Freedson VM3 (2011)” equation in the ActiLife software. The
Freedson VM3 equation has been validated in classifying PA intensity.52
The same user profile (e.g. weight in kg) was used for the GT3X-BTs and ATs.
The low frequency extension (LFE) option was selected in the ActiLife software to detect
lower amplitude movements. The LFE option lowers the baseband of the filter cut-off,
expanding the bandwidth of the accumulated data. The LFE was selected to ensure
acceleration detection at slower oscillation frequencies (e.g. 0.7 Hz).

Activity Trackers
Pre-3-minute oscillation trials and 2-hour oscillation trial. Thirty-minutes prior to
the first 3-minute and the 2-hour oscillation trial, all activity trackers were
initialized/synched using the same user profile (e.g. date of birth, gender, height and
weight) and the same computer was used as was used to initialize the GT3X-BTs. Next,
the GT3X-BT and ATs (FBF, FBO, MFF, MFS, GV and NL) were secured into their
respective customized foam cushion slots within each tray of the electronic orbital shaker
(Figure 12). Two of each device were tested in the electronic orbital shaker.
Immediately prior to each 3-minute oscillation trial and each 2-hour oscillation
trial, all Misfit data were retrieved via the Misfit app (iPhone 6s) and baseline step values
for the MFS and MFF were recorded as neither device is equipped with a real-time
display. Steps from the GV were recorded from the real-time display. The NL
pedometers were set at 0 steps. The values for EE and steps from the FBF, FBO and the
GT3X-BT were retrieved and recorded pre-and post each 3-minute oscillation trial and
each 2-hour oscillation trial. The start and stop time for each 3-minute oscillation trial
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and each 2-hour oscillation trial were synchronized with the time of the same laptop used
for initialization/synching and downloading of all devices.
Data Processing. Following each 3-minute and 2-hour oscillation trial total steps
for the: 1) MFF and MFS were downloaded via Bluetooth and retrieved via the Misfit
app (iPhone 6s), 2) FBF and FBO were synched/downloaded to the Fitbit Dashboard via
Bluetooth and retrieved from the Fitabase website (described below), and 3). Garmin
Vivofit were retrieved from the real-time display. Total steps for the NL pedometer were
retrieved from the real-time display. Total EE for the FBF and FBO were
synched/downloaded to the Fitbit Dashboard via Bluetooth and retrieved from the
Fitabase website (described below). The GT3X-BT data were collected at 80 Hz, with
the low frequency extension for oscillation frequencies <0.7 Hz (3-minute oscillation
trials only), post processed using ActiLife software (v 6.1.3) and aggregated into VM
counts per minute. Total estimated kcals for each 3-minute and 2-hour oscillation trial
were calculated and summed employing the “Freedson VM3 (2011)” equation in Actilife
(v 6.1.3). Total steps from the GT3X-BT were obtained by summing: 1) each 3-minute
oscillation trial, and 2) each 2-hour oscillation trial.

Fitabase (Small Steps Labs, LLC. San Diego, Ca). All Fitbit data were exported
using Fitabase. Fitabase is a research platform that accesses data from Internet connected
consumer devices. The advantage of using this platform to acquire Fitbit data is that it
provides minute-by-minute data for activity minutes (intensity), kcals, MET-minutes and
steps in comparison to the Fitbit software and Dashboard which only provide total
activity minutes (intensity), kcals and steps for the monitoring period.
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Statistical evaluation
All data cleaning, processing and analysis were done using the open source R
statistical software package, version 3.3.3 (www.r-project.org) and computing language
R. 136

Data Analysis. To evaluate AT estimates, we used two statistical tools: bias
(mean difference between the estimate and the reference) provides information about the
accuracy of the estimate and if the upper and lower 95% confidence intervals of the bias
span 0, then the estimate is not significantly different from the reference at α = .05.
Linear mixed effects models assessed main effects of device and frequency and random
effects of trial on activity tracker estimates of EE and steps compared to GT3X-BT
estimates of EE and steps. Significance level was set at α = .05.

Results
Figure 13 shows steps per 3-minutes during electronic oscillation. The NL was
not significantly different from the GT3X-BT beginning at 0.9 Hz (corresponding to
moderate intensity PA). The largest difference between the NL and the GT3X-BT was
142 steps/3-min at 0.8 Hz (corresponding to moderate intensity PA). All other AT step
estimates were significantly different than GT3X-BT steps. For the MFF, the largest
difference was 285 steps/3-min at 1.5 Hz (corresponding to very vigorous intensity PA).
However, these differences were smaller beginning at 2.4 Hz (44 steps/3-min)
(corresponding to very vigorous intensity PA). For the MFS, the largest difference was
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102 steps/3-min at 1.5 Hz (corresponding to very vigorous intensity PA). However, these
differences were smaller beginning at 2.4 Hz (44 steps/3-min) (corresponding to very
vigorous intensity PA). For the FBO, the largest difference was -310 steps/3-min at 2.4
Hz (corresponding to very vigorous intensity PA). However, these differences were
smaller beginning at 2.5 Hz, with the smallest difference at 2.6 Hz (-264 steps/3-min)
(corresponding to very vigorous intensity PA). For the FBF, the largest difference was 385 steps/3-min at 2.4 Hz (corresponding to very vigorous intensity PA). However, these
differences were smaller beginning at 2.5 Hz (corresponding to very vigorous intensity
PA), with the smallest difference at 2.6 Hz (-317 steps/3-min) (corresponding to very
vigorous intensity PA). The GV detected no steps at all frequencies tested.

Figure 14 shows energy expenditure per 3-minutes during electronic oscillation.
Energy expenditure estimates from both the FBO and FBF were significantly different
than GT3X-BT estimates of EE. For the FBO, the largest difference was -35 kcals/3-min
at 2.4 Hz. However, these differences were smaller beginning at 2.5 Hz, with the
smallest difference at 2.6 Hz (-34 kcals/3-min). For the FBF, the largest difference was 39 kcals/3-min at 2.3 Hz. However, these differences were smaller beginning at 2.5 Hz,
with the smallest difference at 2.9 Hz (-31 kcals/3-min).

Figure 15 shows steps per 2-hours during electronic oscillation. Average steps for
the GT3X-BT were, 5831, 5178 and 6301 steps/2hr. for trials 1, 2 and 3, respectively.
On average, the FBO and the GV significantly underestimated steps for all trials. These
underestimations ranged from -6200 to -4200 steps/2-hrs. On average, the FBF
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underestimated steps with two trials significantly different than the GT3X-BT. The NL
significantly underestimated one trial compared to the GT3X-BT. In contrast, the MFS
and MFF significantly overestimated steps for two trials compared to the GT3X-BT.
These overestimations ranged from 50 to 2,200 steps per 2-hrs.

Figure 16 shows energy expenditure per 2-hours during electronic oscillation.
Average kcals for the GT3X-BT were, 601, 508 and 681 for trials 1, 2 and 3,
respectively. The FBF, FBO and the GV significantly underestimated kcals for all trials.
These underestimations ranged from -580 to -65 kcals/2-hrs. In contrast, the MFS and
MFF significantly overestimated kcals for two trials and significantly underestimated
kcals for one trial compared to the GT3X-BT. Average overestimations ranged from 105
to 190 kcals/2-hrs. Average underestimations ranged from -160 to -170 kcals per 2-hrs.

Figure 17 illustrates the relationship between hertz and acceleration. Note that the
relationship between hertz and counts differs, as the relationship is curvilinear starting at
2.5 Hz (see Figure 5).
Discussion
Currently, no published studies have examined ATs during electronic shaker
testing. Therefore, in this discussion interpretation it is necessary to compare our results
to human studies. There is evidence that electronic oscillation of the GT3X simulates hip
rotations similar to ambulation at speeds ranging between 1.5 and 16 miles per hour. 81
Therefore, to provide meaning, and context to the present study’s findings, the following
discussion will present evidence from validation studies comparing Fitbit, Garmin, Misfit
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and NL-1000 estimates of steps and/or EE to criterion measures during lab-based
treadmill walking and running.
The purpose of the present study was to compare consumer ATs with the
ActiGraph™ GT3X-BT accelerometer in estimating EE and steps during orbital shaking
at different frequencies. To address this question, two protocols employing an electronic
orbital shaker were developed: a 3-minute trial at specific frequencies and a 2-hr trial at
various frequencies.

Our main findings from the 3-minute protocol were that for steps, the NL was not
significantly different from the GT3X-BT beginning at 0.9 Hz and held constant through
3.0 Hz. Previously, our group exposed GT3X-BTs to electronic oscillation frequencies
from zero to 3.0 Hz in 0.1 Hz increments and applied the widely used Freedson (VM3)
cut-points to categorize frequencies into corresponding intensity levels. We found that
0.9 Hz elicits GT3X-BT VM counts corresponding to moderate intensity PA.
Additionally, 0.6 to 0.8 Hz corresponds to the change from light to moderate intensity
PA, suggesting, that the NL may be less sensitive to sedentary to light PA as compared to
moderate, vigorous and very vigorous PA. All other AT step estimates were significantly
different than GT3X-BT steps. Another finding was step estimates from devices of the
same company displayed similar trends. For example, both Misfits produced the largest
and smallest errors at 1.5 and 2.4 Hz, respectively. The Fitbits, produced the largest and
smallest errors at 2.4 and 2.6 Hz, respectively. In contrast, the GV detected no steps.
According to the Garmin website, the Vivofit only possesses one sensor: an
accelerometer.151 However, we posit that this device utilizes a gravimeter, which
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continuously identifies true vertical axis. The electronic orbital shaker oscillates in the
horizontal versus the vertical plane. These findings elucidate technological differences
between ATs. For example, ATs employ triaxial accelerometers in concert with user
information, band-pass filters, firmware, and proprietary algorithms to estimate PA
behaviors, such as, steps. For researchers, this “black-box” method of deriving PA
behavior estimates remains a challenge.
Main findings from the 3-minute protocol were that for EE, both the FBO and
FBF were significantly different that GT3X-BT estimates of EE. The largest and
smallest differences ranged from 2.4 to 2.9 Hz. This frequency range corresponds to very
vigorous intensity PA. This suggests that estimates of EE from the FBO and FBF may
not be comparable to EE estimates from the GT3X-BT derived via the Freedson EE
equation. Moreover, these findings strengthen the argument that proprietary algorithms
may be a primary cause of observed differences in AT data compared to GT3X-BT data.

Our main findings from the 2-hour protocol were that for steps, the NL produced
the smallest bias (bias for all trials = -570 steps/per 2-hrs), and two of three trials were
not significantly different than our reference measure (GT3X-BT). Our findings of the
relationship between NL steps and GT3X-BT steps are consistent with the those of Abel
et al. 152 Briefly, 59 participants performed treadmill walking and running at speeds
ranging from 2.2 to 4.0 mph while wearing the NL on the waist. They reported that, the
NL and AG 7164 yielded the most accurate step counts at a range of walking speeds in
individuals with different physical characteristics. Next, we found that, the FBO and the
GV significantly underestimated steps for all trials. Bias for all trials was -5120 and -
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5770 for the FBO and GV, respectively. Additionally, the FBF significantly
underestimated steps for two of the three trials. Bias for all trials was -1651 steps/2-hrs.
Lab-based validation studies have provided evidence that, in general, FBF and FBO
underestimate steps with varying precision compared to criterion measures during
treadmill walking and running. 20,25,26,28-30 Our finding that GV significantly
underestimated steps, is supported by Chen et al. 20 who showed that the GV significantly
underestimated steps compared to DO during treadmill walking and running at speeds
ranging from 2.0 to 5.0 mph (p<.05). Lastly, we found, both Misfits significantly
overestimated steps for two trials. Bias across all trials was 1,921 and 1,332 steps/2-hrs,
for the MFF and MFS, respectively. Two studies have examined the MFS during
treadmill walking and running and results are equivocal. First, Kooiman et al. 21
examined the MFS during treadmill walking at 2.0 mph for 30-minutes compared to
criterion steps (Optogait system) and reported a bias (SD) of -6(43) steps. Chen et al. 20
validated the MFS during treadmill walking and running (speed range: 2.0 to 5.0 mph)
The MFS significantly underestimated steps at all speeds compared to criterion steps
(p<.05), however, accuracy improved at higher speeds. These data provide evidence that,
the NL produced the smallest error compared to the GT3X-BT during 2-hours of
electronic orbital shaking at frequencies ranging from zero to 3.0 Hz, which highlights
potential issues with comparing step estimates from ATs.
Main findings from the 2-hour protocol were that for EE, the FBF, FBO and the
GV significantly underestimated kcals for all trials (range: -580 to -65 kcals/2-hrs)
compared to the GT3X-BT. Several validation studies support and refute this finding.
For example, Price et al. 153 examined FBO (hip-worn) and GV (wrist-worn) EE
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estimates during treadmill walking (1.5, 2.8 and 4.0 mph) and running (5.0, 6.4 and 7.4
mph) compare to indirect calorimetry. They reported, EE estimates from the FBO and
GV correlated significantly (p< 0.01; r= 0.702; 0.854) with criterion across all gait speeds
(1.5 - 7.4 mph). However, EE estimations of single speeds were overestimated by the
FBO and underestimated by the GV. Further, EE estimations of single speeds were
overestimated by the FBO and underestimated by the GV. One reason for these
differences may have been the result of device location. Specifically, the FBO was hipworn and the GV was wrist-worn. Our laboratory compared AG GT3X+ wrist and hip
accelerations (g’s) at different locomotion speeds (unpublished). We found a signiﬁcant
difference between the slopes (m) (speed vs vector magnitude (VM)) for the hip, (m =
0.052 [95% CI: 0.033, 0.103] compared to the wrist, m = 0.195 [95% CI: 0.160, 0.230],
p<0.001), and concluded that the pattern of change is different and more variable
between subjects for the wrist VM. The FBF has also been shown to significantly
overestimate EE during treadmill walking and running compared to indirect calorimetry
(p<.05). 25 The Fitbit One has demonstrated both significant overestimation- 26,30 and
underestimation 27 of EE during treadmill locomotion (p<.05). For these studies,
participant populations and protocols were similar. E.g. healthy adult, age range: 19 – 41
years and treadmill locomotion, respectively. Lastly, we found that the MFS and MFF
significantly overestimated kcals (range: 105 to 190 kcals/2-hrs) for two trials and
significantly underestimated kcals (range: -160 to -170 kcals/2-hrs.) for one trial
compared to the GT3X-BT. Currently, no studies have examined EE estimations from
Misfits during treadmill locomotion, only.
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Energy expenditure estimates from the FBO, FBF, MFS, MFF and GV during
electronic orbital shaking and EE estimates from human, treadmill studies illustrate the
need for further investigation into possible origins of device differences.
This study has several strengths. First, electronic orbital shaker testing removes
human variation. As a result, we are confident that observed differences are due to
technological features of the devices and not impacted by human variation. Second, ATs
were tested over a wide range of frequencies, which allowed identification of exact
frequencies where differences were present. This information may be valuable to both
consumers and manufacturers, depending on their needs. For example, a consumer may
seek to use a device that can detect steps while walking at a moderate pace. A
manufacturer may choose to adjust filters and/or algorithms to allow step detection at
lower oscillation frequencies (e.g. 0.7 Hz). Lastly, we employed a widely used, valid,
and reliable, research-grade accelerometer as our reference.
This study has several limitations. First, the ATs that were tested in the present
study are made to be worn by people. It is possible that these devices possess algorithms,
and/or filters to detect, and remove artificial human movement (i.e. electronic orbital
shaking). Thus, AT data would differ from our reference. Another limitation is that step
estimates and EE estimates from Freedson VM3 equation were developed via humantesting. Though studies have provided evidence that sensor output is often calibrated
during standardized activities such as walking on a treadmill, 154 applying the same
algorithm to electronic oscillations may be inappropriate. Lastly, we did not include
estimated EE from all ATs. Currently, Fitbit is the only AT company that provides
minute-by-minute data via the research platform Fitabase. For all other ATs, the exact
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time between 3-minute trials could not be determined. As a result, it was not possible to
compare EE estimates from these ATs to our reference for the 3-minute protocol.

In conclusion, this study provides the first evidence of AT estimates of steps and
EE compared to the GT3X-BT during electronic shaking. Our main findings were that,
on average, the NL produced the smallest error. All other ATs were equivocal, with
some overestimating steps or EE, and others underestimating steps or EE compared to the
GT3X-BT. This study is a first step toward a more comprehensive understanding of AT
estimates of steps and EE during electronic shaker. More research is needed to identify
specific causes for these differences so to improve the accuracy and precision in AT
estimates of steps and energy expenditure.
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Figure 13. Steps per 3-minutes during electronic oscillation
AG, ActiGraph wGT3X-BT; FBF, Fitbit Flex; FBO, Fitbit One; MFF, Misfit Flash; MFS, Misfit Shine; NL, NL-1000 pedometer;
Vivofit, Garmin Vivofit.
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Figure 14. Energy expenditure per 3-minutes during electronic oscillation
AG, ActiGraph wGT3X-BT; FBF, Fitbit Flex; FBO, Fitbit One
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Figure 15. Steps per 2-hours during electronic oscillation
Data presented as mean and 95% confidence intervals
FBF, Fitbit Flex; FBO, Fitbit One; MFF, Misfit Flash; MFS, Misfit Shine; NL, NL-1000 pedometer: GV, Garmin Vivofit.
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Figure 16. Energy expenditure per 2-hours during electronic oscillation
Data presented as mean and 95% confidence intervals
FBF, Fitbit Flex; FBO, Fitbit One; MFF, Misfit Flash; MFS, Misfit Shine; NL, NL-1000 pedometer: GV, Garmin Vivofit.
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CHAPTER 5
STUDY TWO – VALIDATION OF CONSUMER AND RESEARCH-GRADE
ACTIVITY MONITORS IN FREE-LIVING SETTINGS
Introduction
Lack of physical activity (PA) is strongly implicated in virtually all leading causes
of chronic disease morbidity and mortality. To attenuate the prevalence of these
preventable chronic diseases and promote health benefits, the U.S. Government
recommends that Americans accumulate at least 10,000 steps/day,3 increase daily
expenditure approximately 150 kilocalories (kcals) per day (equivalent to about 1,000
kilocalories/week)2 and/or engage in at least 150 minutes of moderate PA, or 75 minutes
of vigorous PA, or an equivalent of combined moderate-to-vigorous PA (MVPA) per
week.1 Although there are currently no federal guidelines for sedentary behavior (SB)
from the United States, SB recommendations from Australia state that adults should
minimize the amount of time spent in prolonged sitting and break up long periods of
sitting. 4 Dissemination of these recommendations has led to a heightened awareness of
the importance and value of PA monitoring as a strategy for chronic disease management.
Tools such as wearable devices to track personal PA provide a mechanism to be more
informed about activity behavior. As a result, consumer devices that track PA behavior
are increasingly popular for researchers, the general public, and developers and
manufacturers of ATs.

According to a recent report, the global wearable technology market will grow
from over $30 billion in 2016 and should reach over $150 billion in 2026.5 Activity
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trackers such as the Fitbit (FB) (Fitbit Inc., San Francisco, CA) provide estimates of
steps, energy expenditure (EE), activity minutes and sedentary time (sitting). According
to reports, Fitbit remained the leading brand in ATs in 2015, accounting for 79 percent of
sales.6 This expanding market for ATs is driven in part by lower cost, longer battery life
and more memory (e.g. to store data for days or weeks). However, growth of the market
and advances in consumer device technology far outpace our knowledge about the
validity of such devices. This gap is of major concern since it is not clear if these devices
provide accurate information. Therefore, to address this problem, it is essential to
improve our understanding of the accuracy and precision of the activity output measures
of consumer devices. Several studies to validate ATs have been conducted in lab-based
settings. Lab-based activity protocols range from fixed time treadmill and overground
walking and running to SBs and simulated free-living activities (e.g. vacuuming,
computer work). From these studies, we have advanced our knowledge of the accuracy
and precision of ATs in estimating physical activity (PA) and ST in laboratory settings.
However, there is limited knowledge of how ATs perform outside of a laboratory setting
(i.e. free-living environment) where these devices are used by consumers. Addressing this
knowledge gap is essential to a comprehensive understanding of the validity of ATs for
estimating PA and ST.

To date, few studies have validated ATs in free-living settings. Of these studies,
none have employed direct observation (DO) as the criterion measure for steps, EE,
activity minutes or sedentary time. The objective of the present study was to determine
the accuracy and precision of ATs in estimating steps, EE, activity minutes and sedentary
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time compared to direct observation-derived measures (criterion measures) in free-living
settings. We also validated commonly used research-grade devices.
Methods
Eligible participants were 18-59 years of age and were in good physical health.
All participants sign an informed consent document approved by the University of
Massachusetts Institutional Review Board.

Participants wore a variety of activity monitors on the wrists, hips or ankle, and a
biometric shirt, while carrying out their daily activities in the wild (free-living
environments) for three, 2-hour sessions. Participants were videotaped (i.e. direct
observation) for all sessions. The video data were imported and processed in a custom
behavioral analysis program previously validated.42

Instrumentation
Research-grade accelerometer. ActiGraph GT3X-BT (AG) Accelerometer
(ActiGraph™ LLC, Pensacola, Florida). This device is a lightweight triaxial PA monitor
(4.6cm x 3.3cm x 1.5cm, 19g) that measures acceleration ranging in magnitude from -8 to
+8 g’s. The accelerometer output has a sampling output range of 30 to 100 Hz and is
digitized by a twelve-bit analog-to-digital convertor.

Research-grade step counter. StepWatch™ (SW) (Mōdus™ Health llc,
Washington, DC) monitor. The SW is an ankle- worn device (dominant leg) that
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contains a microprocessor-controlled step counter, and detects steps. Step counts can be
recorded every 3 to 60 seconds.

Activity Trackers
Nine different activity trackers were studied: 1) Apple iWatch Sport (AiW)
2) Fitbit Flex (FBF), 3) Fitbit One (FBO), 3) Garmin® Vivofit (GV), 4) Microsoft
Band (MB), 5) Misfit Flash (MFF), 6) Misfit Shine (MFS), 7) Polar Loop (PL), 8)
Withings Pulse (WP) and 9) New Lifestyles NL-1000 pedometer (NL).
Participants’ stride length was determined according to the manufacturers
recommended method and programmed into the devices requiring this input. 139
(See Tables 8 and 9 for detailed specifications of each AT)

Biometric Shirt. The Hexoskin Biometric Shirt (HxSkin) (Carré Technologies
Inc., Montréal, Québec, Canada) is a multi-parameter physiological recording system
designed to monitor levels of PA and EE, which combines measurements of cardiac,
ventilation, and trunk acceleration.

Video Recording and Direct Observation. We employed a GoPro Hero+ LCD
(GOPRO, Inc. San Mateo, Ca) camera to record all observation sessions. The Noldus
Observer® XT (Information Technology B.V: Wageningen, Netherlands) is the software
package for the collection, analysis, and presentation of observational data
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Procedures
Participant height was measured to the nearest 0.25 cm using a standard floor
stadiometer and weight was measured using a Tanita scale (DC-430) to the nearest 0.1
kg.
Research-Grade Accelerometer. Participants were fitted with two AG activity
monitors. Both AG monitors were synced to the same laptop and initialized in advance
to collect data at a sampling rate of 80 Hz. The wrist monitor (AGwrist) was secured
using a Velcro strap to the non-dominant wrist (positioned over the dorsal aspect of the
wrist midway between the radial and ulnar styloid processes), and the hip monitor
(AGhip) was secured using a belt at the iliac crest in line with the anterior axilla. The
initialization and wrist wear location are consistent with the current National Health and
Nutrition Examination Survey (NHANES) activity monitoring study protocol. 145

StepWatch™. Participants were fitted with a SW monitor which was fastened
using a Velcro strap to the dominant ankle (positioned superior to the lateral malleolus).
The SW was programmed to record at 3-second intervals, with sensitivity (the magnitude
of acceleration that the device qualifies as constituting a step) set to 13 and cadence (how
often the device searches for steps taken) set to 73, consistent with a previous study. 112
The cadence setting is the length of time (cadence settings x 0.01 s) after a step is taken
during which a subsequent step cannot be counted and sensitivity setting is the threshold
acceleration that must be exceeded to register a step. 155
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Activity Trackers. The device placement was counterbalanced across subjects.
For example, the total number of devices worn was the same for all subjects but the order
in which the devices were placed on subjects was different between subjects. The same
placement positions within each participant across the 3 observation sessions was used.
(e.g. participant 2, MFF, left hip for all observation sessions)

Direct Observation: criterion
The DO method employed in the present study was previously described by
Lyden et al.42,102 Briefly, participants were met by a trained observer in their natural
environment (e.g. home, place of work, school) and observed for approximately two
consecutive hours. A GoPro video camera was used to record each observation session.
The GoPro video files were imported into the behavioral coding software (Noldus
Observer XT). Focal sampling and duration coding (FSD) were used to record participant
behavior (activity type, body posture, intensity and duration). The FSD method is one
where every time a behavior changes (e.g. sitting to standing) the observer recorded the
new activity type from a coding scheme of general categories from the MET value (from
the Compendium of Physical Activities144) associated with that category. Each entry of
a behavior change was time stamped and the duration of each behavior occurrence was
saved. Steps were manually counted from the video. For a detailed description of the
procedures used to train researchers and the development of a comparable DO technique
see Kozey-Keadle et al.65

Direct observation observer training
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Training involved research assistants learning how to identify and record
activities described in the DO methods. After the training, study observers completed a
testing video (~10 min) that included different activities with various postures. Before
data collection, researchers were required to correctly classify at least 90% (Cohen’s
kappa coefficient (k) ≥ 0.90) of the body positions, intensity levels, and duration of
activities throughout the testing video.

Direct Observation Sessions
Participants were met by a trained observer in their natural environment (e.g.
home, place of work, school) and were observed for approximately two consecutive
hours. Each of the 2-hr observation sessions was done at different times of the day (e.g.
Session 1: morning; Session 2: afternoon; Session 3: evening), including one weekend
day, in the participants’ free-living settings (e.g. home, work, driving). For these three
visits, researchers initialized devices and met the participants in their free-living
environment to be fitted with a variety of activity monitors that were worn on the wrists,
hip and ankle, and a biometric shirt. At the end of the 2-hr recording period, researchers
recorded the data from the ATs via the real-time display or iPhone app, and downloaded
data from monitors and video recording (see table 9 for detailed device initializing and
download).
Data Processing and Statistical Evaluation

Data Processing
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All data cleaning, processing and analysis were done using the open source R
statistical software package (www.r-project.org) and computing language R. 136

Criterion: Direct observation
A log of the start and stop of each behavior recorded by the observer was exported to a
csv file using a custom software and profile (Noldus: The Observer XT 12.5). These data
were used to determine criterion measures of activity and inactivity including, METminutes, MET-hours (where, 1 MET = 1 kcal/kg/hr), kcals per hour (where, Kcals=METs
x time x BW [kg]) and time in categories of intensity. The Mifflin-St Jeor equation was
used to estimate participant resting metabolic rate (RMR), 147 RMR was added to the EE
estimates from the WP monitor only and summed to estimate total calories (e.g. exercise
+ resting).
Total EE was determined by summing/totaling the amount of time spent in all
body positions from the DO coding system (e.g. total MET-minutes). METs were then
converted to Kcals/minute (Kcals= METs x time x body weight in kilograms).
Criterion. DO steps were defined as each event when the foot was completely
lifted off and lowered back to the ground. To determine criterion step count, steps were
manually counted twice for each 2-hour video recording session, and averaged. If there
was a greater than 5% difference between total step counts, the video was analyzed a
third time and the average of the two closest total step counts was used for analysis.
Total steps were determined by summing/totaling the number of steps manually
counted/2-hour session. Two trials required a third measure (2.1%).
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Research-grade accelerometers

ActiGraph GT3X-BT (AG). Accelerometer data were downloaded to a laptop
using the ActiGraph ActiLife v6.1.1 software and were later extracted to match the
corresponding DO time blocks. These data were then processed to derive total time spent
in each activity type (cutpoint/method: AGhip;77 AGwrist156), intensity (cutpoint/method:
AGhip;77 AGwrist156), EE (method: AGhip52) and steps for each participant. The
previous ActiGraph model GT3X+ has been shown to be a valid measure of both step
count compared with observation111,157,158 and MVPA compared to indirect calorimetry.77

StepWatch™ (SW). StepWatch data were downloaded to the same laptop used
for all devices via the SW software (v3.4). The SW data from the observation session
were then exported and saved for analysis. Total steps was determined by
summing/totaling the number of steps taken.

Activity Trackers
Steps, EE, activity minutes (if provided by AT) and sedentary time (if provided
by AT) data from ATs were recorded at the beginning and at the end of each observation
session. Total estimates were then calculated by subtracting the start values from the end
values.

Fitabase (Small Steps Labs, LLC. San Diego, Ca). All FB data were exported
using Fitabase, a research platform that acquires data from Internet connected consumer
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devices. Currently, FB is the only consumer device company that utilizes Fitabase. The
advantage of using this platform to acquire FB data is that it provides minute-by-minute
data for steps, kcals, MET-minutes and activity minutes (intensity) in comparison to the
FB software and Dashboard which only provides totals for steps, kcals and intensity for
the monitoring period.

Biometric Shirt. The HxSkin data were downloaded to the HxServices
Dashboard. Next, an “Activity” was created in the myhexoskin website for the 2-hour
observation session (data are time stamped). Then energy expenditure and step estimates
were recorded for each 2-hour observation session.

Statistical Evaluation

Correlations
We used the Pearson correlation coefficient to determine the strength of the
relationship between criterion measured and device estimated steps, EE, activity minutes
and ST.
Accuracy
We used bias in units of steps, kcals and minutes (AT estimates – criterion) and as
a percentage [(mean difference between the AT estimates and the criterion/ criterion x
100]. The percentage bias is useful because, for instance, a 10% bias of 15,000 steps/2hrs could be applied to an observation time of 2-hrs (a 2-hr overestimate), compared to
bias of +1,500 steps/2-hrs.
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Precision
We used confidence intervals (CI) as measures of precision. If the upper and
lower 95% confidence interval of the bias span 0, then the estimate was not considered
significantly different from the criterion at α = .05. Higher precision was indicated by
higher correlations and smaller CI.
Linear mixed models were used to compare the accuracy and precision of the
steps, EE, activity minutes and ST estimates from the devices.
Results
Table 11 illustrates participant’ characteristics. Thirty-two healthy adults (50%
female, 37.5% minority). Average age (yrs.) and BMI (kg*m-2) were 32.3 and 24.4,
respectively.

Table 12 summarizes participant visits by day of week and time block. Morning
(time from arising from bed for the day until lunchtime [or 12:00 PM if no lunch]),
afternoon (period during lunch [or 12:00 PM] until dinner [or 6:00 PM if no dinner]) and
evening (time after dinner until getting into bed for the night) visits totaled 29, 34 and 33,
respectively. Weekday and weekend visits totaled 62 and 34, respectively.

Table 13 summary statistics (in minutes) of top eight activity categories that
participants engaged in during 2-hr visits. Activity categories are based on the
Compendium of Physical Activities.146 Means ranged from 18.1 minutes
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(Transportation) to 90.5 minutes (Occupational). Minimums ranged from 1.0 minute
(Walking) to 55.0 minutes (Running). Maximums ranged from 12.0 minutes (Walking)
to 120.0 minutes (Conditioning Exercise, Home Activities and Occupational). As a
percent of 2-hours, means were 15.1% minutes, 15.3% minutes, 18.8% minutes, 47.6%
minutes, 54.0% minutes, 59.2% minutes, 62.8% minutes and 75.4% minutes for
transportation, walking, self-care, home activities, miscellaneous, running, conditioning
exercise and occupational, respectively.

Relationship between criterion measured and device estimated steps: Figures 18 - 21
show correlations between DO measured steps and device estimated steps. Correlations
ranged from r= 0.86 (FBF) to r = 0.97 (AGhip, NL).

Differences between criterion measured and device estimated steps: Figure 22 shows
bias of ATs, AGhip, AGwrist, and SW step estimates compared to DO measured steps.
Average steps for DO was 2,623/2-hours. The SW and PL were not significantly
different from DO. Average steps were -119 (CI:-439,201) and -57 (CI:-291,175)
steps/2-hours for the SW and PL, respectively. All other devices significantly
underestimated steps compared to DO. For several devices, underestimations ranged
from -753 to -524 steps/2-hours. The FBF, WP, FBO, MFS, HxSkin, AGhip and MB
underestimates were -753 (CI:-1,144,-362.8), -725 (CI:-887,-564), -647 (CI:-869,-425), 628 (CI:-816,-440), -586 (CI:-768,-403), -558 (CI:-699,-417), and -524 (CI:-689,-358)
steps/2-hours, respectively. For other devices, underestimations ranged from -437 to 285 steps/2-hours. In this range, the NL, MFF, AGwrist, GV, and AiW underestimations
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were -437 (CI:-581,-292), -435 (CI:-621,-250), -379 (CI: -717,-41), -341 (CI:-525,-156),
and -285 (CI:-559,-11) steps/2-hours, respectively.

Percent differences between criterion measured and device estimated steps: Figure
23 shows percent bias of ATs, AGhip, AGwrist, and SW step estimates compared to DO
measured steps.

The SW and PL were not significantly different from DO. Percent

average steps were -4.5% (%CI:-16.7,7.6) and -2.1% (%CI:-11.1,6.7) steps/2-hours for
the SW and PL, respectively. All other devices significantly underestimated steps
compared to DO. For several devices, percent underestimations ranged from -28,7% to 19.9% steps/2-hours. In this range, the FBF, WP, FBO, MFS, HxSkin, AGhip and MB
percent underestimates were -28.7% (%CI:43.6,-13.8), -27.6% (%CI:-33.8,-21.5), -24.6%
(%CI:-33.1,-16.2), -23.9% (%CI:-31.1,-16.7), -22.3% (%CI:-29.3,-15.4), -21.2% (%CI:26.6,-15.8), and -19.9% (%CI:-26.3,-13.6) steps/2-hours, respectively. For other devices,
percent underestimations ranged from -16.6 to -10.8% steps/2-hours. In this range, the
NL, MFF, AGwrist, GV, and AiW percent underestimations were -16.6% (%CI:-22.1,11.1), -16.6% (%CI:-23.6,-9.5), -14.4% (%CI:-27.3,-1.5), -13.0% (%CI:-20.0,-5.9), and 10.8% (%CI:-21.3,-0.4) steps/2-hours, respectively.

Relationship between criterion measured and device estimated kcals Figures 24 -26
show correlations between DO measured kcals and device estimated kcals. Correlations
ranged from r = 0.32 (GV) to r = 0.85 (AGhip)
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Differences between criterion measured and device estimated kcals: Figure 27 shows
bias of AT and AGhip kcal estimates compared to DO measured kcals. Average kcals for
DO was 329/2-hours. The PL, MFF and MFS were not significantly different than DO.
Bias for the PL, MFF and MFS were -7.0 (CI:-37.0,22.8), 6.9 (CI:-36.6,50.4), and 8.3
(CI:-47.1,63.9) kcals/2-hours, respectively. The MB, WP, FBO, FBF, GV, AiW and
AGhip significantly underestimated kcals compared to DO. Underestimates for the MB,
WP, FBO, FBF, GV, AiW and AGhip were -121.8 (CI:-163.7,-79.9), -107.7 (CI:-136.1, 79.4), -90.6 (CI:-120.7,-60.5), -85.3 (CI:-123.8,-46.7), -71.4 (CI:-127.5,-15.3), -60.2 (CI:93.9,-26.5), and -48.8 (CI:-75.3,-22.3) kcals/2-hours, respectively. In contrast, the
HxSkin significantly overestimated kcals compared to DO. Average overestimation was
119.3 (CI:52.2,186.3) kcals/2-hours.

Percent differences between criterion measured and device estimated kcals: Figure
28 shows percent bias of AT and AGhip kcal estimates compared to DO measured kcals.
Average kcals for DO was 329/2-hours. The PL, MFF and MFS were not significantly
different than DO. Percent bias for the PL, MFF and MFS were -2.1% (%CI:-11.2,6.9),
2.0% (%CI:-11.1,15.3), and 2.5% (%CI:-14.3,19.4) kcals/2-hours, respectively. The MB,
WP, FBO, FBF, GV, AiW and AGhip significantly underestimated kcals compared to
DO. Percent underestimates for the MB, WP, FBO, FBF, GV, AiW and AGhip were 36.9% (%CI:-49.7,-24.2), -32.7% (%CI:-41.3,-24.1), -27.5% (%CI:-36.6,-18.3), -25.8%
(%CI:-37.5,-14.2), -21.6% (%CI:-38.7,-4.6), -18.2% (%CI:-28,5,-8.0), and -14.8%
(%CI:-22.8,-6.7) kcals/2-hours, respectively. In contrast, the HxSkin significantly
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overestimated kcals compared to DO. Average percent overestimation was 36.2%
(%CI:15.8,56.5) kcals/2-hours.

Relationship between criterion measured and device estimated MVPA minutes:
Figures 29 and 30 show correlations between DO measured MVPA minutes and device
estimated MVPA minutes. The correlations between DO MVPA minutes and FBF,
AGwrist, FBO and AGhip were r = 0.54, 0.70, 0.71 and 0.75, respectively.

Differences between criterion measured and device estimated MVPA minutes:
Figure 31 shows bias of MVPA minutes per 2-hours for the AGhip, AGwrist, FBO and
FBF compared to DO MVPA minutes. Average MVPA for DO was 27 minutes/2-hours.
The AGhip and FBO significantly underestimated MVPA minutes by -11.8 (CI:-15.5,8.1) and -5.4 (CI:-9.9,-0.9) /2-hours, respectively. In contrast, the AGwrist significantly
overestimated MVPA by 6.9 minutes (CI:2.5,11.4) /2-hours. The FBF was not
significantly different from DO MVPA minutes. On average, the FBF underestimated
MVPA by -3.5 (CI:-9.6,2.4) minutes/2-hours.

Percent differences between criterion measured and device estimated MVPA
minutes: Figure 32 shows percent bias of MVPA minutes per 2-hours for the AGhip,
AGwrist, FBO and FBF compared to DO MVPA minutes. The AGhip and FBO
significantly underestimated MVPA minutes by -43% (%CI:-57.3,-29.9) and -20%
(%CI:-36.7,-3.3) /2-hours, respectively. In contrast, the AGwrist significantly
overestimated MVPA minutes by 25% (%CI:9.2,42.1) /2-hours. The FBF was not
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significantly different from DO MVPA minutes. On average, the FBF underestimated
MVPA minutes by -13% (%CI:-35.6,9.1) minutes/2-hours.

Relationship between criterion measured and device estimated output analogous to
MVPA minutes: Figures 33 and 34 show correlations between DO MVPA minutes and
MVPA minutes from the NL, AiW, MFF, MFS, and PL. The correlations ranged from to
r = 0.20 (NL) to r = 0.64 (MFF). Correlations for the PL, MFS, and the AiW were r=
0.40, 0.56, and 0.57, respectively

Differences between criterion measured and device estimated output analogous to
MVPA minutes: Figure 35 shows bias of MVPA minutes per 2-hours for the AiW, PL,
NL, MFS, and MFF compared to DO MVPA minutes. All ATs significantly
underestimated MVPA minutes. On average, underestimations ranged from -17 to -13
minutes/2-hours. Confidence intervals ranged from -24 to -9 minutes per 2-hours. The
PL and NL estimates resulted in the widest CIs of approximately 14 minutes/2-hours,
respectively.
Percent differences between criterion measured and device estimated output
analogous to MVPA minutes: Figure 36 shows percent bias of MVPA minutes per 2hours for the AiW, PL, NL, MFS, and MFF compared to DO MVPA minutes. All ATs
significantly underestimated MVPA minutes. On average, percent underestimations
ranged from -64 to -48% MVPA minutes per 2-hours. Confidence intervals ranged from
-88 to -36% MVPA minutes per 2-hours. The PL and NL estimates resulted in the widest
CIs of approximately 48% and 50% MVPA minutes/2-hours, respectively.
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Relationship between criterion measured and device estimated sedentary time:
Figure 37 shows correlations between DO sedentary minutes and AT estimates of
sedentary minutes. Correlations for the FBO, FBF AGhip and AGwrist were r = 0.06, 0.06, 0.59 and 0.77, respectively.

Differences between criterion measured and device estimated sedentary time: Figure
38 shows the bias of AT and AGhip sedentary time estimates compared to DO sedentary
time. All devices significantly overestimated sedentary time compared to DO.
Overestimates for the Fitbit One, FBF and AGhip were 14.3 (CI:2.8,25.8), 20.9
(CI:9.3,32,5), and 52.0 (CI:43.6,60.4) sedentary minutes/2-hours, respectively.

Percent differences between criterion measured and device estimated sedentary
time: Figure 39 shows the percent bias of AT and AGhip sedentary time estimates
compared to DO sedentary time. All devices significantly overestimated sedentary time
compared to DO. Overestimates for the FBO, AGwrist, FBF and AGhip were 34%
(%CI:7.7,61.5), 47% (%CI:31.3,64.0), 50% (%CI:23.0,77.1), and 118%
(%CI:101.1,135.5) sedentary minutes/2-hours, respectively.

Discussion
The purpose of the present study was to validate ATs and research-grade
accelerometers in free-living settings to estimate steps, EE, activity minutes and
sedentary time using DO as the criterion method. In general, all devices accurately
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estimated steps and the estimates were highly correlated with DO. Estimates of EE,
MVPA minutes were less accurate and more variable across devices and correlations
between the estimated measure and the measure derived from DO ranged from weak
(r=0.20) to moderate (r=0.75). Devices were the least accurate in estimating sedentary
time, although one method156 was more correlated with DO (AGwrist r=0.77) (Table 14).
Activity Trackers
To date, several studies have validated ATs in estimating steps, EE, MVPA
minutes and sedentary time and the results are equivocal. Activity trackers have been
reported to significantly under- and- overestimate PA and ST. Most studies have used AG
accelerometer measures as the reference. The results from our study indicate that this is
not an appropriate reference measure, given the differences we observed between AG
measures of PA and ST in comparison to the measures derived from DO.
Steps
Our main findings were that ATs produced accurate step estimates and were
highly correlated to criterion measures. Current research has compared steps from
consumer ATs and research-grade devices in free-living settings. Some studies reported
that ATs overestimated steps, 21,32-34,159-161 while others reported that ATs underestimated
steps. 21,31,32,159 Differences in step results from previous studies compared to this study
may be related to the use of different reference measures. We reported that the AGhip
significantly underestimates steps by -558 (CI:-699,-417)/2-hours. Therefore, in most of
the studies that used the AG as the reference tool would yield results that indicate an
overestimation of steps by the ATs. For example, Ferguson et al32. reported that the WP
significantly underestimated daily steps by -632 compared to hip-worn ActiGraph
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GT3X+ steps (reference measure). Applying our AGhip findings (significant
underestimation [-558 steps/2-hrs]} to Ferguson’s may impact their findings (e.g. the WP
overestimates daily steps).

Energy Expenditure
We found that AT estimates of EE were less accurate than step estimates, and
highly correlated with criterion measures. Similar findings have been reported.37 The
current research comparing the EE estimates of ATs in free-living settings has primarily
used research-grade devices as the reference measure, with one study employing doublylabeled water (DLW).37 For EE, two studies showed ATs overestimated kcals,31,37 and
three studies showed that ATs underestimated kcals32,162,163 with variable precision in
free-living settings.31,32,37,162,163 We compared EE data recorded by ATs to EE data
estimated from DO. Because the DO system used has been validated as a criterion for
free-living PA and ST,42 our study improves upon the current literature.
MVPA Minutes/ Sedentary Time
The U.S. PA Guidelines (Guideline) define MVPA as activities where intensity is
greater than 2.99 METS. Currently, devices from one AT company (Fitbit) provide MET
values, retrievable via the research platform Fitabase. Accordingly, these data are
directly comparable to our criterion measure. Although ATs from other companies
provide proprietary estimates of PA intensity, they do not explicitly define MVPA (i.e.
Non-Guideline; Table 10).
In general, we found AT estimates of MVPA minutes (Guideline and NonGuideline) were less accurate than step and EE estimates, and were moderately to weakly
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correlated with criterion measures. To date, one validation study examining ATs in freeliving settings on adults employed Fitabase to retrieve MET-minutes of activity.164 They
reported, that the FBF significantly overestimated daily MET rate (mean difference 0.7,
SD 0.09, METs/day, P<.001), proportion of time in moderate (mean difference 3.0%, SD
11.0%, per day, P<.001) and vigorous PA (mean difference 3.0%, SD 1.0%, per day,
P<.001 compared to the AG GT3X. Several studies have examined estimates of NonGuideline MVPA minutes from ATs compared to accelerometer derived MVPA minutes
in free-living adults. Two studies reported ATs underestimated MVPA minutes,31,33 three
studies reported ATs overestimated MVPA minutes, 43,161,165,166 and one study reported
ATs underestimated and overestimated MVPA minutes in free-living settings.32
We reported that ATs were the least accurate at estimates of sedentary time
(overestimated) and were weakly correlated with criterion measures. Underestimations164
and overestimations41,166 of sedentary time by ATs have been previously reported. Two
studies164,41 used the AG accelerometer as the comparison measure and applied different
count cutpoints to define sedentary time. One study used the activPAL as the comparison
measure.166 The contrasting findings of previously reported sedentary time to ours may
be reflective of reference measures used to compare ATs: accelerometers versus DO.
Direct observation is considered superior to accelerometers in estimating PA behaviors167
as it provides instant, visual information regarding activity type, posture and contextaspects that govern PA intensity- and may influence device output. For example, we
coded all seated activity (e.g. seated typing) as sedentary, while a wrist-worn AT may
detect hand/wrist accelerations as steps. We are confident that employing DO provides
us with a true measure of free-living behaviors.
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Research-grade accelerometers
We found that step estimates from research-grade accelerometers were accurate
and highly correlated with DO (range: r=0.91 (SW) to 0.97 (AGhip)). Despite statistical
differences (e.g. over-or-underestimations), the AGhip and AGwrist were highly
correlated with DO (AGhip range: r=0.56 (sedentary time) to 0.97 (steps); AGwrist
range: r=0.70 (MVPA) to 0.95 (steps). Similar to our findings, the SW has been shown to
accurately estimate steps in simulated free-living laboratory investigations.112 Accept for
sedentary time, AGwrist estimates were greater than AGhip estimates. Several studies
have reported the wrist location produces greater output as compared to the hip location,
in free-living settings.168,169 For MVPA, the AGwrist and AGhip were less accurate (than
for steps) (percent bias: 25.6% and -43.6, respectively) but remained moderately
correlated with DO (r=0.70 and 0.75, respectively). This may be the result of differences
in wear-location and/or methods used to derive MVPA minutes (e.g. raw accelerations
for AGwrist compared to counts per minute for AGhip). This is in contrast to the study
by Murakami et al.37 who reported that AGhip underestimated EE (bias -534.9 kcals/d)
compared to doubly-labeled water with strong correlations (r=0.80) during 15-days of
free-living time. Similar to previous studies AGhip tended to underestimate102 and
AGwrist overestimated MVPA minutes169 compared to reference measures (DO and
AGhip, respectively). AGhip and AGwrist overestimated sedentary time (percent bias:
118.3 and 47.5%, respectively). Previous studies are in agreement with our AGwrist
findings156 but disagree with our AGhip findings.65 It is possible that the
underestimation of sedentary time in the present study is due to differences in data
processing techniques to estimate sedentary time. For example, Kozey-Keadle et al.65
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used AG counts per minute to categorize ST compared to Staudenmayer et al. who used
AG 15-second epochs from raw-accelerations and machine-learning techniques to
categorize ST.
Activity trackers compared to Research-grade accelerometers
We showed that ATs perform similar to research-grade accelerometers is
estimating steps and EE. However, ATs are less precise and accurate in estimating
MVPA minutes and sedentary time. These differences are likely the result contrasting
methods used to define MVPA minutes and sedentary time. For example, we defined
MVPA and ST using posture and intensity, whereas ATs rely entirely on proprietary
algorithms. For the AGs, MVPA and ST were defined using counts/min (AGhip) and 15second epochs (from raw-accelerations) and random forest (machine-learning technique)
(AGwrist).
There is a growing movement toward using ATs as a measurement tool in PA
intervention trials. There are many clinical trials underway that are employing ATs to
estimate PA and ST exposures and outcomes. Our findings suggest that ATs are accurate
in estimating PA behaviors such as steps in free-living settings. In fact, step accuracy
was similar between ATs and research-grade accelerometers. Though more research
validating ATs in free-living settings compared to DO is needed, it is reasonable to
employ these devices to estimate measures of steps, EE and MVPA minutes. On the
other hand, our results indicate that the accuracy and precision of ATs in estimating ST is
less certain.
Given the widespread use of ATs, we have an opportunity to engage the public
and industry leaders who sell these devices in conversations about their experiences in
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using these devices with the goal to improve the user experience to enhance long-term
compliance and adapting a more active lifestyle. Evidence presented in this study
support the accuracy and serve as an anchor for these conversations.
Strengths and Limitations
The primary strengths of this study were the use of a validated DO method42 to
derive criterion measures for PA and sedentary behavior measures and conducting this
study in the natural environment Most previous free-living studies employed
accelerometers as a surrogate for gold-standard criterion measures (e.g. DO, doubly
labeled water) to assess steps, EE, activity minutes and/or ST. 32-34,43-46 Another strength
was the wide range of activities, intensities of activities and the duration of activities
performed naturally by participants. Activities ranged from sleeping to trail running.
Intensities ranged from 1.0 to 12.0 METs, and duration of specific activities ranged from
seconds to hours. All provided a unique opportunity to capture a rich dataset critical to
proper scrutiny of AT estimates of PA and ST. Additional strengths included having
observations conducted at all times of day ranging from 5:00 am to after 11:00 pm and
conducted in multiple settings as diverse as a Zumba class to a nightclub (Tables 12 and
13).
This study also has limitations. We employed a validated DO system that used
the Compendium of Physical Activities to apply MET values to activities. The values in
the Compendium do not estimate the energy cost of PA in individuals in ways that
account for differences in body mass, adiposity, age, sex, efficiency of movement, and
environmental conditions in which the activities are performed.146 Therefore, it is
possible that activities were misclassified by intensity category, which may have resulted
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in inaccuracies of activity minutes, sedentary time and energy expenditure. The
observation duration within each trial was another limitation. We observed participants
for three, 2-hour time frames. Compared to previous free-living AT validation studies,
the time frame for observation is short. In general, ATs are designed to be worn during
waking hours and while sleeping. Thus, our findings may not be a true representation of
whole day behavior. However, we do have a broad range of activities ranging from light
to very vigorous activity and a balanced distribution of time of day and day of week that
participants were observed (Tables 12 and 13).
In conclusion, this study provides evidence that ATs are accurate with varying
precision in estimating steps, EE and activity minutes. Sedentary time estimates from
ATs were less accurate. Further, AT and research-grade accelerometers performed
similarly (e.g. both were more accurate in estimating steps and less accurate in estimation
MVPA minutes). This work significantly advances the field of activity monitor
validation that should set the standard for future work.
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Device
Cost
Wear location
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Tracks Calories
Burned
Tracks Active
Time
Tracks Steps
Tracks
Distance
Tracks
Elevation/Stairs
Tracks Sleep
Tracks Heart
Rate
Battery or
Chargeable
Uploading Data
Tracker Display

Apple
iWatch
Sport
$350.99
Wrist

Fitbit Flex

Fitbit One

Garmin
Vivofit

Microsoft
Band

Misfit
Flash

Misfit
Shine

Polar loop

Withings
Pulse

$99.99
Wrist

New
Lifestyles
NL-1000
$54.95
Hip

$79.95
Wrist

$99.95
Clip on
(multiple
locations)

$199.99
Wrist

$29.99
Clip on
(multiple
locations)

$69.99
Clip on
(multiple
locations)

$109.95
Wrist

$119.95
Clip on and
wrist band

✓

✓

✓

✓

✗

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

!

!

✓

!

!

!

!

!

!

✓

✓
✓

✓
!

✓
!

✓
!

!
!

✓
✓

✓
!

✓
!

✓
✓

✓
✓

Chargeable
(every 18
hours)
Bluetooth

Chargeable
(every 5
days)
Bluetooth

Chargeable
(every 10+
days)
Bluetooth

Battery
(every 1+
years)
Bluetooth

Chargeable
(every 48
hours)
USB

Battery
(lasts up to
6 months)

Battery
(lasts up to
6 months)

Chargeable
(up to 6
days)
USB

Chargeable
(every 2
days)
Bluetooth

Real-time
data

LED
progress
indicator

Real-time
data

Realtime data

Battery
(up to 18
months)
Real-time
data
Real-time
data

Real-time
data

LED
progress
indicator

LED
progress
indicator

Real-time
data

Real-time
data

Table 8. Features of consumer-based activity trackers
LED, Light-Emitting Diode; USB, Universal Serial Bus

Device (Location)

Output

Data Extraction Method
Upload

Retrieval
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Apple iWatch Sport (W)

EE, steps, active calories, min: exercise, total active time, stand hours

Bluetooth

Apple Activity App

GT3X-BT (W & H)

Steps, min: Sedentary, light, moderate, vigorous

USB cable

ActiLife

Fitbit Flex /One (W/H)

EE, steps, MET-min, min: sedentary, light, moderate, vigorous

Bluetooth

Fitabase

Garmin Vivofit (W)

EE, steps, active calories, %: sedentary, active, highly active

Bluetooth

Garmin Connect™ App

Hexoskin (T)

EE, steps

USB cable

Hexoskin dashboard

Microsoft Band (W)

EE, steps, active min

USB cable

MB dashboard

Misfit Flash/Shine (H/W)

EE, steps, active min: light, moderate, vigorous

Bluetooth

Misfit App

New Lifestyles NL-1000 (H)

Steps, MVPA min

RTD

RTD

The Observer XT (NA)

MET-hours, MET-min

The Observer XT

The Observer XT

Polar Loop (W)

EE, steps, time: lying, sitting, active, sitting, min: stand, walk, run

USB cable

Polar dashboard

StepWatch (A)

Steps

USB cable

StepWatch dashboard

Withings Pulse (H)

EE, steps

Bluetooth

Withings App

Table 9. Devices with corresponding output and data extraction method
H, hip; W, wrist: T, torso; A, Ankle; NA, not applicable; EE, energy expenditure; min, minutes; MVPA, moderate-to-vigorous
physical activity; MB, Microsoft Band; RTD, real-time display

Device

Output

Definition

Apple iWatch

Exercise minutes

Anything above a brisk walk is classed as exercise. Every full minute of
movement equaling or exceeding the intensity of a brisk walk counts towards
daily Exercise goal (30 min).

Fitbit Flex/One

Active minutes

Activities at or above about 3 METs. Minutes are only awarded after 10
minutes of continuous moderate-to-intense activity.

Misfit Flash/Shine

Light-, moderate-,

No definitions provided.
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vigorous- minutes
NL-1000

MVPA

Moderate-to-vigorous physical activity (MVPA) time accumulation.

Polar Loop

WALK and JOG

Medium and high intensity activity, respectively.

Table 10. Activity tracker intensity outputs and definitions

Characteristic
Age (yrs.)
BMI (kg*m-2)

Mean (SD)
32.3 (13.3)
24.4 (3.3)

N (%)
Female
Minority

16 (50)
12 (37.5)
Table 11. Participant characteristics (N = 32)
SD, standard deviation; BMI, body mass index
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Weekday

Weekend Day

Total Visits

Morning

18

11

29

Afternoon

20

14

34

Evening

24

9

33

Total Visits

62

34

96

Table 12. Summary of visits by day of week and time block
Morning, the time from arising from bed for the day until lunchtime (or 12:00 PM if no
lunch); Afternoon, the period during lunch (or 12:00 PM) until dinner (or 6:00 PM if no
dinner); Evening, the time after dinner until getting into bed for the night
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Mean

SD

Minimum Maximum

Conditioning Exercise

75.4

33.5

5.0

120.0

Home Activities

57.1

43.5

1.0

120.0

Miscellaneous

64.8

43.4

2.5

120.0

Occupational

90.5

38.0

5.0

120.0

Running

71.0

17.7

55.0

90.0

Self-Care

22.5

24.6

1.0

66.0

Transportation

18.1

12.7

5.0

45.0

Walking

18.3

23.7

1.0

12.0

Table 13. Summary statistics (in minutes) of top eight activity categories that
participants engaged in during 2-hr visits
Activity categories are based on the Compendium of Physical Activities
SD, standard deviation; NA, not applicable
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Criterion (avg)
Device
AGhip
AGwrist
SW
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AiW
FBF
FBO
GV
HxSkin

Accuracy (%)
Precision
Correlation
Accuracy (%)
Precision
Correlation
Accuracy (%)
Precision
Correlation
Accuracy (%)
Precision
Correlation
Accuracy (%)
Precision
Correlation
Accuracy (%)
Precision
Correlation
Accuracy (%)
Precision
Correlation
Accuracy (%)
Precision
Correlation

Steps
2,623

EE (kcals)
329.0

MVPA (min)
27.0

SED (min)
43.0

-579⨢ (-22.0%)
-718,-439
0.97
⨢
-379 (-14.4%)
-717,-40
0.95
-180 (-6.8%)
-421,60
0.92
-285⨢ (-10%)
-559,-11
0.91
⨢
-753 (-28.7%)
-1,144,-362
0.83
⨢
-647 (-24.6%)
-869,-425
0.96
-341⨢ (-13.0%)
-525,-156
0.95
-586⨢ (-22.3%)
-768,-403
0.96

-48.8⨢ (-14.8%)
-75.3,-22.3
0.85
NA
NA
NA
NA
NA
NA
⨢
-60.2 (-18.2%)
-93.9,-26.5
0.75
⨢
-85.3 (-25.8%)
-123.8,-46.7
0.71
⨢
-90.6 (-27.5%)
-120.7,-60.5
0.76
-71.4⨢ (-21.6%)
-127.5,-15.3
0.32
119.3⨢ (36.2%)
52.2, 186.3
0.67

-11.8⨢ (-43.6%)
-15.5, -8.3
0.75
⨢
6.9 (25.6%)
2.5, 11.4
0.70
NA
NA
NA
⨢
-16.8 (-62.0%)
-21.8,-11.7
0.57
-.35 (-13.2%)
-9.6,2.4
0.54
⨢
-5.4 (-20.0%)
-9.9,-0.9
0.71
NA
NA
NA
NA
NA
NA

50.6⨢ (118.3%)
43.2,57.9
0.59
⨢
20.3 (47.5%)
13.3,27.3
0.77
NA
NA
NA
NA
NA
NA
⨢
21.4 (50.0%)
9.8,33.0
-0.06
⨢
14.8 (34.6%)
3.3,26.3
0.06
NA
NA
NA
NA
NA
NA

Criterion (avg)
Device
MB
MFF
MFS
NL
148

PL
WP

Accuracy (%)
Precision
Correlation
Accuracy (%)
Precision
Correlation
Accuracy (%)
Precision
Correlation
Accuracy (%)
Precision
Correlation
Accuracy (%)
Precision
Correlation
Accuracy (%)
Precision
Correlation

Steps
2,623

EE (kcals)
329.0

MVPA (min)
27.0

SED (min)
43.0

-524⨢ (-19.9%)
-689,-358
0.96
⨢
-435 (-16.6%)
-621,-250
0.96
-628⨢ (-23.9%)
-816,-440
0.96
-437⨢ (-16.6%)
-581,-292
0.97
-57 (-2.1%)
-291,175
0.95
⨢
-725 (-27.6%)
-887,-564
0.96

-121.8⨢ (36.9%)
-163.7,-79.9
0.41
6.9 (2.0%)
-36.6,50.4
0.75
8.3 (2.5%)
-47.1,63.9
0.71
NA
NA
NA
-7.0 (-2.1%)
-37.0,22.8
0.8
⨢
-107.7 (-32.7%)
-136.1, -79.4
0.77

NA
NA
NA
⨢
-13.1 (-48.4%)
-17.7,-8.5
0.64
-15.7⨢ (-57.9%)
-20.5,-10.9
0.56
-16.6⨢ (-61.2%)
-24.4,-9.7
0.20
⨢
-17.4 (-64.4%)
-23.9,-10.8
0.40
NA
NA
NA

NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA

Table 14. Summary of device accuracy, percent accuracy, precision and correlations in estimating steps, energy expenditure,
MVPA and sedentary minutes compared to criterion measures
MVPA, moderate-to-vigorous physical activity; SED, sedentary; EE, energy expenditure; avg, average; AGhip, hip-worn GT3X-BT;
AGwrist, wrist-worn GT3X-BT; NA, not applicable.
⨢, significantly different than criterion (p<0.05).

AGhip Steps
(Steps)

(Steps)

AGwrist Steps

(Steps)

(Steps)

MFS Steps
(Steps)

(Steps)
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MFF Steps

(Steps)

(Steps)

Figure 18. Relationship between criterion steps and hip- and- wrist-worn ActiGraph, Misfit Flash and Misfit Shine estimated
steps

FBO Steps
(Steps)

(Steps)

FBF Steps

(Steps)

(Steps)

SW Steps
(Steps)

(Steps)
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NL Steps

(Steps)

(Steps)

Figure 19. Relationship between criterion steps and Fitbit One, Fitbit Flex, NL-1000 and StepWatch estimated steps

WP Steps
(Steps)

(Steps)

GV Steps

(Steps)

(Steps)

HxSkin Steps
(Steps)

(Steps)
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PL Steps

(Steps)

(Steps)

Figure 20. Relationship between criterion steps and Withings Pulse, Garmin Vivofit, Polar Loop and Hexoskin estimated
steps

MB Steps
(Steps)

(Steps)

AiW Steps

(Steps)

(Steps)
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Figure 21. Relationship between criterion steps and Apple iWatch and Microsoft Band estimated steps

Bias: Steps
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Figure 22. Bias for Fitbit Flex (FBF), Withings Pulse (WP), Fitbit One (FBO), Misfit Shine (MFS), Hexoskin (HxSkin), hipworn ActiGraph (AGhip), Microsoft Band (MB), NL-1000 (NL), Misfit Flash (MFF), wrist-worn ActiGraph (AGwrist),
Garmin Vivofit (GV), Apple iWatch (AiW), StepWatch (SW) and Polar Loop (PL), step estimates compared to criterion
steps
Data presented as mean and 95% confidence intervals
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Figure 23. Percent bias Fitbit Flex (FBF), Withings Pulse (WP), Fitbit One (FBO), Misfit Shine (MFS), Hexoskin (HxSkin),
hip-worn ActiGraph (AGhip), Microsoft Band (MB), NL-1000 (NL), Misfit Flash (MFF), wrist-worn ActiGraph (AGwrist),
Garmin Vivofit (GV), Apple iWatch (AiW), StepWatch (SW) and Polar Loop (PL), step estimates compared to criterion
steps
Data presented as mean and 95% confidence intervals
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FBO Kcals
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MFS Kcals
(Kcals)

(Kcals)
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MFF Kcals

(Kcals)

(Kcals)

Figure 24. Relationship between criterion energy expenditure and Fitbit One (FBO), Fitbit Flex (FBF), Misfit Flash (MFF)
and Misfit Shine (MFS) estimated energy expenditure
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(Kcals)

HxSkin Kcals
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PL Kcals

(Kcals)

(Kcals)

Figure 25. Relationship between criterion energy expenditure and Withings Pulse (WP), Garmin Vivofit (GV), Polar Loop
(PL) and Hexoskin HxSkin) estimated energy expenditure
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MB Kcals
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Figure 26. Relationship between criterion energy expenditure and hip-worn ActiGraph (AGhip), Apple iWatch (AiW) and
Microsoft Band (MB) estimated energy expenditure

Bias: Energy Expenditure
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Figure 27. Bias from Microsoft Band (MB), Withings Pulse (WP), Fitbit One (FBO), Fitbit Flex (FBF), Garmin Vivofit (GV),
Apple iWatch (AiW), hip-worn ActiGraph (AGhip), Polar Loop (PL), Misfit Flash (MFF), Misfit Shine (MFS) and Hexoskin
(HxSkin) energy expenditure estimates compared to criterion energy expenditure
Data presented as mean and 95% confidence intervals

Percent Bias: Energy Expenditure
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Figure 28. Percent bias from Microsoft Band (MB), Withings Pulse (WP), Fitbit One (FBO), Fitbit Flex (FBF), Garmin
Vivofit (GV), Apple iWatch (AiW), hip-worn ActiGraph (AGhip), Polar Loop (PL), Misfit Flash (MFF), Misfit Shine (MFS)
and Hexoskin (HxSkin) energy expenditure estimates compared to criterion energy expenditure
Data presented as mean and 95% confidence intervals

Figure 29. Relationship between criterion MVPA minutes and hip- and- wrist-worn ActiGraph (AGhip, AGwrist) estimated
MVPA minutes
160

FBO MVPA

FBF MVPA

Figure 30. Relationship between Criterion MVPA minutes and Fitbit One (FBO) and Fitbit Flex (FBF) estimated MVPA
minutes

Bias: MVPA

10

0

-5

-10

AGwrist
AGwrist

fitbitflex
FBF

fitbitone
FBO

-15

AGhip
AGhip

161

Device-Criterion (95% CI)

5

Figure 31. Bias from hip- and wrist-worn ActiGraph (AGhip, AGwrist), Fitbit One (FBO) and Fitbit Flex (FBF) MVPA
minutes estimates compared to criterion MVPA minutes
Data presented as mean and 95% confidence intervals
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Figure 32. Percent bias from hip- and wrist-worn ActiGraph (AGhip, AGwrist), Fitbit One (FBO) and Fitbit Flex (FBF)
MVPA minutes estimates compared to criterion MVPA minutes
Data presented as mean and 95% confidence intervals
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Figure 33. Relationship between criterion MVPA minutes and NL-1000 (NL) and Apple iWatch (AiW)estimated MVPA
minutes

MFF MVPA

MFS MVPA

PL MVPA
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Figure 34. Relationship between criterion MVPA minutes and Misfit Flash (MFF), Misfit Shine (MFS) and Polar Loop (PL)
estimated MVPA minutes
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Figure 35. Bias from Apple iWatch (AiW), Polar Loop (PL), NL-1000 (NL), Misfit Shine (MFS) and Misfit Flash (MFF)
MVPA minutes estimates compared to criterion MVPA minutes
Data presented as mean and 95% confidence intervals
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Figure 36. Percent bias from Apple iWatch (AiW), Polar Loop (PL), NL-1000 (NL), Misfit Shine (MFS) and Misfit Flash
(MFF) MVPA minutes estimates compared to criterion MVPA minutes
Data presented as mean and 95% confidence intervals
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Figure 37. Relationship between criterion sedentary minutes and Fitbit One (FBO), Fitbit Flex (FBF) and hip- and- wristworn ActiGraph (AGhip, AGwrist) estimated sedentary minutes
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Figure 38. Bias from Fitbit One (FBO), wrist-worn ActiGraph (AGwrist), Fitbit Flex (FBF) and hip-worn ActiGraph
(AGhip) sedentary minutes estimates compared to criterion sedentary minutes
Data presented as mean and 95% confidence intervals
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Figure 39. Percent bias from Fitbit One (FBO), wrist-worn ActiGraph (AGwrist), Fitbit Flex (FBF) and hip-worn ActiGraph
(AGhip) sedentary minutes estimates compared to criterion sedentary minutes
Data presented as mean and 95% confidence intervals

CHAPTER 6
STUDY THREE - ACTIVITY TRACKERS ARE SENSITIVIE TO CHANGE IN
PHYSICAL ACTIVITY AND SEDENTARY BEHAVIORS IN FREE-LIVING
SETTINGS
Introduction
Tools such as wearable devices to track personal physical activity (PA) provide a
mechanism to be more informed about activity behavior. Consumer devices that track PA
behavior are increasingly popular for consumers, researchers, clinicians and of interest to
the National Institutes of Health66 who recognize the value of using sensor-based
wearable monitors to assess PA behaviors. Consumers are using these devices to monitor
and track personal PA. In many cases, clinicians and researchers are using consumer
devices to track change in PA behavior44 and to assess PA exposure170 and outcomes.165
Currently, there are at least 149 active or recruiting clinical trials funded by NIH that are
employing consumer ATs to measure (estimate) change in PA behaviors such as energy
expenditure (EE) and/or steps. 67
The research and clinical communities have rapidly adapted ATs, however, their
utility within these communities has yet to be realized. Moreover, unlike research-grade
devices that have been utilized by the research and clinical communities in the past, ATs
have yet to undergo rigorous testing in both laboratory and free-living settings. In
particular, there is no evidence examining the effectiveness of ATs for detecting change
in PA behaviors in free-living settings. This knowledge gap is of major concern since
ATs are widely used to monitor change in PA behaviors. Therefore, the aims of the
present study were to: 1) examine the ability of ATs to detect change in PA and ST in
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free-living settings and 2) examine the ability of research-grade accelerometers to detect
change in PA and ST in free-living settings.
Methods
Procedures
The data used in the present study are from our previous study, “Validation of
Consumer and Research-Grade Activity Monitors in Free-Living Settings.” Briefly,
thirty-two healthy men and women (50% female, 37.5% minority; mean ± SD: Age =
32.3 ± 13.3 years; BMI = 24.4 ± 3.3 kg·m-2) were directly observed while completing
three, 2-hour visits on different days. During these visits, participants wore several
different ATs, research-grade devices and a biometric shirt. At the end of each visit, data
from all devices were recorded and processed for analysis. For comparison, a validated
DO system (The Observer XT) was used to compute criterion measures for activity and
sedentary time outcomes. (See Tables 12 and 13 for detailed description of devices).

Data Processing and Statistical Evaluation
For both the criterion measure and the device estimates, we calculated the
differences between the visits (i.e. visit 1 minus visit 2, visit 1 minus visit 3 and visit 2
minus visit 3) for estimated steps, EE (Except AGwrist. No validated EE estimates from
a wrist-worn AG), activity minutes, and or sedentary time. We then classified the
criterion and device measured outcomes for visit-to-visit change into one of three
categories: increase, no change or decrease where an increase or decrease was defined as
a change that was greater than the within-subject standard deviation of the criterion
measure (estimated by a linear-mixed model). Finally, confusion matrices were used to
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determine percent agreement between criterion visit-to-visit change and device visit-tovisit change.

All data cleaning, processing and analysis were performed using the open source
R statistical software package (www.r-project.org) and computing language R. 136

Results

Table18 shows percent agreement between criterion measured visit-to-visit
change and device estimated visit-to-visit change for each output metric. Correct
classification of steps ranged from 79.2% (AiW) to 93.3% (MFS and WP). Correct
classification of energy EE ranged from 71.2% (MB) to 82.1% (AiW). Correct
classification of moderate-to-vigorous physical activity (MVPA) change in minutes
ranged from 77.6% (FBF) to 74.7% (AGwrist). Non-Guideline MVPA minutes
(previously described in study 2, see Table 15 for definitions) ranged from 58.4 (PL) to
73.8% (MFF). Correct classification of sedentary time change ranged from 43.4 % (FBF)
to 53.1% (AGhip).

Figures 40 to 43 illustrate criterion measured visit-to-visit change with FBO (A)
and/or FBF (B) visit-to-visit change, for steps, EE, MVPA minutes and sedentary time.
Correct classifications ranged from 46.8% (sedentary minutes) to 89.1% (steps) and from
43.4% (sedentary minutes) to 88.3% (steps) for the FBO and FBF, respectively.
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Figure 44 illustrates criterion measured visit-to-visit change versus SW visit-tovisit change, for steps (91.1% correct classification).

Figures 46 to 48 illustrate criterion measured visit-to-visit change versus AGhip
(A) and/or AGwrist (B) visit-to-visit change, for steps, EE, MVPA minutes and sedentary
time. Correct classifications ranged from 53.1% (sedentary minutes) to 91.4% (steps) and
from 53.1% (sedentary minutes) to 88.3% (steps) for the AGhip and AGwrist,
respectively.

Discussion
The purpose of the present study was to examine the ability of ATs to detect
change in PA and ST during free-living time. This discussion will highlight key findings
from the FBF and FBO since this AT is the one most widely used in intervention research
and by consumers. Discussion will also include an analysis of the change classification
results for the AG hip, AGwrist and SW research-grade devices (Table 18 presents a
summary of the percent agreement between criterion visit-to-visit change and device
estimated visit-to-visit change for all the outcome measures).

All ATs detected change in PA with varying levels of agreement with criterion
change (see Appendices G – J). For example, percent agreement for ATs that provided
estimates of Non-Guideline MVPA minutes (previously described in study 2, see Table
15 for definitions) ranged from 55.8% (PL) to 71.4% (MFF). Fitbit Flex and FBO
percent agreement for steps, EE and Guideline MVPA minutes (previously described in
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study 2) were 65% or greater. Agreement was lowest for sedentary time (46.8% FBO,
42.3% FBF) (Figures 39-42).
Fitbit and AG change estimates for PA and ST were similar to criterion measures
with a few exceptions. For the hip location, percent agreement for Guideline MVPA
minutes and sedentary time was approximately 8% and 12% higher for the FBO versus
the AGhip, respectively. For the wrist location, percent agreement for Guideline MVPA
minutes was approximately 8% higher for the FBF versus the AGwrist. Additionally,
percent agreement for sedentary time was approximately 30% higher for the AGwrist
versus the FBF. These findings suggest that the hip-worn FBO and FBF may be suitable
alternative devices to research-grade devices for detecting change in free-living steps, EE
and Guideline MVPA minutes. However, accurately estimating change in sedentary time
will require further refinement in prediction models for this behavior.
Currently, there are at least 117 active clinical trials employing the FB as either an
outcome or an exposure measure of PA, and the rate of adoption of this tool is rapidly
increasing.67 To date, the ability of these measurement tools to detect increases,
decreases or no change in PA behaviors is largely unknown. The evidence from the
present study is the first study addressing this issue. The findings of this study support the
use of this device to detect and monitor changes in free-living steps, EE and Guideline
MVPA minutes. The accuracy of the FB for detecting and monitoring change in ST is
not sufficient and thus changes in ST may be harder to accurately assess from the FB and
AG.
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All research-grade devices (AGhip, AGwrist and SW) detected change in PA (see
Figures 43-46). The highest percent agreement was for steps (88.3% AGwrist, 91.1%
SW, 91.4% AGhip classification), followed by EE (77.0% AGhip classification), MVPA
minutes (71.2% AGwrist, 77.0% AGhip classification) and sedentary time (53.1%
AGhip, 72.7% AGwrist classification). Hip-and ankle-worn research-grade devices have
been examined and been shown to detect change in steps and activity minutes in labbased settings.96,171,172 We were unable to examine changes in EE from the AGwrist since
there are no widely accepted validated algorithms to estimate EE from this wrist-worn
AG. There are no validated EE estimates from a wrist-worn AG.

This study has several strengths. The primary strength was the study design.
These data are from our validation study of AT in free-living settings, where we
employed a validated direct observation (DO) system as the criterion measure.42 Our use
of DO to derive criterion measures of PA and ST is a major advance in this line of
research since previous free-living studies employed accelerometer estimates of activity
and ST as a substitute for gold-standard criterion measures to assess PA.32-34,43-46 Second,
an ecological study setting allowed us to examine AT performance while participants
wore them in their natural environment which has high research-translation value. Third,
the use of within-subject standard deviation (SD) of the criterion measures allowed us to
use an evidence-based behavior cut-point of the minimum outcome level to define
change.

For example, based on our data, if an activity intervention observed a ±3,000

step/2hr change, the FBF could detect this change.
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This study also has limitations. We employed a validated DO system that uses
the Compendium of Physical Activities to apply MET values to activities. The values in
the Compendium do not estimate the energy cost of physical activity in individuals that
account for differences in body mass, adiposity, age, sex, efficiency of movement, and
environmental conditions in which the activities are performed.146 Therefore, it is
possible that activities were misclassified by intensity category, which may have resulted
in inaccuracies of criterion EE, activity minutes and sedentary time.. The trial duration
was another limitation. We observed participants for three, 2-hour time frames versus a
whole-day, thus, our findings may not represent change in whole day behavior.

In summary, the present study is a major advance beyond traditional validation
studies in the lab and simulated free-living studies where activities are performed over
fixed time and activity menu driven fixed time and activity studies. This study used a
novel protocol that is truly free-living, which is relevant to real-life applications. Thus
far, no studies have examined ATs ability to detect change in PA and ST in free-living
settings where these devices are used. Our findings suggest that in general, there is
similar agreement between the hip-worn FBO and FBF with hip- and- wrist-worn AGs in
estimates of change in steps, EE (accept AGwrist) and MVPA minutes (except FBF) with
criterion measured change. However, change in ST was more difficult to detect for the
FB and AGhip.
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Device
Cost
Wear location
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Tracks Calories
Burned
Tracks Active
Time
Tracks Steps
Tracks
Distance
Tracks
Elevation/Stairs
Tracks Sleep
Tracks Heart
Rate
Battery or
Chargeable
Uploading Data
Tracker Display

Apple
iWatch
Sport
$350.99
Wrist

Fitbit Flex

Fitbit One

Garmin
Vívofit

Microsoft
Band

Misfit
Flash

Misfit
Shine

Polar loop

Withings
Pulse

$99.99
Wrist

New
Lifestyles
NL-1000
$54.95
Hip

$79.95
Wrist

$99.95
Clip on
(multiple
locations)

$199.99
Wrist

$29.99
Clip on
(multiple
locations)

$69.99
Clip on
(multiple
locations)

$109.95
Wrist

$119.95
Clip on and
wrist band

✓

✓

✓

✓

✗

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✗

✗

✓

✗

✗

✗

✗

✗

✗

✓

✓
✓

✓
✗

✓
✗

✓
✗

✗
✗

✓
✓

✓
✗

✓
✗

✓
✓

✓
✓

Chargeable
(every 18
hours)
Bluetooth

Chargeable
(every 5
days)
Bluetooth

Chargeable
(every 10+
days)
Bluetooth

Battery
(every 1+
years)
Bluetooth

Chargeable
(every 48
hours)
USB

Battery
(lasts up to
6 months)

Battery
(lasts up to
6 months)

Chargeable
(up to 6
days)
USB

Chargeable
(every 2
days)
Bluetooth

Real-time
data

LED
progress
indicator

Real-time
data

Realtime data

Battery
(up to 18
months)
Real-time
data
Real-time
data

Real-time
data

LED
progress
indicator

LED
progress
indicator

Real-time
data

Real-time
data

Table 15. Features of consumer-based activity trackers
LED, Light-Emitting Diode; USB, Universal Serial Bus

Device (Location)

Output

Data Extraction Method
Upload

Retrieval
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Apple iWatch Sport (W)

EE, steps, active calories, min: exercise, total active time, stand hours

Bluetooth

Apple Activity App

GT3X-BT (W & H)

Steps, min: Sedentary, light, moderate, vigorous

USB cable

ActiLife

Fitbit Flex /One (W/H)

EE, steps, MET-min, min: sedentary, light, moderate, vigorous

Bluetooth

Fitabase

Garmin Vivofit (W)

EE, steps, active calories, %: sedentary, active, highly active

Bluetooth

Garmin Connect™ App

Hexoskin (T)

EE, steps

USB cable

Hexoskin dashboard

Microsoft Band (W)

EE, steps, active min

USB cable

MB dashboard

Misfit Flash/Shine (H/W)

EE, steps, active min: light, moderate, vigorous

Bluetooth

Misfit App

New Lifestyles NL-1000 (H)

Steps, MVPA min

RTD

RTD

The Observer XT (NA)

MET-hours, MET-min

The Observer XT

The Observer XT

Polar Loop (W)

EE, steps, time: lying, sitting, active, sitting, min: stand, walk, run

USB cable

Polar dashboard

StepWatch (A)

Steps

USB cable

StepWatch dashboard

Withings Pulse (H)

EE, steps

Bluetooth

Withings App

Table 16. Device output and data extraction methods
H, hip; W, wrist: T, torso; A, Ankle; NA, not applicable; EE, energy expenditure; min, minutes; MVPA, moderate-to-vigorous
physical activity; MB, Microsoft Band; RTD, real-time display

Device

Output

Definition

Apple iWatch

Exercise minutes

Anything above a brisk walk is classed as exercise. Every full minute of
movement equaling or exceeding the intensity of a brisk walk counts towards
daily Exercise goal (30 min).

Fitbit Flex/One

Active minutes

Activities at or above about 3 METs. Minutes are only awarded after 10
minutes of continuous moderate-to-intense activity.

Misfit Flash/Shine

Light-, moderate-,

No definitions provided.

vigorous- minutes
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NL-1000

MVPA

Moderate-to-vigorous physical activity (MVPA) time accumulation.

Polar Loop

WALK and JOG

Medium and high intensity activity, respectively.

Table 17. Activity tracker intensity outputs and definitions

CRIT
w/i Sub
SD

Device – Percent Agreement (%)
AGhip AGwrist SW AiW FBF

FBO

GV

HxSkin

MB

MFF

MFS

NL

PL

WP

Metric
Steps
±2,809
91.4
88.3
91.1 79.2 88.8 89.1 88.0
89.4
89.1 82.5 93.3 91.4 84.9 93.3
EE
±213.0
77.0
NA
NA 82.1 72.8 76.5 72.3
78.2
71.2 77.2 77.7
NA
74.0 78.2
(kcals)
MVPA
±28.0
77.0
71.2
NA 67.1⨣ 65.2 79.7 NA
NA
NA 71.4⨣ 64.1⨣ 63.5⨣ 55.8⨣ NA
(min)
SED
±41.0
53.1
72.7
NA
NA
42.3 46.8 NA
NA
NA
NA
NA
NA
NA
NA
(min)
Table 18. Percent agreement between criterion measured visit-to-visit change and device estimated visit-to-visit change for
each output metric
CRIT, criterion; Sub, subject: SD, standard deviation; AGhip, hip-worn GT3X-BT; AGwrist, wrist-worn GT3X-BT; SW,
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StepWatch; AiW, Apple iWatch; FBF, Fitbit Flex; FBO, Fitbit One; GV, Garmin Vivofit; HxSkin, Hexoskin; MB, Microsoft Band;
MFF, Misfit Flash; MFS, Misfit Shine; NL, New Lifestyles-1000; PL, Polar Loop; WP, Withings Pulse; MVPA, moderate-tovigorous physical activity; SED, sedentary; min, minutes; EE, energy expenditure; kcals, calories; NA, not applicable;
⨣,

Non-Guideline MVPA minutes.
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Figure 40. Steps: criterion measured visit-to-visit change and Fitbit One (A) Fitbit
Flex (B) visit-to-visit change
The open circles are visit-to-visit change, dotted lines are the criterion measured withinsubject standard deviation, the dashed line is the line of identity, and the shaded areas
illustrate agreement.
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Fitbit Flex Kcals
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Figure 41. Energy expenditure: criterion measured visit-to-visit change and Fitbit
One (A) Fitbit Flex (B) visit-to-visit change
The open circles are visit-to-visit change, dotted lines are the criterion measured withinsubject standard deviation, the dashed line is the line of identity, and the shaded areas
illustrate agreement.
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Figure 42. Moderate-to-vigorous physical (MVPA): criterion measured visit-to-visit
change and Fitbit One (A) and Fitbit Flex (B) visit-to-visit change
The open circles are visit-to-visit change, dotted lines are the criterion measured withinsubject standard deviation, the dashed line is the line of identity, and the shaded areas
illustrate agreement.
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Figure 43. Sedentary time: criterion measured visit-to-visit change and Fitbit Flex
(A) and Fitbit One (B) visit-to-visit change
The open circles are visit-to-visit change, dotted lines are the criterion measured withinsubject standard deviation, the dashed line is the line of identity, and the shaded areas
illustrate agreement.
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Figure 44. Steps: criterion measured visit-to-visit change and ActiGraph hip (A)
ActiGraph wrist (B) visit-to-visit change
The open circles are visit-to-visit change, dotted lines are the criterion measured withinsubject standard deviation, the dashed line is the line of identity, and the shaded areas
illustrate agreement.
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Figure 45. Steps: criterion measured visit-to-visit change and StepWatch visit-tovisit change
The open circles are visit-to-visit change, dotted lines are the criterion measured withinsubject standard deviation, the dashed line is the line of identity, and the shaded areas
illustrate agreement.
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% Agreement
76.0

Figure 46. Energy expenditure: criterion measured visit-to-visit change and
ActiGraph hip visit-to-visit change
The open circles are visit-to-visit change, dotted lines are the criterion measured withinsubject standard deviation, the dashed line is the line of identity, and the shaded areas
illustrate agreement.
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Figure 47. Moderate-to-vigorous physical (MVPA): criterion measured visit-to-visit
change and ActiGraph hip (A) and ActiGraph wrist (B) visit-to-visit change
The open circles are visit-to-visit change, dotted lines are the criterion measured withinsubject standard deviation, the dashed line is the line of identity, and the shaded areas
illustrate agreement.
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Figure 48. Sedentary time: criterion measured visit-to-visit change and ActiGraph
hip (A) and ActiGraph wrist (B) visit-to-visit change
The open circles are visit-to-visit change, dotted lines are the criterion measured withinsubject standard deviation, the dashed line is the line of identity, and the shaded areas
illustrate agreement.
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CHAPTER 7
OVERALL SUMMARY AND CONCLUSIONS
The overall goal of this dissertation was to develop a comprehensive
understanding of AT estimates of PA and SB using innovative methods to address critical
knowledge gaps in the field of PA and health.
Study One
This study was the first to examine AT performance under highly
controlled conditions using an electronic orbital shaking protocol. We showed that, on
average, the NL produced the smallest error and detected steps similar to our reference
(AG) at a 0.9 Hz (corresponding to moderate intensity) and maintained this small error up
to a 3.0 Hz (corresponding to very vigorous intensity). Estimates from all other ATs
were equivocal, with some overestimating steps or EE, and others underestimating steps
or EE compared to the AG. Isolating devices from external influences allowed us to
glean valuable insight. There is strong evidence of differences in prediction algorithms
by device. Shaking devices across a wide range of frequencies in short increments
allowed us to understand how the behavior of the output from the ATs changed across
different oscillation frequencies. We were able to also associate oscillation frequencies
with intensity levels to provide PA context.
Study Two
In study two, we compared consumer ATs and research-grade activity monitors
with DO in free-living settings. Estimates of PA and ST from three research-grade
accelerometers and 11 activity monitors during 192 DO-hours were analyzed. The
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innovation of study two was rooted in the DO criterion measure. We are the first to
provide evidence of AT estimates of PA and SB in free-living settings compared to DO.
This unique dataset revealed that ATs are accurate with varying precision in estimating
PA behaviors in free-living settings. Additionally, ATs and research-grade
accelerometers perform similarly (e.g. more accurate in estimating steps and less accurate
in estimating MVPA minutes [Table 13]). For all devices, step estimates were accurate
and strongly correlated but EE and MVPA estimates were less accurate and more
variable but at least moderately correlated. For ATs, estimates of sedentary time were the
least accurate and weakly correlated with criterion measures. These findings may stem
from the fact that typically, acceleration signals (e.g. vertical accelerations) are used to
detect steps, however, ATs use proprietary prediction equations to estimate EE, MVPA
and sedentary time. These methods work for some individuals and for others they do not.
Implications from this novel study are that consumers and the research community using
ATs such as Fitbit, to track steps can be confident in their estimates of PA but less
confident in estimating sedentary time. This study advances our understanding of the
performance characteristics of ATs in free-living natural settings using a validated DO
method to derive PA and SB measures.
Study Three
To date, more than 230 clinical trials have used Fitbit to measure PA behaviors as
an outcome and/or exposure,67 for example, daily step accumulation pre and post PA
behavior intervention. Until the current study, no evidence existed of ATs ability to
detect change in PA behaviors in free-living settings. Study three was pioneering as it
addressed this knowledge gap by examining the ability of ATs to detect change in PA
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and SB in free-living settings. Our findings suggested that in general, there is similar
agreement between the hip-worn FBO and FBF with hip- and- wrist-worn AGs in
estimates of change in PA behaviors with criterion measured change. However, change
in SB was more difficult to detect for the FBO, FBF and AGhip. Results from study two
suggest that the reason for the poorer performance to detect SB change is related to the
large bias and inaccuracies of these devices in estimating SB. Results from this
innovative study have significant implications regarding the deployment of ATs to
estimate PA and SB exposure and outcome measures. We have advanced the field by
translating our findings from study two into real-world applications. For example, as an
alternative to research-grade accelerometers, researchers may employ FB to measure step
accumulation pre- and post-intervention and have confidence in FB step estimates. If the
goal of the intervention was to increase steps/2-hrs beyond baseline, average 2-hr step
count from the FB should be able to detect that change. Our findings are applicable to
activity monitor users worldwide and should be used to disseminate a positive public
health message. For example, using activity monitors to promote increasing PA and
decreasing ST to produce positive health outcomes.
.
Strengths
Study one was the first to employ electronic orbital shaker testing over a wide
range of frequencies to examine AT estimates of steps and EE compared to a widely used
research-grade accelerometer. The orbital shaker methods remove the subject to subject
variation. As a result, we are confident that observed differences are due to technological
features of the devices and are not a function of human variation.
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For studies two and three we employed a validated DO system as the criterion
measure.42 An ecologically valid study setting allowed us to examine AT performance
while participants wore these devices in their natural environment. Other strengths were
the wide range of activities (sleep to trail running), intensities (1.0 to 12.0 METs),
activity duration (seconds to hours) and the range of settings and times used for data
collection.
In study three, we used the within-subject standard deviation (SD) of the criterion
measures to define change, which allowed us to use an evidence-based behavior cut-point
of the minimum outcome level to define change.
Limitations
A limitation was that we used the EE estimates from Freedson VM3
equation which was developed via human-testing.52 Though studies have provided
evidence that sensor output is often calibrated during standardized activities such as
walking on a treadmill, 154 applying the same algorithm to electronic oscillations may be
inappropriate.
In studies two and three the DO procedures used to derive PA and ST measures
are not ideal. We employed a validated DO system that uses the Compendium of
Physical Activities to apply MET values to activities. The values in the Compendium do
not estimate the energy cost of PA in individuals in ways that account for differences in
body mass, adiposity, age, sex, efficiency of movement, and environmental conditions in
which the activities are performed.146 Therefore, it is possible that activities were
misclassified by intensity category, which may have resulted in inaccuracies of activity
minutes, sedentary time and EE. The study trial duration was another limitation for study
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two. We observed participants for three, 2-hour time frames versus whole-day. Thus, our
findings may not be a true representation of whole day behavior. Misclassifications may
have impacted study three in at least two ways: (1) the magnitude and direction of visitto-visit change and, (2) within-subject SD of visit-to-visit change.
Significance and Future Directions
Each study in the present dissertation provides new evidence of wearable monitor
estimates of PA and ST. Study one, shows how electronic orbital shaking affects device
output. Ultimately, these data provided clear evidence of differences in algorithm by
device. The evidence from study two offers a major new contribution to the field of PA
measurement. We reported how AT estimates of PA and ST performed under free-living
settings. In study three we employed analytic procedures that defines translational
research. Our evidence examining the detection of change in PA and ST provides direct
meaning and value in using these devices for research, clinical applications and the
individual consumer.
Collectively, these studies provide the foundation to building a more
comprehensive understanding of the performance characteristics of consumer and
research-grade monitors. This is the first evidence detailing how these devices behave in
highly controlled and free-living settings. The study designs and data should become the
foundation for future work in this field and can be used as evidence for best practices in
activity monitor validation studies.
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University of Massachusetts Amherst
108 Research Administration Bldg.
70 Butterfield Terrace
Amherst, MA 01003-9242

Research Compliance
Human Research Protection Office (HRPO)
Telephone: (413) 545-3428
FAX: (413) 577-1728

Certification of Human Subjects Approval
Date:

May 11, 2015

To:

Albert Mendoza, Kinesiology

Other Investigator:

Patty Freedson, Kinesiology

From:

Lynnette Leidy Sievert, Chair, UMASS IRB

Protocol Title:Validation of activity trackers in estimating energy expenditure, activity minutes and steps in free-living settings
Protocol ID: 2015-2492
Review Type:EXPEDITED - NEW
Paragraph ID: 4,6
Approval Date: 05/11/2015
Expiration Date:05/10/2016
OGCA #:115-0883
This study has been reviewed and approved by the University of Massachusetts Amherst IRB, Federal Wide Assurance # 00003909. Approval is
granted with the understanding that investigator(s) are responsible for:
Modifications - All changes to the study (e.g. protocol, recruitment materials, consent form, additional key personnel), must be submitted for
approval in e-protocol before instituting the changes. New personnel must have completed CITI training.
Consent forms - A copy of the approved, validated, consent form (with the IRB stamp) must be used to consent each subject. Investigators must
retain copies of signed consent documents for six (6) years after close of the grant, or three (3) years if unfunded.
Adverse Event Reporting - Adverse events occurring in the course of the protocol must be reported in e-protocol as soon as possible, but no later
than five (5) working days.
Continuing Review - Studies that received Full Board or Expedited approval must be reviewed three weeks prior to expiration, or six weeks for Full
Board. Renewal Reports are submitted through e-protocol.
Completion Reports - Notify the IRB when your study is complete by submitting a Final Report Form in e-protocol.
Consent form (when applicable) will be stamped and sent in a separate e-mail. Use only IRB approved copies of the consent forms, questionnaires,
letters, advertisements etc. in your research.
Please contact the Human Research Protection Office if you have any further questions. Best wishes for a successful project.
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Consent Form for Participation in a Research Study
University of Massachusetts Amherst

Researcher(s):
Study Title:
Funding Agency:

Albert Mendoza, M.S., Principal Investigator, Dr. Patty Freedson,
Amanda Hickey, M.S.
Validation of Activity Trackers in Estimating Energy Expenditure,
Activity Minutes and Steps in Free-living Settings
NIH: National Heart, Lung, and Blood Institute

1. WHAT IS THIS FORM?
This form is called the Informed Consent. It will give you information about the study so you can
make an informed decision about participation in this research. This information will outline
everything you will need to do to participate and any known risks, discomfort, or inconveniences
that may occur during your participation in this research. Feel free to ask questions at any time.
If you decide to participate in this study, you will be asked to sign this form and initial each page.
You will be given a copy for your records.
2. WHO IS ELIGIBLE TO PARTICIPATE?
To participate in this study:
(1) You must be between 18 and 59 years of age, and women must not be pregnant.
(2) You must be in good physical health (no diagnosed cardiovascular, metabolic, joint, or
chronic diseases).
(3) You must be able to do normal daily activities and are not limited by musculoskeletal
problems that would impair your ability to be normally active.
(4) You must be willing to comply with the study protocol described below.
3. WHAT IS THE PURPOSE OF THIS STUDY?
The purpose of this study is to determine the accuracy and precision of activity trackers in
estimating energy expenditure, activity minutes and steps in free-living settings. Researchers will
also examine whether activity trackers can detect changes in your activity behavior (e.g. classify
you as inactive or active) in free-living settings.
4. WHERE WILL THE STUDY TAKE PLACE AND HOW LONG WILL IT LAST?
The study will consist of four visits.
Visit One: Informed consent visit will take place in the Physical Activity and Health Lab on the
UMass Amherst campus (~30 min).
Visits 2, 3 and 4: Observations sessions: Each of the observation visits will last 2-hrs and 15
min: 10 min to put on monitors, 2-hrs of observation while you perform normal daily activities, 5
min to remove monitors.
Your total time commitment while participating in this study will be approximately 7.25 hours
over a 3 week time period. After the fourth visit your participation in the study will be complete.
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(413) 545-3428
Approval Date: 04/12/2016
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5. WHAT WILL I BE ASKED TO DO?
If you agree to participate in this study during the first visit you will be asked to initial the bottom
of each page of this informed consent and sign the last page. During the first visit you will fill out
a Physical Activity Status (PAS) Questionnaire and a Physical Activity Readiness Questionnaire
(PAR-Q), which will ask questions about how active you are and if you have any injuries or
health impairments that prevent you from physical activity. Based on your answers to the
questionnaire you may not qualify for this study. Then you will also fill out a School of Public
Health Compensation Form and a W9 form. Researchers will record your height and weight
and demographic information like your date of birth and ethnicity (Visit One). You may skip any
question you feel uncomfortable answering. You will then be scheduled for 3, 2-hr and 15 min
testing sessions including one weekend testing session (Visits 2, 3 and 4). The first visit will be
approximately 30 minutes.
Visits 2, 3 and 4. Each of the 2-hr 15 min observation sessions (scheduled at the end of Visit
1) will be done at different times of the day (e.g. Session one: morning; Session 2: afternoon;
Session 3: evening), in your free-living settings (e.g. home, work, driving). If/when you drive,
researchers will follow from a safe distance in a separate car. Two researchers (or 1 researcher
and 1 research assistant) will always be present during the observation sessions, and for female
participants, at least one of the 2 researchers will be female. For these three visits, you will
come to the Physical Activity and Health Laboratory to be fitted with a variety of activity monitors
that will be worn on the upper arm, wrists, hip and ankle, and a smart shirt. You will wear 1
monitor on the upper arm, 8 monitors on the wrists (4 on the right wrist and 4 on the left wrist), 2
monitors on the right hip, and 1 smart shirt to be worn as an undergarment. The smart shirt
estimates energy expenditure and steps, as well as respiration (how much you breathe) and
heart-rate. You will then leave the lab with two researchers who will stay with you for the 2-hr
session. The researchers will be video recording you for each of the entire 2-hr sessions while
you carry out your normal activities (including driving). Every attempt will be made to avoid
including your head in these video recordings. If your head does appear in the video we will edit
these shots to blur or eliminate your head from the video recording. If private time is required
(i.e. going to the bathroom), we will not observe you during these private time periods. At the
end of the 2-hr recording period, the researchers will remove the activity monitors, you will
remove the smart shirt in private wherever you feel most comfortable (e.g. restroom or secured
room) and your testing session is complete. Your data from these monitors will be downloaded
to computer. Visits 2, 3 and 4 will each take approximately 2 hours and 15 minutes.
6. WHAT ARE MY BENEFITS OF BEING IN THIS STUDY?
You may not directly benefit from this research; however we hope that your participation in the
study may provide valuable information about the accuracy and precision of activity monitors in
free-living settings and will provide evidence about how the consumer monitors compare to one
another (using direct observation/video recording as the criterion [truth] measure) for estimating
energy expenditure, activity minutes, steps and sedentary time. Once all data are collected and
analyzed, we will provide you with your results that will describe the number of minutes you
were active and sedentary during the observation periods and your estimated activity energy
expenditure and steps during the observation periods.
7. WHAT ARE MY RISKS OF BEING IN THIS STUDY?
All possible attempts will be made to minimize any risks. The risks are minimal and are simply
risks that occur carrying out your normal daily activities. We will not ask you to do anything out
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of the ordinary pattern of what you would typically do. You may be uncomfortable with the video
recording but we will make every attempt to record your body movements without your head
being recorded. In the event your head is recorded we will use our software to blur or edit out
your face from all video recordings when the recordings are downloaded into the computer.
You may notice that you are wearing several devices on your upper arm, wrists, hip, and ankle,
and a smart shirt. There is a very minimal risk that a device or devices you are wearing become
uncomfortable or cause you discomfort. You are free to remove any device and/or the smart
shirt if you feel that causes you a problem during the observation sessions.
8. HOW WILL MY PERSONAL INFORMATION BE PROTECTED?
The information obtained in this study will be regarded as privileged and confidential. If the
results of this study are published in a scientific journal or presented at a scientific meeting, your
name will not be used. All records, including questionnaire data, activity monitor data, and video
data will be identified only with a numerical ID. Activity monitor data will be stored on a
password protected PC and a password protected portable hard drive (portable hard drive will
be stored in a locked file cabinet). Video data will be downloaded into a PC and portable hard
drive (hard drive will be stored in locked file cabinet). The video data will then be deleted from
the camera. All efforts will be made to not capture your head in the video recordings. In the
event that head data are contained in the video file, we will either blur the face images or edit
these images out of the video recording. After we code the data from the PC files, we will delete
this record and will only keep the video record stored on the hard drive in the event we have to
go back to review and verify coding.
9. WILL I RECEIVE ANY PAYMENT FOR TAKING PART IN THE STUDY?
Payment will be sent as a check by mail to the address you provide in 6-8 wks. You will receive
partial payment if you decide to leave the study at any point. For each 2-hr observation period
completed, you will receive $25.00 (maximum will be $75.00 for completion of all 3, 2-hr
observation sessions). If you complete at least 1-hr of any observation period, you will receive
$12.50. After completing all visits you will be paid $75.00 total.
10. WHAT IF I HAVE QUESTIONS?
You are encouraged to ask any questions, voice any concerns or doubts regarding the study at
any time. Investigators will attempt to answer all questions to the best of their ability. The
investigators fully intend to conduct the study with your best interest, safety, and comfort in mind.
Mr. Mendoza can be reached at 413.545.1583 or by cell at 415.297.9327, Professor Freedson
can be reached at 413.545.2620 and Ms. Hickey may be reached at 413.545.1583. If you would
like to discuss your rights as a participant in a research study or wish to speak with someone not
directly involved with the study you may contact the Human Research Protection Office at
humansubjects@ora.umass.edu.
11. CAN I STOP BEING IN THE STUDY?
Participation in this study is completely voluntary. You may withdraw consent at any time in
writing or by telephone (413.545.1583) and discontinue participation in the study without
prejudice to you or your medical care at UMass Amherst.
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12.WHAT IF I AM INJURED?
In the unlikely event of an injury resulting directly from participation in this study, investigators
will assist you in every way to insure that you receive proper medical attention. The University of
Massachusetts does not have a program to compensate subjects for injury or complications
related to human subjects research but the study personnel will assist you in getting treatment.
It also should be understood that by your agreement to participate in this study, you are not
waiving any of your legal rights.
13. SUBJECT STATEMENT OF VOLUNTARY CONSENT
I confirm that this document has explained the purpose of the research, the study procedures
that I will undergo and the possible risks and discomforts as well as the benefits I may
experience. I have read and I understand the consent form. Therefore, I agree to participate in
this study.
Recall, that the video will not include your face.
______I agree that segments of the recordings made of my participation
in this research may be used for conference presentations, as well as
education and training of future researchers/practitioners.

______I agree to have my recordings archived for future research in the
field of Kinesiology.

______I do not agree to have my recordings archived for future
research in the field of Kinesiology.

______I do not agree to allow segments of recordings of my
participation in this research to be used for conference presentations or
education and training purposes.

________________________
Participant Signature:

____________________
Print Name:

__________
Date:

By signing below I indicate that the participant has read and, to the best of my knowledge,
understands the details contained in this document and has been given a copy.
_________________________
Signature of Person
Obtaining Consent

____________________
Print Name:

__________
Date:

The investigators will retain the original copy of this document for their records. You will be
given a copy of the document if you would like one.
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PHYSICAL ACTIVITY READINESS QUESTIONNAIRE (PAR-Q)
Please read the following questions carefully and answer each one honestly: check
YES or NO.
YES

NO

o

o

1. Has your doctor ever said that you have a heart condition and
that you should only do physical activity recommended by a
doctor?

o

o

2. Do you feel pain in your chest when you do physical activity?

o

o

3. In the past month, have you had chest pain when you were not
doing physical activity?

o

o

4. Do you lose your balance because of dizziness or do you ever
lose consciousness?

o

o

5. Do you have a bone or joint problem that could be made worse
by a change in your physical activity?

o

o

6. Is your doctor currently prescribing drugs (for example, water
pills) for your blood pressure or heart condition?

o

o

7. Do you know of any other reason why you should not do
physical activity?

PAR-Q (Thomas, Reading, & Shephard, 1992)
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Participant ID: __________

Date: ______________

Physical Activity Status
Using the descriptions below, record the highest number (0 to 7) which best describes
your general activity level during the previous month. If you did more than section
1, then move on to section 2, and so on. You want to pick the highest number in this
list to represent your activity level.
Section 1: Did not participate regularly in programmed recreational sport or heavy
physical activity.
0

Avoided walking or exertion, e.g. always used the elevator, drove
whenever possible instead of walking.

1

Walked for pleasure, routinely used the stairs, occasionally exercised
sufficiently to cause heavy breathing or perspiration.

Section 2: Participated regularly in recreation or work requiring modest physical
activity, such as golf, horseback riding, calisthenics, gymnastics, table tennis, bowling,
weight lifting, yard work.
2

10 to 60 minutes per week.

3

Over 1 hour per week.

Section 3: Participated regularly in heavy physical exercise such as running or
jogging, swimming, cycling, rowing, skipping rope, running in place or engaged in
vigorous aerobic activity type of exercise such as tennis, basketball, or handball.
4

Ran less than 1 mile per week or spent less than 30 minutes per week
in comparable physical activity.

5

Ran 1 to 5 miles per week or spent 30 to 60 minutes per week in
comparable physical activity.
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6

Ran 5 to 10 miles per week or spent 1 to 3 hours per week in
comparable physical activity.

7

Ran more than 10 miles per week or spent over 3 hours per week in
comparable physical activity.

Physical Activity Status during the previous month (highest score): ______
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Device
Cost
Wear location
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Tracks Calories
Burned
Tracks Active
Time
Tracks Steps
Tracks
Distance
Tracks
Elevation/Stairs
Tracks Sleep
Tracks Heart
Rate
Battery or
Chargeable
Uploading Data
Tracker Display

Apple
iWatch
Sport
$350.99
Wrist

Fitbit Flex

Fitbit One

Garmin
Vívofit

Microsoft
Band

Misfit
Flash

Misfit
Shine

Polar loop

Withings
Pulse

$99.99
Wrist

New
Lifestyles
NL-1000
$54.95
Hip

$79.95
Wrist

$99.95
Clip on
(multiple
locations)

$199.99
Wrist

$29.99
Clip on
(multiple
locations)

$69.99
Clip on
(multiple
locations)

$109.95
Wrist

$119.95
Clip on and
wrist band

✓

✓

✓

✓

✗

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✓
✓

✗

✗

✓

✗

✗

✗

✗

✗

✗

✓

✓
✓

✓
✗

✓
✗

✓
✗

✗
✗

✓
✓

✓
✗

✓
✗

✓
✓

✓
✓

Chargeable
(every 18
hours)
Bluetooth

Chargeable
(every 5
days)
Bluetooth

Chargeable
(every 10+
days)
Bluetooth

Battery
(every 1+
years)
Bluetooth

Chargeable
(every 48
hours)
USB

Battery
(lasts up to
6 months)

Battery
(lasts up to
6 months)

Chargeable
(up to 6
days)
USB

Chargeable
(every 2
days)
Bluetooth

Real-time
data

LED
progress
indicator

Real-time
data

Realtime data

Battery
(up to 18
months)
Real-time
data
Real-time
data

Real-time
data

LED
progress
indicator

LED
progress
indicator

Real-time
data

Real-time
data

LED, Light-Emitting Diode; USB, Universal Serial Bus

APPENDIX F
STUDY INFORMATION SHEET
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ACTIVITY TRACKER
VALIDATION STUDY

• The Physical Activity and Health Lab is conducting a study to test the accuracy of

consumer activity trackers in estimating how active people are
• Participants are directly observed (recorded with a GoPro) while engaging in

their daily activities while wearing several activity trackers
• We are sensitive to participants privacy and those persons of the surrounding

environment
• To ensure privacy preservation:
• Sound is not recorded
• Identities (faces) of all individuals in the video will be blurred
• Individuals will not be identifiable
• This study protocol has been approved by the UMass Amherst Human Subjects

Board (IRB)
• If further clarification is needed please contact:
• Dr. Patty Freedson at 413-545-2620 or psf@kin.umass.edu
• Albert Mendoza at 413-545-1583 or amendoza@kin.umass.edu
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ESTIMATED VISIT-TO-VISIT CHANGE
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AG Wrist Steps

10000
5000
0
-10000

-5000

0

5000

10000

15000

-10000

-5000

0

5000

10000

15000

Criterion Visit to Visit Change

Criterion Visit to Visit Change

StepWatch Steps

NL-1000 Steps

10000
5000
0
-5000
-10000

-10000

-5000

0

5000

10000

Device Visit to Visit Change

15000

15000

-10000

Device Visit to Visit Change

-5000

Device Visit to Visit Change

10000
5000
0
-5000
-10000

Device Visit to Visit Change

15000

15000

AG Hip Steps

-10000

-5000

0

5000

10000

15000

-10000

Criterion Visit to Visit Change

-5000

0

5000

10000

15000

Criterion Visit to Visit Change
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Fitbit Flex Steps

10000
5000
0
-10000

-5000

0

5000

10000

15000

-10000

-5000

0

5000

10000

15000

Criterion Visit to Visit Change

Criterion Visit to Visit Change

Misfit Flash Steps

Misfit Shine Steps

10000
5000
0
-5000
-10000

-10000

-5000

0

5000

10000

Device Visit to Visit Change

15000

15000

-10000

Device Visit to Visit Change

-5000

Device Visit to Visit Change

10000
5000
0
-5000
-10000

Device Visit to Visit Change

15000

15000

Fitbit One Steps

-10000

-5000

0

5000

10000

15000

-10000

Criterion Visit to Visit Change

-5000

0

5000

10000

15000

Criterion Visit to Visit Change
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Polar Loop Steps

10000
5000
0
-10000

-10000

-5000

0

5000

10000

15000

-10000

-5000

0

5000

10000

15000

Criterion Visit to Visit Change

Apple iWatch Steps

Microsoft Band Steps

10000
5000
0
-5000
-10000

-5000

0

5000

10000

Device Visit to Visit Change

15000

15000

Criterion Visit to Visit Change

-10000

Device Visit to Visit Change

-5000

Device Visit to Visit Change

10000
5000
0
-5000
-10000

Device Visit to Visit Change

15000

15000

Garmin Vivofit Steps

-10000

-5000

0

5000

10000

15000

-10000

Criterion Visit to Visit Change

-5000

0

5000

10000

15000

Criterion Visit to Visit Change
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Hexoskin Steps

10000
5000
-5000

0

Device Visit to Visit Change

10000
5000
0
-5000
-10000

Device Visit to Visit Change

15000

15000

Withings Pulse Steps

-10000

-5000

0

5000

10000

15000

-5000

Criterion Visit to Visit Change

0

5000

10000

15000

Criterion Visit to Visit Change
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ENERGY EXPENDITURE: CRITERION MEASURED VISIT-TO-VISIT
CHANGE WITH DEVICE ESTIMATED VISIT-TO-VISIT CHANGE
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500
0
-1000

-500

0

500

1000

-1000

-500

0

500

1000

Criterion Visit to Visit Change

Criterion Visit to Visit Change

Fitbit One Kcals

Fitbit Flex Kcals

500
0
-500

-500

0

500

Device Visit to Visit Change

1000

1000

-1000

Device Visit to Visit Change

-500

Device Visit to Visit Change

500
0
-500
-1000

Device Visit to Visit Change

1000

Polar Loop Kcals

1000

AG Hip Kcals

-500

0

500

1000

-500

Criterion Visit to Visit Change

0

500

1000

Criterion Visit to Visit Change
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1000
-1000

-1000

0

1000

2000

-1000

0

1000

Apple iWatch Kcals

Garmin Vivofit Kcals

2000

1000
0
-1000
-2000

-1000

0

1000

Device Visit to Visit Change

2000

Criterion Visit to Visit Change

2000

Criterion Visit to Visit Change

-2000

Device Visit to Visit Change

0

Device Visit to Visit Change

1000
0
-1000

Device Visit to Visit Change

2000

Misfit Shine Kcals

2000

Misfit Flash Kcals

-2000

-1000

0

1000

2000

-2000

Criterion Visit to Visit Change

-1000

0

1000

Criterion Visit to Visit Change
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2000

500
0
-1000

-500

Device Visit to Visit Change

500
0
-500
-1000

Device Visit to Visit Change

1000

Withings Pulse Kcals

1000

Microsoft Band Kcals

-1000

-500

0

500

1000

-1000

Criterion Visit to Visit Change

-500

0

500

1000

Criterion Visit to Visit Change
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APPENDIX I
MODERATE-TO-VIGOROUS PHYSICAL ACTIVITY (MVPA): CRITERION
MEASURED VISIT-TO-VISIT CHANGE WITH DEVICE ESTIMATED VISITTO-VISIT CHANGE
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AG Wrist MVPA

50
-50

0

Device Visit to Visit Change

50
0
-50

Device Visit to Visit Change

100

100

AG Hip MVPA

-50

0

50

100

-50

50

Criterion Visit to Visit Change

Fitbit One MVPA

Fitbit Flex MVPA

100

50
-50

0

0

50

Device Visit to Visit Change

100

100

Criterion Visit to Visit Change

-50

Device Visit to Visit Change

0

-50

0

50

100

-50

Criterion Visit to Visit Change

0

50
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